Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.151035033112071,0.00295875904255626,0.145235865388661,0.156834200835481,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,39858,-0.175888144677187,0.00413797964086849,-0.18399858477329,-0.167777704581085,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.125017005367617,0.00287381176788095,0.11938433430257,0.130649676432663,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,39477,-0.446075346818728,0.0117255567974514,-0.469057438141733,-0.423093255495723,6.17549152426772e-303
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,37437,-0.136035552425318,0.00385435500704748,-0.143590088239132,-0.128481016611505,3.78816034920193e-261
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,37437,-0.276297812980665,0.00790367182745653,-0.29178900976248,-0.260806616198851,1.89891206450425e-256
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39931,0.091191421663801,0.00271502026520354,0.085869981944002,0.0965128613835999,4.30635597499133e-239
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,39805,-0.119615930255041,0.00388235705101955,-0.127225350075039,-0.112006510435042,1.5773761710037e-202
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,37021,-0.266365216296929,0.00896356473878225,-0.283933803184942,-0.248796629408916,7.01720627485996e-188
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40017,0.345272120613019,0.0119598798982008,0.321830756012546,0.368713485213493,9.72545699071315e-179
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,37445,0.0726814250212509,0.00251565539818085,0.0677507404408164,0.0776121096016854,3.51147320426279e-178
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C9,Complement component C9,37445,0.146544523807855,0.00515833321556501,0.136434190705347,0.156654856910362,1.63051903762322e-172
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,40030,-0.18273444900309,0.00645520830431052,-0.195386657279538,-0.170082240726641,4.20932125405134e-172
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,40058,-0.143609799729197,0.00521899044464195,-0.153839021000695,-0.133380578457698,6.03649783243807e-163
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,40009,-0.364102505066483,0.013531976644812,-0.390625179290314,-0.337579830842651,4.93621202279757e-156
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39749,-0.075490754583293,0.00284326229724297,-0.0810635486858892,-0.0699179604806968,5.11551548294527e-152
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,39854,-0.203651615227153,0.00777664692950461,-0.218893843208982,-0.188409387245324,4.77741547700662e-148
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,39882,-0.134259278315885,0.00513233207503199,-0.144318649182948,-0.124199907448822,9.55957602360457e-148
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37368,-0.141282235512209,0.00544174973370379,-0.151948064990268,-0.130616406034149,4.59522128358199e-145
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,39788,-0.2256160838403,0.00872285319166706,-0.242712876095967,-0.208519291584633,1.56674734813898e-144
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,39868,0.117095319128353,0.00462825827675465,0.108023932905914,0.126166705350792,1.65556629692065e-138
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,40030,0.0835479003419695,0.00344226673567689,0.0768010575400428,0.0902947431438962,7.57750357178414e-128
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,39976,0.084125346097704,0.00352249063074005,0.0772212644614535,0.0910294277339544,6.58302570921762e-124
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,37453,0.154044879446321,0.0064798747924382,0.141344324853142,0.1667454340395,1.97880057573056e-122
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,39908,0.0620265706525078,0.00261462524704562,0.0569019051682984,0.0671512361367172,2.64171244476243e-122
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,39858,-0.0956054499133175,0.00406545335928676,-0.10357373849752,-0.0876371613291154,3.00339502318865e-120
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37124,0.0688865424964219,0.00295375730168467,0.0630971781851199,0.0746759068077238,6.20850153237316e-118
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,39585,-0.146135333770165,0.00630048783082533,-0.158484289918582,-0.133786377621747,4.7545495442527e-117
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,40011,-0.263192518029354,0.0117175336670586,-0.286158884016788,-0.240226152041919,4.76880861719496e-110
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,39866,-0.116213233897015,0.00520167674992961,-0.126408520326877,-0.106017947467153,6.71293216485434e-109
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,39644,0.118307331389198,0.00529805477787216,0.107923144024568,0.128691518753827,9.01511785230143e-109
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,39840,0.0969384831004592,0.00444894567119809,0.088218549584911,0.105658416616007,9.4868642688618e-104
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39949,-0.0988667610760577,0.0046486161914996,-0.107978048811397,-0.0897554733407185,5.1631263362804e-99
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,39858,0.074873325427382,0.00360632714576634,0.0678049242216799,0.081941726633084,1.6892111071174e-94
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,39955,-0.0702119349662913,0.00339345038956176,-0.0768630977298323,-0.0635607722027502,7.01862409010683e-94
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,39904,-0.0677021489899226,0.0032865966994005,-0.0741438785207476,-0.0612604194590977,4.42925518309771e-93
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,40009,0.0430063438692376,0.00210056599244956,0.0388892345240365,0.0471234532144387,5.42575285435026e-92
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,39868,-0.123247030042724,0.00608460406154052,-0.135172854003343,-0.111321206082104,4.26211576186618e-90
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,39949,0.0550613087784017,0.00273192485229931,0.049706736067895,0.0604158814889083,3.0808266186699e-89
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FURIN,Furin,39913,-0.0670128658666574,0.00333858283818048,-0.0735564882294912,-0.0604692435038237,1.57005664429449e-88
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,39758,-0.150769726980734,0.00753611191250581,-0.165540506329246,-0.135998947632223,5.85470555898509e-88
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,37039,-0.157775571921458,0.00788135136619947,-0.173223020599209,-0.142328123243707,7.5880487556133e-88
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,40052,-0.102652050061469,0.00514225364251671,-0.112730867200801,-0.0925732329221358,1.31955593584863e-87
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,39862,-0.103702808825857,0.00519680158313764,-0.113888539928806,-0.0935170777229068,1.56665250564463e-87
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,39826,-0.195121398512994,0.00987621623938535,-0.21447878234219,-0.175764014683799,7.43705607150733e-86
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39931,0.0635268027144826,0.0032265885801829,0.0572026890973241,0.069850916331641,2.73084193505434e-85
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,37043,-0.0845806505280925,0.0043083145767478,-0.0930249470985182,-0.0761363539576668,1.32624662551581e-84
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37254,-0.0494864342281405,0.00252368518731935,-0.0544328571952864,-0.0445400112609946,1.97834100233155e-84
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40052,0.0655774682651454,0.00335200410087762,0.0590075402274252,0.0721473963028655,2.95962669698659e-84
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,39587,-0.151953244580655,0.00780626734999819,-0.167253528586652,-0.136652960574659,2.05835618508832e-83
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39820,-0.102020411282457,0.00527151975455702,-0.112352590001389,-0.0916882325635257,1.68886538264017e-82
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,39858,0.0506161606563286,0.00263167969376722,0.0454580684565449,0.0557742528561124,1.61574966725933e-81
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,39843,0.0596231093112342,0.00310208150008717,0.0535430295710633,0.065703189051405,2.0701881049484e-81
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,39919,-0.111190207642953,0.0057964951529934,-0.12255133814282,-0.0998290771430863,4.19423192231263e-81
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,40030,-0.0626833003397201,0.00327103992636591,-0.0690945385953973,-0.0562720620840429,5.93353134004155e-81
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,39868,-0.117906962398741,0.00617014212964042,-0.130000440972836,-0.105813483824646,1.66274017779676e-80
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36838,-0.059489626916572,0.00315738928974318,-0.0656781099244687,-0.0533011439086754,3.80226129006782e-78
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,37124,-0.0536119387392248,0.00284617349823671,-0.0591904387957688,-0.0480334386826809,3.95493187449889e-78
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,-0.101323515297518,0.00540456026415078,-0.111916453415253,-0.0907305771797823,1.41304361297831e-77
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39489,-0.0943245247229053,0.00504190468838354,-0.104206657912137,-0.0844423915336736,2.96366326107475e-77
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,39839,-0.0531538584997515,0.00285497229367971,-0.0587496041953637,-0.0475581128041392,1.48087266357205e-76
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37410,0.0888576188621707,0.00477692019039828,0.07949485528899,0.0982203824353513,2.77967611542993e-76
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,-0.108597560347344,0.00584896653602693,-0.120061534757957,-0.0971335859367312,3.91997674471659e-76
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39868,0.0491668257361946,0.00265100902772689,0.0439708480418499,0.0543628034305393,5.44284232045981e-76
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,38721,-0.0719444565014805,0.00388346435598655,-0.0795560466392141,-0.0643328663637469,9.09855428909523e-76
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,37445,0.094390528140375,0.00509729790294609,0.0843998242506006,0.104381232030149,1.26286161393192e-75
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,36780,0.0784489789728777,0.00428527886782237,0.0700498323919458,0.0868481255538095,6.28556412842881e-74
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39908,0.0518323527581098,0.00284334549308209,0.0462593955916689,0.0574053099245507,1.66423600607456e-73
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39585,-0.260674193073334,0.0143184122189104,-0.288738281022398,-0.232610105124269,2.63895284586312e-73
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40012,0.111435899001511,0.00613732861923957,0.0994067349078018,0.123465063095221,5.99597318843096e-73
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,39899,-0.0535236554372083,0.00295799334435483,-0.0593213223921437,-0.0477259884822728,1.84659852298762e-72
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,39908,-0.0324410773905711,0.00179816069369965,-0.0359654723502224,-0.0289166824309198,4.75690632527459e-72
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,39879,0.0348217199632224,0.00193104507972409,0.0310368716069632,0.0386065683194816,5.56452267382998e-72
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,-0.150288088900706,0.00833587019094527,-0.166626394474959,-0.133949783326453,6.10165535942181e-72
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,-0.0563738894095972,0.00313468184357893,-0.0625178658230119,-0.0502299129961825,1.33411375106207e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,37437,-0.163528495477363,0.00910746552925904,-0.18137912791471,-0.145677863040015,2.89743492774002e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,37124,-0.0730812619218865,0.00409080108944022,-0.0810992320571893,-0.0650632917865837,1.48506913899541e-70
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,-0.109832280518808,0.00617414411483792,-0.121933602983891,-0.0977309580537261,4.21945939851821e-70
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37124,-0.0653573195058963,0.00368514654820794,-0.0725802067403839,-0.0581344322714087,1.4194310095932e-69
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,-0.138422759119542,0.00786150978958438,-0.153831318307127,-0.123014199931957,9.63343031848569e-69
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,39841,-0.146374903723994,0.00840197609179868,-0.162842776863919,-0.129907030584068,2.37454469101275e-67
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,37382,-0.123541102915962,0.00708864978225844,-0.137434856489189,-0.109647349342736,2.74509330854196e-67
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,40003,-0.0328139009442461,0.00191177259302295,-0.0365609752265711,-0.0290668266619211,1.87669438281016e-65
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37368,-0.142628510516129,0.00835793652797887,-0.159010066110968,-0.126246954921291,1.28332184607847e-64
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39948,-0.0520840974280531,0.00307600242608058,-0.058113062183171,-0.0460551326729351,9.25452729209347e-64
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40030,-0.0540024469904345,0.00323527599260491,-0.0603435879359401,-0.0476613060449289,4.97128204337248e-62
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,37437,0.0948405869045342,0.00575729387454185,0.0835562909104321,0.106124882898636,2.20366451036633e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,-0.124891690307313,0.00760141035528458,-0.139790454603671,-0.109992926010955,4.44530633532553e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,39933,-0.104560887232379,0.0063816274463846,-0.117068877027292,-0.0920528974374647,7.51883513099975e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39585,-0.0807398463348054,0.00492871956510957,-0.0904001366824202,-0.0710795559871906,8.10989852608055e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,-0.106602288555456,0.00659318023655217,-0.119524921819098,-0.0936796552918134,2.44776145407452e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,39931,0.0695242345284765,0.00430321835475104,0.0610899265531644,0.0779585425037885,2.94785447321348e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,37382,-0.17683915766881,0.0109492713524,-0.198299729519514,-0.155378585818105,3.92067575313817e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AFM,Afamin,37453,-0.0303481426550727,0.00188075658736575,-0.0340344255663095,-0.0266618597438358,4.91599679817554e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39545,-0.119578135767833,0.00745372985166007,-0.134187446277087,-0.104968825258579,1.84121910443537e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,39489,-0.0802237832289564,0.00501724999263869,-0.0900575932145282,-0.0703899732433846,4.28288719120125e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,-0.0735381114956603,0.00460564525869848,-0.0825651762027093,-0.0645110467886113,6.04599998650291e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39477,-0.130062106160491,0.00818828883961696,-0.146111152286141,-0.114013060034842,2.26250307520955e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,39477,-0.119978619615873,0.00757711893014383,-0.134829772718955,-0.105127466512791,4.92064951241213e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,37411,-0.0693578918141466,0.00440520363372207,-0.0779920909362418,-0.0607236926920513,2.3158093730698e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,37088,-0.0589004195020121,0.0037521060070798,-0.0662545472758885,-0.0515462917281357,4.89715725461498e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MME,Neprilysin,39788,-0.12233954602828,0.00780239239894001,-0.137632235130202,-0.107046856926357,5.36260880942746e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,40058,-0.0527812006200617,0.00336766385910554,-0.0593818217839085,-0.0461805794562148,5.86702686025314e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,40012,0.0814167585758461,0.00522022644701438,0.0711851147396979,0.0916484024119943,1.92125896768703e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,39885,0.0600231539527248,0.00384979550528608,0.0524775547623641,0.0675687531430855,2.09493025221556e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,-0.164679902549022,0.0105657247975561,-0.185388723152232,-0.143971081945812,2.27608311152407e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,0.0593195227767461,0.00381080345794312,0.0518503479991776,0.0667886975543146,3.07675915607884e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39788,-0.134031613964121,0.00861108484739562,-0.150909340265016,-0.117153887663226,3.15655768902244e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,-0.0535228252293389,0.00345028059203779,-0.0602853751897329,-0.0467602752689448,7.01453343310593e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39868,-0.0463628639525401,0.00299225119845698,-0.0522276763015158,-0.0404980516035645,9.30951154921607e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,39931,-0.0630531856713449,0.00407331225506896,-0.0710368776912801,-0.0550694936514098,1.16248087286694e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39788,-0.0830671340681118,0.00539449901800698,-0.0936403521434055,-0.0724939159928181,4.04389007154443e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,40009,-0.0896875332043574,0.00582812869252159,-0.1011106654417,-0.078264400967015,4.6359866389378e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,37043,-0.0793760572828087,0.00517664109537885,-0.0895222738297512,-0.0692298407358661,1.29824873311266e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0555090353359149,0.00363641973307743,0.0483816526590832,0.0626364180127467,3.57184222592589e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELE,E-selectin,40052,-0.0752403003726045,0.00493600705923938,-0.0849148742087137,-0.0655657265364954,4.20470017616579e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POSTN,Periostin,37437,0.0561814693337988,0.00368398946838876,0.0489608499757568,0.0634020886918407,4.43319271244563e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39858,0.04030601389797,0.00264625254251115,0.0351193589146482,0.0454926688812919,5.07393267204321e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,40058,-0.0387515913942258,0.00255113471116936,-0.0437518154281178,-0.0337513673603339,9.37027052011502e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,39949,-0.0467835235197688,0.00308369305190469,-0.052827561901502,-0.0407394851380356,1.24759340374526e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39585,-0.0595479507546773,0.00393204822454746,-0.0672547652747904,-0.0518411362345643,1.90653422580878e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40011,-0.0639596699267022,0.00423208586037315,-0.0722545582130336,-0.0556647816403708,2.97784284709702e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,39858,-0.0840497339376349,0.00560449262763402,-0.0950345394877976,-0.0730649283874722,1.6964842320782e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37437,-0.095980485926282,0.00640805086908633,-0.108540265629691,-0.0834207062228728,2.57392599715274e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,40030,0.0245201433285968,0.00163957093274884,0.021306584300409,0.0277337023567845,3.12012808949588e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,40058,-0.0442762789919271,0.00296976623213181,-0.0500970208069054,-0.0384555371769487,6.17303306153173e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39788,-0.120078114981014,0.00807155864396417,-0.135898369923184,-0.104257860038845,1.00723578111208e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,-0.07697250826544,0.00518392394257854,-0.087132999192894,-0.0668120173379861,1.5141201743607e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,-0.0795695295907029,0.00536086750046038,-0.0900768298916052,-0.0690622292898006,1.66553066100439e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,-0.133669725501355,0.00901737815540141,-0.151343786685941,-0.115995664316768,2.22232654886238e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,37437,-0.0415889181843063,0.00280457183530135,-0.047085878981497,-0.0360919573871157,2.31519754917279e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,37424,0.0548494360057002,0.00371715196256845,0.0475638181590661,0.0621350538523344,6.75864436147545e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,40052,-0.0619388416730285,0.0042059701194427,-0.0701825431071362,-0.0536951402389208,9.02019338720887e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,39788,-0.081537438002829,0.00555556106323287,-0.0924263376867654,-0.0706485383188926,1.8828728952379e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,-0.04778359695532,0.0032619345880643,-0.054176988747926,-0.0413902051627139,2.81318813639042e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,-0.0834450850049181,0.00570489478534093,-0.0946266787841863,-0.0722634912256498,4.50004291128299e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,39974,-0.0368892775636886,0.00252817427481805,-0.041844499142332,-0.0319340559850453,6.45132939645409e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASPN,Asporin,37437,0.0390290090198021,0.00267918050076191,0.0337778152383088,0.0442802028012955,1.03500305052083e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,39749,0.0479532504552401,0.00330344420349392,0.041478499816392,0.0544280010940882,1.92652666509011e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,40058,-0.0398671866194659,0.00274876659243511,-0.0452547691406387,-0.0344796040982931,2.27506253531938e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39893,-0.032368546985306,0.00223759832564379,-0.0367542397035679,-0.0279828542670442,3.94938555884149e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40030,-0.0532347848323031,0.00369555145194513,-0.0604780656781156,-0.0459915039864907,9.35927947397143e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,-0.0484157066320712,0.00336159612635602,-0.055004435039729,-0.0418269782244134,9.70027059930057e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37445,0.0362882014424573,0.00254165295307678,0.0313065616544268,0.0412698412304878,6.50149105524932e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,-0.0969124333665101,0.00679936091434287,-0.110239180758622,-0.0835856859743981,9.37936580686401e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,39858,-0.033440268449183,0.00235181711148257,-0.0380498299876889,-0.0288307069106772,1.32593510606211e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,39866,0.0478844362799326,0.00337756800300656,0.0412644029940398,0.0545044695658255,2.38583986803412e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,39846,-0.0396297718262277,0.0027998375290724,-0.0451174533832096,-0.0341420902692458,3.29381193955894e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,-0.0481501950540458,0.0034290300971607,-0.0548710940444808,-0.0414292960636109,1.58354116843166e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,39984,-0.0684529110350543,0.0048815039469399,-0.0780206587710565,-0.0588851632990521,2.05841233386367e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,40052,-0.0797578751013637,0.00569994286615788,-0.0909297631190332,-0.0685859870836943,3.12369146628155e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,40052,-0.060092419556131,0.00430269091349099,-0.0685256937465734,-0.0516591453656887,4.51329739453391e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,39730,0.0385844190152461,0.00279930104402627,0.0330977889689546,0.0440710490615376,5.65791493568828e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,37383,0.025580884320429,0.00185522124588545,0.0219446506784936,0.0292171179623645,5.82849549453657e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,39868,0.0698135175530834,0.00508373874530037,0.0598493896122947,0.0797776454938721,1.12865937718569e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,39908,-0.0458701395347096,0.00334286398422828,-0.052422152943797,-0.0393181261256222,1.30781896920289e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,39865,-0.0421304083264288,0.00307948296631573,-0.0481661949404076,-0.0360946217124499,2.2827797648505e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,-0.04903884673867,0.00358511714762479,-0.0560656763480146,-0.0420120171293254,2.34802893544851e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,-0.0408881368885392,0.0029912951870611,-0.046751075455179,-0.0350251983218995,2.692661379968e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,37296,-0.037461442615193,0.00274512961814256,-0.0428418966667524,-0.0320809885636335,4.04150973014408e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,40052,0.0216901645952843,0.00159206900168264,0.0185697093519863,0.0248106198385822,4.92386351473429e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,37043,-0.087861779795164,0.00644497855358343,-0.100493937760188,-0.0752296218301405,4.93858405429959e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,-0.049015428559091,0.00360422217019858,-0.0560797040126802,-0.0419511531055018,6.85192447574717e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,-0.0563379313600458,0.00415220766551338,-0.064476258384452,-0.0481996043356396,1.06144876723361e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,0.0575403681937098,0.00425441257180959,0.049201719552963,0.0658790168344566,1.88917090891086e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,0.0446082258733657,0.00329974995392737,0.038140715963668,0.0510757357830633,2.0468508569921e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,39866,-0.0613224254667282,0.00454118607339318,-0.0702231501705788,-0.0524217007628775,2.5070670193052e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,39906,0.0516136154129729,0.00382914269924678,0.0441084957224492,0.0591187351034966,3.4759256208008e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,40052,0.0356521412778275,0.00264526742708583,0.0304674171207393,0.0408368654349157,3.52776082527439e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,-0.0728466720033249,0.00540643647288421,-0.0834432874901779,-0.0622500565164718,3.76043489794598e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,39846,0.241370753320572,0.0179269662636974,0.206233899443725,0.276507607197419,4.25981984131345e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39713,-0.0962971592088602,0.00715351292530168,-0.110318044542452,-0.0822762738752689,4.42938314906679e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37437,-0.0424244293094722,0.00315420005449672,-0.0486066614162858,-0.0362421972026587,5.62125322669882e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAST,Gastrin,37388,-0.154870984476588,0.0115459099175872,-0.177500967915059,-0.132241001038117,9.18092249455724e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,39868,-0.0842112820886618,0.00629071000075422,-0.09654107369014,-0.0718814904871835,1.19786881564066e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39786,0.0840840965977283,0.00628743934736472,0.0717607154768934,0.0964074777185631,1.43275304765354e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,0.0515009060988232,0.00385794868277634,0.0439393266805816,0.0590624855170648,1.96721227234402e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40009,-0.0447868951434934,0.00336086786475731,-0.0513741961584177,-0.0381995941285691,2.66824448540632e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,40009,0.0485383641636098,0.00364343559236701,0.0413972304025704,0.0556794979246491,2.80790533595958e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,37309,-0.0332063005608868,0.00250407684057181,-0.0381142911684076,-0.0282983099533661,6.9438899816026e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,39738,-0.0485667184100979,0.00367150008617978,-0.0557628585790103,-0.0413705782411855,9.80870434996116e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,39464,-0.07700144979482,0.00585943726152372,-0.0884859468274064,-0.0655169527622335,3.07909142536524e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,39749,-0.0468257240828837,0.00356620392304668,-0.0538154837720551,-0.0398359643937122,3.52627461286736e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39931,-0.0363438682091825,0.00278142692598469,-0.0417954649841125,-0.0308922714342525,8.05567502534174e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD248,Endosialin,37437,0.051250348857388,0.00393978265423499,0.0435283748550874,0.0589723228596885,1.86009480726061e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37043,0.0783321768339975,0.00602872711537511,0.0665158716878623,0.0901484819801327,2.3011794657513e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,39788,-0.0602441737449336,0.00464919903645922,-0.0693566038563936,-0.0511317436334735,3.30371217544511e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,39749,0.0326192030302721,0.00252213430012535,0.0276758198020264,0.0375625862585178,4.55225810415854e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,39788,-0.0883477477964332,0.00684375332567241,-0.101761504314751,-0.0749339912781152,6.18568754570932e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,39858,0.0365146699084492,0.00283028651009479,0.0309673083486634,0.042062031468235,6.8290626568138e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39364,-0.128172220748086,0.00994966846052855,-0.147673570930722,-0.10867087056545,8.87431348035756e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,40030,-0.164905352715471,0.0128065715281235,-0.190006232910593,-0.139804472520349,9.34337402254493e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,-0.062456945040521,0.00487709785591168,-0.0720160568381079,-0.0528978332429341,2.51893273374579e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,39839,-0.0613222797899994,0.00481624854946559,-0.070762126946952,-0.0518824326330468,5.90856126801599e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39900,0.0394290661398144,0.00309798395135436,0.0333570175951599,0.045501114684469,6.2889365655375e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,40003,-0.0415421873667185,0.00326552885275087,-0.0479426239181102,-0.0351417508153268,6.75992626668605e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37368,-0.0658904533451213,0.00520527728239744,-0.0760927968186202,-0.0556881098716223,1.62039350224576e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,0.0386083485795286,0.00306301458340758,0.0326048399960498,0.0446118571630075,2.9446014317978e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,40058,-0.0405976595740261,0.00323510053876397,-0.0469384566300035,-0.0342568625180487,5.90800312708797e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39913,-0.0268648917361081,0.00214190025422054,-0.0310630162343803,-0.0226667672378358,6.43580820616659e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,37409,0.0897210888294771,0.00716433080808102,0.0756790004456383,0.103763177213316,8.78414966797361e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,40030,0.0561264541092594,0.00448394175835227,0.047337928262889,0.0649149799556299,8.80648331195003e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40040,-0.047763539043953,0.00382589971196878,-0.0552623024794118,-0.0402647756084942,1.32737472876625e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,0.0302926607687983,0.00242706286427641,0.0255356175548166,0.0350497039827801,1.37853122252922e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,40058,-0.0952381366346138,0.00763067135997083,-0.110194252500157,-0.080282020769071,1.38241445611099e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,37424,-0.0348643217506313,0.00280292138618436,-0.0403580476675526,-0.0293705958337099,2.51453958925385e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39866,0.0429387715536412,0.00345652384634351,0.0361639848148079,0.0497135582924745,2.86778449392645e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,39931,-0.0632101340491814,0.00510410209696231,-0.0732141741592275,-0.0532060939391352,4.60058028026996e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,37124,-0.0334381132355055,0.00269986081039385,-0.0387298404238775,-0.0281463860471336,4.91322216757731e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,39868,-0.0313078844317965,0.00253656713262836,-0.0362795560117481,-0.0263362128518449,7.68990267843136e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,37056,-0.054577162136211,0.00443279058795983,-0.0632654316886123,-0.0458888925838098,1.20718825975957e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,39979,-0.0724191974385414,0.00588621558634288,-0.0839561799877734,-0.0608822148893093,1.24530282407713e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,39858,-0.0398713066892432,0.00324209279381104,-0.0462258085651129,-0.0335168048133736,1.33038741376882e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39788,0.0292740002325892,0.00238881928261655,0.0245919144386608,0.0339560860265177,2.2673437778811e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,37437,-0.13510044695505,0.0110761501870161,-0.156809701321601,-0.113391192588498,4.83461592096285e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,-0.0574397830325593,0.00472465030089026,-0.0667000976223042,-0.0481794684428144,7.92520091382574e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,37124,0.0268776894252089,0.00221428739522724,0.0225376861305635,0.0312176927198543,9.98950749422442e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,39866,0.0515614841148586,0.00426010267993358,0.0432116828621888,0.0599112853675285,1.42127556265651e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,-0.0856559980019289,0.00707522326494942,-0.0995234356012298,-0.0717885604026281,1.45325613384109e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39866,-0.060996807569133,0.00504222099479442,-0.0708795607189301,-0.051114054419336,1.53048685355107e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,37420,0.040528905121123,0.00337739139000485,0.0339092179967135,0.0471485922455325,5.21700972294211e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,40002,-0.0590087621600802,0.00492674338115369,-0.0686651791871414,-0.0493523451330189,6.44840141241471e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,39993,-0.0677419038801226,0.00566566672886911,-0.0788466106687061,-0.0566371970915392,8.25561961778225e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0300667518801322,0.00252196604446214,0.0251236984329864,0.035009805327278,1.25128352033916e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,39315,-0.0477472735177879,0.0040100395806009,-0.0556069510957656,-0.0398875959398101,1.51144177819578e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37388,-0.0557734650069717,0.00468653088929838,-0.0649590655499965,-0.0465878644639469,1.70264518785185e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,37437,-0.0671438866446347,0.00564755149168951,-0.0782130875683461,-0.0560746857209232,1.95504368384114e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39931,0.0353416375034668,0.00297982771428472,0.0295011751834688,0.0411820998234649,2.59557578509111e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39477,-0.129476980471252,0.0109528321860555,-0.150944531555921,-0.108009429386583,4.15096410349036e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39866,-0.032708927331098,0.00276775093474903,-0.0381337191632061,-0.0272841354989899,4.29072704731305e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39788,-0.0700959901350615,0.00593646876068132,-0.0817314689059969,-0.0584605113641261,4.84534120474323e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39758,-0.0305091668430721,0.00258738536656506,-0.0355804421615396,-0.0254378915246045,5.86657829506963e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,39788,-0.0419869797437265,0.00357259110022734,-0.0489892583001721,-0.0349847011872809,9.27017086959092e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,39785,-0.083414869320838,0.00711049126697374,-0.0973514322041066,-0.0694783064375695,1.18992130863961e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39913,-0.106403021789721,0.0090731361825814,-0.124186368707581,-0.0886196748718616,1.24373208681456e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELN,Elastin,37437,-0.0391763555129713,0.00334536648162042,-0.0457332738169474,-0.0326194372089953,1.59397853678642e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,39866,-0.0470807454203024,0.00402325342805359,-0.0549663221392874,-0.0391951687013173,1.66969343663402e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,-0.0786781751686115,0.00672362053114211,-0.0918564714096501,-0.065499878927573,1.68984146989996e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.0301826845759064,0.00258406120891941,0.0251179246064243,0.0352474445453884,2.14695738705731e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37283,-0.0369417325397511,0.00316656302964495,-0.0431481960778552,-0.030735269001647,2.68617394088243e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,-0.0859211496696661,0.00736870815131721,-0.100363817646248,-0.0714784816930844,2.72754717391521e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,39585,-0.0607849384317863,0.00522463149924009,-0.0710252161702968,-0.0505446606932757,3.70075103594665e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40009,-0.0771763118856789,0.00663719100152634,-0.0901852062486705,-0.0641674175226872,3.95797005265186e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,39585,0.0269993421268886,0.00232321923457723,0.0224458324271173,0.03155285182666,4.29284295507128e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,40030,-0.0750889951227275,0.00646418416459747,-0.0877587960853385,-0.0624191941601164,4.53204845837999e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39866,-0.0729871125803086,0.00629054430021656,-0.0853165794087331,-0.0606576457518842,5.31481297201907e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40052,-0.0778259389790329,0.00672868770577965,-0.091014166882361,-0.0646377110757047,8.07128762550105e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,40009,-0.0426935418296002,0.00369758958920492,-0.0499408174244418,-0.0354462662347585,1.01719727813036e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39826,-0.0569396464666154,0.00493664978021966,-0.0666154800358459,-0.0472638128973848,1.17522525483493e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,37382,-0.111280497794674,0.00965474165649636,-0.130203791441407,-0.0923572041479408,1.35599979601709e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,-0.0654286569795011,0.00567829679835991,-0.0765581187042865,-0.0542991952547157,1.41068502580605e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,40030,-0.0524952549257411,0.00456192905188526,-0.0614366358674362,-0.043553873984046,1.59465984587381e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,39897,-0.0303637072156151,0.00264236279667478,-0.0355427382970976,-0.0251846761341325,1.92369723423068e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,39871,0.0310163605967114,0.00270835781552161,0.025707979278289,0.0363247419151337,3.01044227908011e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,0.0270745309472469,0.00236625755831457,0.0224366661329503,0.0317123957615434,3.37950804939128e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,0.0225479923845525,0.00197062479379451,0.0186855677887152,0.0264104169803897,3.3815180535984e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37056,0.0363615455782073,0.00317894227910513,0.0301308187111612,0.0425922724452533,3.73430288515242e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,-0.0620867109859357,0.00543119294744569,-0.0727318491629293,-0.0514415728089422,3.83915661400135e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,40052,-0.0671084722103499,0.00588159441194049,-0.0786363972577532,-0.0555805471629465,4.85968115331483e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39866,-0.0417090190549725,0.00366117493443809,-0.0488849219264712,-0.0345331161834739,5.96126980278239e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,-0.110453768393351,0.00971761780434011,-0.129500299289858,-0.0914072374968445,8.01436046710742e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,-0.0330925213287083,0.00291529172033554,-0.038806493100566,-0.0273785495568507,9.4855387833519e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,37437,-0.10298707090762,0.00909255115007648,-0.12080847116177,-0.08516567065347,1.31661409611641e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,39866,-0.0600968862075935,0.00531045109377665,-0.0705053703513958,-0.0496884020637913,1.4048775130552e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,39868,-0.0393661798510914,0.00349033329478753,-0.0462072331088749,-0.0325251265933078,2.16003773834238e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,39788,-0.127790215302246,0.0113477821769551,-0.150031868369078,-0.105548562235414,2.63065611201815e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,39847,0.0573968682067836,0.00509781600651784,0.0474051488340086,0.0673885875795585,2.69231019902937e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,37043,-0.0677104213349866,0.00602342950460564,-0.0795163431640136,-0.0559044995059595,3.47457436615619e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37368,-0.0775352575122135,0.00690382474443144,-0.0910667540112991,-0.0640037610131279,3.87639014355121e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,39575,0.0334558028373686,0.00298318505224536,0.0276087601349677,0.0393028455397695,4.44880426140802e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,40030,-0.0312804044836703,0.00279577070705769,-0.0367601150695034,-0.0258006938978373,5.93206027203629e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,39836,-0.101858176040957,0.00911645216276877,-0.119726422279984,-0.0839899298019302,7.07287458187237e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,-0.115790250047767,0.0103976588885925,-0.136169661469408,-0.0954108386261254,1.06776887369255e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39858,0.0433113857627706,0.0038987561403537,0.0356698237276773,0.0509529477978638,1.44233496881895e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,39963,-0.0756659686222664,0.00681458292820472,-0.0890225511615477,-0.0623093860829852,1.53066032142366e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,0.0292703033114171,0.0026379154482635,0.0240999890328207,0.0344406175900136,1.66863557404157e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,39843,-0.0372623352490825,0.00335840468193368,-0.0438448084256725,-0.0306798620724925,1.68117626274701e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,-0.0432239844198656,0.00389670327390602,-0.0508615228367214,-0.0355864460030098,1.73564498590925e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39858,-0.0578791600326093,0.00522342369226709,-0.0681170704694528,-0.0476412495957658,1.97526553509682e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEP,Leptin,39868,-0.0746550927325854,0.00674067313728773,-0.0878668120816693,-0.0614433733835014,2.09623225092504e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PXN,Paxillin,39489,-0.0569401152218545,0.00514274046517274,-0.067019886533593,-0.0468603439101159,2.18862637250013e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39788,-0.137074933400574,0.0123940476108881,-0.161367266717915,-0.112782600083234,2.49377535085123e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,0.0284551911144925,0.00257303556528115,0.0234120414065415,0.0334983408224436,2.61921906427541e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39868,-0.0382047412335286,0.00346319791380077,-0.0449926091445781,-0.031416873322479,3.39792401407874e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,-0.0231953541705665,0.00210572778243052,-0.0273225806241303,-0.0190681277170027,4.05818744970729e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,39897,0.0393302263869815,0.00357748005179392,0.0323183654854654,0.0463420872884976,5.15140114792117e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,39846,-0.0316484930762572,0.00288082559169397,-0.0372949112359774,-0.026002074916537,5.62454270515988e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OCLN,Occludin,37411,-0.0470347437472374,0.00428130293661274,-0.0554260975029984,-0.0386433899914765,5.84988630115346e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39866,-0.065942382838792,0.00603295901248526,-0.0777669825032631,-0.0541177831743209,1.034042164335e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,37056,-0.0921302099924665,0.00842819711191318,-0.108649476331816,-0.0756109436531166,1.0747776042962e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,39995,-0.0407196600638234,0.00372747169690457,-0.0480255045897563,-0.0334138155378904,1.10401397798862e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,-0.045478637562717,0.00416512048915522,-0.0536422737214612,-0.0373150014039728,1.17165110047842e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37268,-0.0323738780496737,0.00296387113115585,-0.0381830654667391,-0.0265646906326082,1.17236559634759e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,39866,-0.0498903987507155,0.00456927426865331,-0.058846176317276,-0.040934621184155,1.17494875597827e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,39749,-0.0965748578098223,0.00887639887603512,-0.113972599606851,-0.0791771160127935,1.79522427297553e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37056,-0.0929663317195546,0.00857725801958389,-0.109777757437939,-0.0761549060011702,2.93927345080543e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,37453,-0.0215418891122516,0.00198914593033349,-0.0254406151357053,-0.017643163088798,3.21485735080023e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,39913,-0.0284840075232214,0.00263105693047815,-0.0336408791069586,-0.0233271359394842,3.21654075470713e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,40008,-0.0628642756785034,0.00581025936688867,-0.0742523840376052,-0.0514761673194016,3.44837856198969e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,-0.0763925540790222,0.00706299537896836,-0.0902360250218002,-0.0625490831362442,3.61330548370745e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37056,-0.0857259149610796,0.00792701806368091,-0.101262870365894,-0.0701889595562651,3.82349779999063e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,39666,-0.038837207109333,0.00360196811181251,-0.0458970646084855,-0.0317773496101805,5.18590747742157e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,-0.0934945521698296,0.00867475952250336,-0.110497080833936,-0.076492023505723,5.64142410791866e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37021,-0.0659673438756431,0.00612246446322118,-0.0779673742235566,-0.0539673135277296,5.87581131506e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,37043,-0.0650543833911914,0.006041217157918,-0.0768951690207107,-0.0532135977616722,6.2798434986544e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,-0.0292858569278066,0.00272987153177032,-0.0346364051300764,-0.0239353087255368,9.28154080932216e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37056,-0.129212706457047,0.0120451986243315,-0.152821295760736,-0.105604117153357,9.76450017912671e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,37390,-0.116398947307499,0.0109190026374732,-0.137800192476946,-0.0949977021380513,1.98898056179671e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,-0.0901696960903032,0.00847270111036007,-0.106776190266609,-0.0735632019139975,2.42046686283672e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,40058,-0.0480874550216513,0.0045255643964291,-0.0569575612386523,-0.0392173488046502,2.76111263805341e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,37241,-0.024758379792576,0.0023321782767147,-0.0293294492149369,-0.0201873103702152,3.19283685617569e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,40058,-0.0800417748977953,0.00755108991139795,-0.0948419111241353,-0.0652416386714554,3.62894239267666e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,-0.0464319322339299,0.00438614540934604,-0.0550287772362481,-0.0378350872316117,4.22349083263779e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,-0.0629567506244423,0.00595025356028674,-0.0746192476026043,-0.0512942536462803,4.63921226899177e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,37124,-0.0484965742010012,0.00458574270927215,-0.0574846299111746,-0.0395085184908278,4.91373379576229e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40009,-0.101077622085268,0.00957901100589818,-0.119852483656829,-0.082302760513708,6.04086828138256e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39677,-0.0380617863559045,0.003612967252301,-0.0451432021704145,-0.0309803705413946,7.27516138814247e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,37453,0.0286602669322662,0.00272164276286198,0.0233258471170568,0.0339946867474757,7.8582356609962e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,40030,-0.0274922996635127,0.00261878311301659,-0.0326251145650252,-0.0223594847620001,1.06590584028139e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,39862,0.0226764027273813,0.00216149158817474,0.0184398792145588,0.0269129262402038,1.14997697048348e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39788,-0.0883078232508159,0.00841838803550562,-0.104807863800407,-0.0718077827012249,1.16581314095168e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,-0.0585402046599703,0.00560390179616809,-0.0695238521804598,-0.0475565571394809,1.91515364807628e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,-0.0453292928634124,0.00434582803492806,-0.0538471158118714,-0.0368114699149534,2.17157676588758e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39858,0.0539423102064768,0.00517554098729663,0.0437982498713754,0.0640863705415782,2.35862587449917e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,0.0446510829607583,0.00428640418333106,0.0362497307614294,0.0530524351600872,2.49950886374799e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,-0.0860933660049201,0.00826452496041618,-0.102291834927336,-0.0698948970825044,2.50486298051989e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38022,0.0319542306783134,0.00306742328863556,0.0259420810325877,0.0379663803240391,2.55244422964832e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39862,-0.0290267307781099,0.00278760367340291,-0.0344904339779796,-0.0235630275782402,2.61141454025876e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39587,-0.0883131292320484,0.00848390334669888,-0.104941579791578,-0.0716846786725186,2.71158522484975e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,39866,0.0479267503790178,0.00460905249455126,0.0388930074896973,0.0569604932683382,3.03426638782081e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39788,-0.0707833663534096,0.00680964708142612,-0.0841302746330048,-0.0574364580738144,3.16044902365222e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,39858,0.0290928031171626,0.00280125338151865,0.023602346489386,0.0345832597449391,3.4658142606892e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,39788,-0.0752478151086294,0.00726568512080113,-0.0894885579453996,-0.0610070722718592,4.69074234500606e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,37445,-0.0273725491924167,0.00264368170285057,-0.0325541653300038,-0.0221909330548296,4.97541039633721e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39816,-0.0205155758329362,0.00198343975364752,-0.0244031177500854,-0.0166280339157871,5.37583075292098e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39698,-0.0283264919370232,0.00274380978789281,-0.0337043591212931,-0.0229486247527533,6.59841160196982e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,37051,-0.0267428258026701,0.00259046077397948,-0.0318201289196699,-0.0216655226856703,6.85663810855325e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,-0.0771043441504733,0.00747372955810947,-0.0917528540843678,-0.0624558342165787,7.3641024378937e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39489,-0.0278654680054024,0.00270844449417378,-0.033174019213983,-0.0225569167968218,9.53653281159245e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,39866,-0.0786679239310476,0.00768927773495075,-0.093738908291551,-0.0635969395705441,1.7158054784631e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39984,-0.0737260363329607,0.00720818032571074,-0.0878540697713537,-0.0595980028945676,1.7627317219496e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,37124,-0.0538692177690583,0.00527117285471823,-0.064200716564306,-0.0435377189738106,1.99573712182486e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,39858,0.0290372664240707,0.00284395016507818,0.0234631241005175,0.034611408747624,2.12091472970033e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,-0.0883318469857378,0.00865716078408949,-0.105299882122553,-0.0713638118489224,2.28596907317565e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,39749,-0.0528836275223788,0.00518318474029679,-0.0630426696133605,-0.0427245854313971,2.28737007119543e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,0.0452303014093239,0.00443456940346518,0.0365385453785322,0.0539220574401156,2.36278937102877e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,40009,-0.0605715069827262,0.00593990834721971,-0.0722137273432768,-0.0489292866221756,2.41407097510011e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39866,0.0532388958249776,0.00522324411124055,0.0430013373669462,0.0634764542830091,2.53656802969593e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,37382,-0.108116301514706,0.0106106585426534,-0.128913192258306,-0.0873194107711049,2.70631541772224e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,-0.0263364925386836,0.00258610407175356,-0.0314052565193206,-0.0212677285580466,2.86421009191857e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,-0.0710409038459839,0.00698958675562779,-0.0847404938870144,-0.0573413138049535,3.53087608223159e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,-0.0830056080212697,0.00817675793448949,-0.0990320535728691,-0.0669791624696703,3.98674162267701e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,37437,-0.0266417616362018,0.00262538403725554,-0.0317875143492226,-0.0214960089231809,4.1332239566445e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGRN,Agrin,39931,-0.0328276232098107,0.00324372415788128,-0.039185322559258,-0.0264699238603634,5.29669450669944e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,39477,-0.0626690720396356,0.00621129249565438,-0.0748432053311182,-0.0504949387481531,7.27307302978857e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,37056,0.0298118258681117,0.00296104393924814,0.0240081797471853,0.0356154719890381,9.32125578787914e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,40058,-0.0412115807863713,0.00410037094978581,-0.0492483078479515,-0.0331748537247911,1.07042116356185e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39858,-0.0400683043324562,0.00399003884531695,-0.0478887804692774,-0.032247828195635,1.16982668239558e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39788,-0.0354099722870503,0.00352962671539693,-0.0423280406492283,-0.0284919039248723,1.2929897232406e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,39866,-0.0324317755744096,0.00323397491602348,-0.0387703664098156,-0.0260931847390036,1.34178526891761e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,37368,-0.0996604922286631,0.00993759591284008,-0.11913818021783,-0.0801828042394965,1.37954907752734e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39477,-0.0492305300442593,0.00491095992622479,-0.0588560114996599,-0.0396050485888587,1.40007145822156e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,-0.038398563948441,0.00383176464004578,-0.0459088226429307,-0.0308883052539512,1.48733010211655e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,40058,-0.0336737058304339,0.00336681689876254,-0.0402726669520085,-0.0270747447088594,1.7534475590331e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39866,-0.0562871713250784,0.00563618148782508,-0.0673340870412155,-0.0452402556089412,2.039658702555e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,-0.0385801461867026,0.00386391606049106,-0.0461534216652651,-0.0310068707081401,2.0839773841385e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,39788,-0.050776126104132,0.00509157976986855,-0.0607556224530743,-0.0407966297551896,2.35290744639474e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,37386,-0.0274074349031363,0.00275579822210477,-0.0328087994184617,-0.022006070387811,3.1742310081665e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,37437,-0.0680783400795387,0.00684768559547148,-0.0814998038466628,-0.0546568763124145,3.28691470890156e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MLN,Promotilin,39866,-0.0880980011114582,0.00887433852267106,-0.105491704615893,-0.0707042976070229,3.69585977437316e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,-0.0884669418926177,0.0089140872380086,-0.105938552879115,-0.0709953309061209,3.80874612925551e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,39866,-0.0732911553275507,0.00738664194435214,-0.0877689735384809,-0.0588133371166205,3.89058885747691e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39477,-0.063087726790139,0.00636163033061748,-0.0755565222381492,-0.0506189313421287,4.11334778960905e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,39875,-0.046404598171053,0.00469746004585275,-0.0556116198609244,-0.0371975764811817,5.99210187043824e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,-0.0602459177225608,0.00611562070187542,-0.0722325342982366,-0.048259301146885,7.87080618164131e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,-0.0505697287582536,0.00513416787067553,-0.0606326977847776,-0.0405067597317295,8.01599845136647e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,39913,-0.0556925063350998,0.0056573417059857,-0.0667808960788318,-0.0446041165913679,8.41793265533672e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,-0.0563665084105794,0.00572631691037781,-0.0675900895549199,-0.0451429272662388,8.48589314325154e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39489,-0.0834735141606077,0.00849155131489065,-0.100116954737793,-0.066830073583422,9.71503624245784e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,39868,0.0302178146030435,0.00307707874295163,0.0241867402668583,0.0362488889392287,1.06725794870003e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,39455,-0.0384004205221202,0.00391129248906618,-0.0460665538006899,-0.0307342872435505,1.09771040917475e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,37437,-0.077923456393196,0.00794297059111465,-0.0934916787517807,-0.0623552340346113,1.20819878690414e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,37043,-0.0306418545187295,0.00312808669633816,-0.0367729044435523,-0.0245108045939067,1.40256899745915e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REN,Renin,39868,-0.0642612186152466,0.00656315367947407,-0.0771249998270157,-0.0513974374034774,1.42113432451067e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,40030,-0.0534377249785044,0.0054587610927424,-0.0641368967202795,-0.0427385532367293,1.44525683243106e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37411,-0.0566627716689302,0.00578802424779453,-0.0680072991946075,-0.0453182441432529,1.4814902475652e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39859,-0.0489362476587344,0.00500896807364379,-0.0587538250830762,-0.0391186702343925,1.75514549562048e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,-0.0258152566409837,0.00264527326684553,-0.030999992244001,-0.0206305210379665,1.94958757978865e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39866,-0.0483161098780377,0.00495204358646729,-0.0580221153075135,-0.0386101044485618,1.99214789694208e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,39913,-0.0377595336271094,0.0038715827085625,-0.0453478357358919,-0.0301712315183269,2.06695556139159e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,-0.0557986421124573,0.00572392011995025,-0.0670175255475598,-0.0445797586773548,2.1668704136086e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,39858,-0.0434415798374167,0.00447354229355255,-0.0522097227327797,-0.0346734369420537,3.12437742029936e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39477,-0.0592391054731139,0.00610911496796586,-0.071212970810327,-0.0472652401359008,3.59133976525835e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39931,-0.0395794867676335,0.00408736926165416,-0.0475907305204756,-0.0315682430147913,4.0781380382515e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39587,-0.0682319091575299,0.00705112129794589,-0.0820521069015039,-0.054411711413556,4.36242242793555e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37368,-0.0770248865107873,0.00796953112621409,-0.0926451675181669,-0.0614046055034077,5.00769266521246e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,39314,-0.0883823428258041,0.00915013790952348,-0.10631661312847,-0.070448072523138,5.18937049169472e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,37453,-0.0197333899380135,0.00204701016105743,-0.023745529853686,-0.0157212500223409,6.36218319868284e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,39931,-0.0374920211362117,0.00389320365850886,-0.0451227003068891,-0.0298613419655343,6.83602413317638e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39862,0.032626800533875,0.00338948930171601,0.0259834015025116,0.0392701995652384,7.12679799828787e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,39504,-0.0475356352301774,0.00494361227444382,-0.0572251152880873,-0.0378461551722675,7.89795363794022e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,39477,-0.0707059012490593,0.00735892139283894,-0.0851293871790236,-0.056282415319095,8.48329055582541e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37437,0.0314265102962508,0.00327266313067682,0.0250120905601242,0.0378409300323774,9.12905155679929e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,40058,0.00857104135546691,0.00089701564830396,0.00681289068479115,0.0103291920261427,1.40790671958352e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,39720,-0.026333745243817,0.00275605501192267,-0.0317356130671854,-0.0209318774204485,1.41446094529343e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,-0.103994608973533,0.010894310653459,-0.125347457854313,-0.0826417600927536,1.57975230480972e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.046585275683514,0.00489034851337728,-0.0561703587697334,-0.0370001925972945,1.86333143989305e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,37169,-0.122079587386857,0.0128326700038236,-0.147231620594352,-0.0969275541793632,2.16240849302758e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,-0.0299955710686729,0.0031637213999274,-0.0361964650125306,-0.0237946771248152,2.86071692523977e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,39866,-0.0527396466569546,0.0055662265378526,-0.0636494506711457,-0.0418298426427635,3.03429449230282e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39868,-0.0819869447591357,0.00866188387786646,-0.098964237159754,-0.0650096523585175,3.32720506407965e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39489,-0.0475886353928925,0.00502962750839665,-0.0574467053093499,-0.0377305654764351,3.45354203272022e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,39749,-0.0397245400136088,0.00419954331650194,-0.0479556449139526,-0.031493435113265,3.52608583512243e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,40009,-0.0394573142918996,0.00417210820442567,-0.0476346463725739,-0.0312799822112253,3.58121937023889e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNST,Consortin,39868,-0.101713126984196,0.0107574904945838,-0.12279780835358,-0.0806284456148114,3.66466104510832e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37411,-0.0591586003909974,0.00626579091972599,-0.0714395505936603,-0.0468776501883344,4.2653160792744e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,40009,-0.0544150734523135,0.0057704867020691,-0.065725227388369,-0.0431049195162581,4.65023215294812e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,39713,-0.0745975635486593,0.00795286239799902,-0.0901851738487374,-0.0590099532485813,7.47360148235251e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37039,-0.113175672014953,0.012073386017376,-0.136839508609009,-0.0895118354208956,8.10814129009423e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,-0.0773355498596147,0.00825437150533215,-0.0935141180100657,-0.0611569817091637,8.48584786101499e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39908,-0.048470796750705,0.00517929694348721,-0.0586222187599399,-0.0383193747414701,9.12920532050442e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,39913,-0.0376342530010991,0.00402552845243067,-0.0455242887678632,-0.029744217234335,9.99815636058264e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37124,-0.0707195275529042,0.0075678075847976,-0.0855524304191075,-0.0558866246867009,1.06590201928633e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,37453,-0.0159142296037392,0.00170385809390381,-0.0192537914677906,-0.0125746677396877,1.10974110452348e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,39913,0.0368317994087085,0.00394750622789194,0.0290946872020403,0.0445689116153767,1.18957891311306e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,-0.0472449602724608,0.00506433736329155,-0.0571710615045123,-0.0373188590404094,1.20985497003066e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,37124,0.0468556220197689,0.00503284771136375,0.0369912405054959,0.0567200035340418,1.47717105889675e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,-0.0415745159931048,0.0044676468910591,-0.0503311038995806,-0.0328179280866289,1.53858685347717e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,39931,-0.0933443008940172,0.0100575495854021,-0.113057098081405,-0.0736315037066291,1.8882807832713e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39489,-0.0568504937627325,0.00612876292976304,-0.0688628691050681,-0.0448381184203969,1.9851205340873e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,-0.090460607476448,0.00976165418881269,-0.109593449686521,-0.0713277652663751,2.20058504236148e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0360585320186728,0.0038920065661814,0.0284301991489573,0.0436868648883884,2.20299268850717e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,-0.0704766672399932,0.00761713141259428,-0.085406244808678,-0.0555470896713084,2.51889093352355e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,-0.0442984005287477,0.00479117638174617,-0.0536891062369702,-0.0349076948205252,2.62777748176437e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,39788,-0.0946727973222475,0.0102409678926812,-0.114745094391903,-0.0746005002525924,2.65606804531661e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,-0.0381895163924019,0.00413195195225156,-0.0462881422188149,-0.0300908905659888,2.70384713591296e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40009,-0.0756401739846726,0.00819599538057723,-0.0917043249306039,-0.0595760230387412,3.06550492673003e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39477,-0.0596060814702666,0.00645947007333204,-0.0722666428139974,-0.0469455201265358,3.11232516051913e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,37021,-0.0620932380287622,0.00672743405827223,-0.0752790087829758,-0.0489074672745486,3.11871566571415e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,39866,-0.0846797631206333,0.00918423736369941,-0.102680868353484,-0.0666786578877825,3.32976070370773e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,-0.0711137953575842,0.00771953884735773,-0.0862440914984054,-0.0559834992167631,3.6598830347723e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,-0.0695563210764207,0.00755129820329099,-0.0843568655548711,-0.0547557765979704,3.69239992842496e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,39913,-0.0759977157078911,0.00826709412508613,-0.0922012201930599,-0.0597942112227222,4.2873660332122e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VASN,Vasorin,39642,0.0249757367883447,0.00272384330783528,0.0196370039049876,0.0303144696717019,5.33708227341157e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,37021,-0.0391392352247807,0.00427641681289073,-0.0475210121780466,-0.0307574582715149,6.38199805642338e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,-0.0698558100355762,0.00765090154952665,-0.0848515770726484,-0.0548600429985039,7.627926596275e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,-0.0464620102035386,0.00508978685362939,-0.0564379924366522,-0.036486027970425,7.94895248582046e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,-0.0891902408018609,0.00977973912608437,-0.108358529488986,-0.0700219521147355,8.3958417497559e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.0217845395076367,0.00239188793360356,0.0170964391577737,0.0264726398574997,9.38710179653712e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39913,0.0369874426641133,0.00406611141252784,0.0290178642955587,0.0449570210326678,1.04000528014805e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,39795,-0.0411806152858902,0.00452887007390163,-0.0500572006307374,-0.032304029941043,1.07574640162967e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,-0.0629884922171721,0.00692565041179968,-0.0765627670242995,-0.0494142174100447,1.0764900310221e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,-0.0533690555790289,0.00586980563372763,-0.064873874621135,-0.0418642365369227,1.08590636493529e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,39713,-0.0551896022590037,0.00607281344431336,-0.0670923166098579,-0.0432868879081495,1.12604518712103e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39489,-0.0510470199534539,0.0056170862360309,-0.0620565089760745,-0.0400375309308333,1.12954523145388e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39866,-0.0780114049999784,0.00860440163122163,-0.0948760321971727,-0.061146777802784,1.36939068282052e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,-0.0456848369325362,0.00504398731586965,-0.0555710520716408,-0.0357986217934317,1.51835346227876e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,39660,-0.0338830696512247,0.00374346699805975,-0.0412202649674219,-0.0265458743350276,1.57518818901464e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,39803,-0.0270245400716867,0.00298606040516191,-0.0328772184658041,-0.0211718616775694,1.58837849376097e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,39866,0.0231859996961236,0.00256449409216898,0.0181595912754724,0.0282124081167748,1.72447092906972e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,37453,-0.0196884656568034,0.00217817119484527,-0.0239576811987002,-0.0154192501149067,1.79228922590514e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39866,-0.0957038131799627,0.0105974471243892,-0.116474809543766,-0.0749328168161599,1.89426980659673e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37382,0.0264228226926606,0.0029256883156755,0.0206884735939367,0.0321571717913846,1.92295499974541e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,37056,-0.0833535348606075,0.00923294130262051,-0.101450099813744,-0.0652569699074713,1.99077199558822e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,-0.017302432674922,0.00191946637783856,-0.0210645867754856,-0.0135402785743584,2.2107559798135e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40052,-0.0192677188740339,0.0021393668474526,-0.023460877895041,-0.0150745598530268,2.36481436738566e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,39587,-0.0427077443433735,0.00474653483568557,-0.0520109526213172,-0.0334045360654298,2.56443308843387e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39858,0.0382930910197064,0.00426441428662364,0.0299348390179241,0.0466513430214887,3.01237416895192e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37437,0.0194675930058028,0.0021678956888696,0.0152185174556184,0.0237166685559872,3.06105620739323e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,39720,-0.0460149957269662,0.00512709623793846,-0.0560641043533256,-0.0359658871006069,3.14933248121415e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40052,-0.0359168081496663,0.00400691092059287,-0.0437703535540283,-0.0280632627453042,3.47562437234197e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,39866,-0.0355845139962507,0.00397479187962697,-0.0433751060803195,-0.0277939219121818,3.84858167922191e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37043,-0.026349965059302,0.0029434346171598,-0.0321190969089352,-0.0205808332096688,3.94899076000754e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,-0.101338412460452,0.0113256445907586,-0.123536675858339,-0.0791401490625651,4.10452241265726e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39866,-0.0553191044009624,0.00618892020678868,-0.0674493880062682,-0.0431888207956565,4.37139559873995e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39866,-0.0487393368111223,0.00545775659205743,-0.0594365397315548,-0.0380421338906897,4.70285460918128e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39842,-0.0581369540291628,0.00651821292334447,-0.070912651358918,-0.0453612566994077,5.19862191860831e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OPTC,Opticin,39788,0.0392109483287303,0.0043976429516856,0.0305915681434265,0.0478303285140341,5.33284183698653e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,39798,-0.0270234966920113,0.00303169530347772,-0.0329656194868277,-0.021081373897195,5.46322792476149e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,39880,-0.051845584461644,0.00582165541256517,-0.0632560290702717,-0.0404351398530163,5.86769230528425e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,-0.0474058814847543,0.00532422674162489,-0.0578413658983391,-0.0369703970711695,5.97009657990014e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,39973,-0.0475068966852069,0.00533731748509626,-0.0579680389559955,-0.0370457544144182,6.11948248446539e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,37368,-0.0389617335920952,0.00437674604962928,-0.0475401558493685,-0.0303833113348218,6.17683702262249e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,37445,-0.0198980907625632,0.00223835497220524,-0.0242852665080855,-0.015510915017041,6.8963625412591e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,37124,0.0250887052452404,0.00282370212550622,0.0195542490792482,0.0306231614112326,7.2041147733823e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,-0.0237329362642253,0.00267440443188521,-0.0289747689507203,-0.0184911035777302,7.78047941814041e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,-0.0561652937081019,0.00633105330463393,-0.0685741581851844,-0.0437564292310194,7.97387191959854e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,40058,-0.0834813241428768,0.00943681392996352,-0.101977479445605,-0.0649851688401483,9.96043204538012e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37382,-0.07400470708349,0.0083638835048073,-0.0903979187529124,-0.0576114954140677,9.99220140405019e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39931,-0.0230624738827971,0.00260716373014663,-0.0281725147938845,-0.0179524329717097,1.00158162663197e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,39866,-0.0719698001473983,0.00813890943240005,-0.0879220626349024,-0.0560175376598942,1.03028038452946e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,0.0226723674816998,0.00256363371136179,0.0176476454074307,0.0276970895559689,1.03784682871313e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,37124,-0.0608464198953371,0.00689157524172944,-0.0743539073691268,-0.0473389324215474,1.18616527094511e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,39885,-0.0412169399646955,0.00467754254011452,-0.0503849233433199,-0.032048956586071,1.35744543382439e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,-0.0339696757428842,0.00385730900512847,-0.041530001392936,-0.0264093500928324,1.44923636069543e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,39866,-0.0837646350032274,0.00951453386463041,-0.102413121377903,-0.0651161486285518,1.45497035137047e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,37124,-0.0557831155919755,0.00634327377554464,-0.068215932192043,-0.043350298991908,1.61863083148207e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0284321830368986,0.00323336396809674,0.022094789659429,0.0347695764143682,1.62413751903183e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,39858,-0.0315116415590958,0.00358534231068211,-0.0385389124880327,-0.0244843706301588,1.65964116454316e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,37445,0.041748299768031,0.00475396703572829,0.0324305243780035,0.0510660751580584,1.79947819109795e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39788,0.0567478472988145,0.00647244480861301,0.044061855473933,0.069433839123696,2.00661638021498e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,-0.0824860640244017,0.0094251322340942,-0.100959323203226,-0.0640128048455771,2.30716809738758e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,39476,-0.0606890329405855,0.00695885287667878,-0.0743283845788759,-0.0470496813022951,3.02816495059918e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELP,P-selectin,39931,-0.0498143453407677,0.00571700539221443,-0.061019675909508,-0.0386090147720274,3.23328342943501e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37043,-0.0632304698704027,0.00726778020947743,-0.0774753190809784,-0.0489856206598269,3.70523842216768e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,-0.0531775663610815,0.00611562145557524,-0.0651641844140089,-0.041190948308154,3.78952384384576e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,39931,-0.0569329561998921,0.00655924870790195,-0.06978908366738,-0.0440768287324043,4.33957858926009e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,39843,-0.0718439267105446,0.00827880138138798,-0.088070377418065,-0.0556174760030242,4.40831587336414e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BGN,Biglycan,39448,0.103089970697907,0.0118889054349332,0.0797877160454383,0.126392225350376,4.69538076513262e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,39866,-0.0701597198943502,0.00809635388292473,-0.0860285735048826,-0.0542908662838177,4.91524494405379e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,37430,-0.0486618336020004,0.00561728042662312,-0.0596717032381817,-0.0376519639658191,5.11482756547158e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37368,-0.0988738830071674,0.0114186118613017,-0.121254362255319,-0.0764934037590161,5.29307645334851e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,0.0181168049566993,0.00209296279930224,0.0140145978700669,0.0222190120433317,5.44540976967565e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,-0.0814833718682728,0.00942723765606722,-0.0999607576741646,-0.0630059860623811,5.96963398765553e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,39866,-0.0540065971520819,0.00626032757600831,-0.0662768392010582,-0.0417363551031056,6.89334348883345e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.0327006681669677,0.0037907863286751,-0.0401306093711709,-0.0252707269627645,6.92145646094937e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,37411,-0.0438848197311361,0.0051035189962161,-0.0538877169637197,-0.0338819224985526,8.92079636852251e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,-0.0853467256204226,0.00992786403148189,-0.104805339122127,-0.0658881121187181,8.94471107583556e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,-0.0380218266893494,0.00442774715749619,-0.0467002111180419,-0.0293434422606568,9.729583798832e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39489,-0.0680823664790735,0.00793221886736841,-0.0836295154591156,-0.0525352174990315,1.0100657044434e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39931,0.0172052494818409,0.00200582662964211,0.0132738292877424,0.0211366696759395,1.05564194059805e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,37388,-0.0539339845584567,0.00629856350061771,-0.0662791690196674,-0.041588800097246,1.21841288196078e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37437,-0.0502199164606245,0.00588157232675484,-0.061747798221064,-0.0386920347001851,1.50279422945952e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37388,-0.0751086105675442,0.00880438312609002,-0.0923652014946806,-0.0578520196404077,1.60626983647204e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,39489,-0.0550809702093229,0.00646931516632651,-0.0677608279353228,-0.0424011124833229,1.82844665602595e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,39817,0.0538436301016924,0.006328708025936,0.0414393623708579,0.066247897832527,1.92749739059676e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,39794,-0.0714724580280921,0.00841098852742331,-0.0879579955418417,-0.0549869205143424,2.1063390904448e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39788,-0.116571843938722,0.013724974382673,-0.143472793728761,-0.0896708941486832,2.18173004433904e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,-0.067671053904222,0.00798281944999451,-0.0833173800262112,-0.0520247277822327,2.55290120237424e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,39489,-0.0513902261965262,0.00607202904457012,-0.0632914031238836,-0.0394890492691687,2.82390284919377e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,-0.0876231543696597,0.0103603849995767,-0.10792950896883,-0.0673167997704893,2.96434288718827e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,40024,0.0299311793341103,0.00354032538784158,0.0229921415739408,0.0368702170942798,3.04295683233688e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39868,-0.0655906978743002,0.00775973749757812,-0.0807997833695534,-0.0503816123790471,3.08885850446508e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40052,-0.0408624200808425,0.00483549276469631,-0.0503399858996472,-0.0313848542620377,3.14384098236992e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,39866,-0.0773167552462247,0.00916646419607491,-0.0952830250705315,-0.0593504854219179,3.5995158452192e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,-0.0862656539486374,0.0102333648059765,-0.106323048968351,-0.0662082589289235,3.80869999391693e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,40030,-0.0336304489330222,0.00399051657651968,-0.0414518614230008,-0.0258090364430436,3.82213378574853e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,37437,-0.023524933852758,0.00279491717181666,-0.0290029715095186,-0.0180468961959973,4.24457476545528e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,39868,0.0310507733909076,0.00369274158144436,0.0238129998912767,0.0382885468905385,4.49520829950698e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,39858,0.0199356344622831,0.00237495851402894,0.0152807157747864,0.0245905531497799,5.08352592776176e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,-0.0344991683335376,0.00411364765967306,-0.0425619177464968,-0.0264364189205784,5.49943908876277e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,-0.0725169401890569,0.00865533790678471,-0.089481402486355,-0.0555524778917589,5.80991551769839e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,-0.117690699566989,0.014075009022693,-0.145277717251467,-0.0901036818825105,6.78334777028884e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,-0.0606682979161616,0.00725995119496268,-0.0748978022582884,-0.0464387935740347,7.08253327881432e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,-0.0805408344604066,0.0096427840570923,-0.0994406912123076,-0.0616409777085057,7.23851151791797e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREH,Trehalase,37437,-0.062739811937714,0.00751404933861451,-0.0774673486413985,-0.0480122752340296,7.50325022732824e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,39749,-0.0435757119689565,0.00522062928575224,-0.0538081453690309,-0.0333432785688821,7.58314084367116e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,39984,-0.0196009023670083,0.00234959559273285,-0.0242061097287647,-0.0149956950052519,7.87290221826407e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,36763,-0.0196153684244228,0.00235519832450881,-0.0242315571404601,-0.0149991797083855,9.00503139951871e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RETN,Resistin,39790,-0.0338201766349309,0.00406292406807928,-0.0417835078083663,-0.0258568454614955,9.1801301671672e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,40052,0.0249429912260531,0.00299897470903172,0.0190650007963509,0.0308209816557553,9.7179369344064e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,-0.0901117081118899,0.0108340213371062,-0.111346389932618,-0.0688770262911617,9.83854814766382e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,40009,-0.0506264692002811,0.00609165888769948,-0.0625661206201721,-0.0386868177803901,1.02553437711535e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,37373,-0.0493575232059784,0.00594196473675291,-0.0610037740900141,-0.0377112723219427,1.07791628941607e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,40030,0.0277232441377479,0.00333868811088488,0.0211794154404135,0.0342670728350822,1.08883085093663e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40052,-0.0594098088230636,0.00715679802702349,-0.0734371329560296,-0.0453824846900976,1.11142894292486e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,39866,-0.0695764852156788,0.00838620956925556,-0.0860134559714197,-0.0531395144599379,1.15646648521158e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37124,-0.032244556714456,0.00388655518377668,-0.0398622048746583,-0.0246269085542537,1.17567495611047e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,-0.0286560219896725,0.00346527543957214,-0.0354479618512339,-0.0218640821281112,1.45023248995678e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,39788,-0.0607360158844629,0.00734524605195183,-0.0751326981462885,-0.0463393336226373,1.45954509773809e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,-0.0228953819666283,0.00277137974363086,-0.0283272862641448,-0.0174634776691118,1.57584526380738e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,-0.0615684914695256,0.00745384428158339,-0.0761780262614291,-0.0469589566776222,1.59523517456406e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,-0.0241165899411652,0.00292310196017137,-0.0298458697831011,-0.0183873100992293,1.72387414333e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,39843,-0.0494942022040054,0.00602949708945421,-0.0613120164993356,-0.0376763879086751,2.4055079312493e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,40058,-0.0428035984017837,0.00521705000368593,-0.0530290164090081,-0.0325781803945593,2.48666335518104e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,37411,-0.063631737079106,0.00776321597209426,-0.0788476403844108,-0.0484158337738013,2.69410805201446e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37382,-0.0628048489236791,0.00766596397909591,-0.0778301383227071,-0.0477795595246512,2.78252368820571e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,37437,-0.0291338930102311,0.00356118394498816,-0.0361138135424079,-0.0221539724780543,3.06474388379892e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COCH,Cochlin,37437,-0.0373138631071401,0.00456561183108441,-0.0462624622960655,-0.0283652639182147,3.27804080299247e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39931,-0.0696016362120162,0.00852949109857681,-0.0863194387652268,-0.0528838336588057,3.59272519505584e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,-0.0574913895849559,0.00704449638352504,-0.071298602496665,-0.0436841766732468,3.61662987723619e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,39858,-0.0434052459983003,0.00532049632066439,-0.0538334187868025,-0.0329770732097981,3.65351579725113e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,39858,0.0372820619685817,0.0045730617044644,0.0283188610278315,0.046245262909332,3.82546468743971e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39477,-0.0277484532275989,0.00340901052334955,-0.034430113853364,-0.0210667926018338,4.25782171636988e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,-0.0570219422943352,0.00701449214644991,-0.070770346901377,-0.0432735376872933,4.64218168939598e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,39729,0.0271079722999934,0.00333515947718573,0.0205710597247094,0.0336448848752774,4.68606904063701e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39749,-0.0470171022057109,0.00578568903248752,-0.0583570527093865,-0.0356771517020354,4.74336881957894e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,37411,-0.0855952728372709,0.0105330591193111,-0.106240068711121,-0.0649504769634213,4.80528695060679e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,-0.0189475156446007,0.0023376849534937,-0.0235293781534483,-0.014365653135753,5.6415035062789e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,37445,-0.0586650863375071,0.00723661377785921,-0.0728488493421111,-0.044481323332903,5.64346162850091e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,40058,-0.030803528979368,0.00380495250751117,-0.0382612358940899,-0.0233458220646461,6.09793829427079e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,39859,-0.0253665536784842,0.0031335349235912,-0.031508282128723,-0.0192248252282455,6.12575889062561e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37124,-0.0181757794782252,0.0022458268809867,-0.0225776001649592,-0.0137739587914913,6.31833460016594e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,40009,-0.0523425048858703,0.00647232871953373,-0.0650282691761564,-0.0396567405955842,6.53933494278489e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,39858,0.0206694110614916,0.00255984192349815,0.0156521208914352,0.025686701231548,7.25479969869512e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,39913,0.0216426343461888,0.00268206504816757,0.0163857868517804,0.0268994818405973,7.56099594605723e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39862,-0.07510861654094,0.00932198996021083,-0.0933797168629533,-0.0568375162189268,8.35655812795612e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,40052,0.0230442038472503,0.00286225450168085,0.0174341850239558,0.0286542226705448,8.77346531517444e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,39829,-0.0532574476941396,0.0066270905006976,-0.0662465450755069,-0.0402683503127723,9.90009670275908e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,37437,-0.0183649003451428,0.00228525441762749,-0.0228439990036927,-0.0138858016865929,1.00226624544463e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,-0.0387989539229665,0.00482820478420992,-0.0482622353000179,-0.029335672545915,1.00563823748041e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39788,-0.0677779327761604,0.0084434441517083,-0.0843270833135087,-0.0512287822388122,1.06558948245051e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,-0.0331867674907851,0.00413497407524263,-0.0412913166782606,-0.0250822183033095,1.07757418545937e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,37437,-0.0657402506313255,0.00819081289425902,-0.0817942439040731,-0.0496862573585778,1.08842929163386e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37382,-0.0689350165994464,0.00859061698569607,-0.0857726258914107,-0.0520974073074821,1.10336141842692e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,-0.0413718336518242,0.0051604956247414,-0.0514864050763173,-0.031257262227331,1.17407543615229e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37124,-0.0623771028059546,0.00778960335522945,-0.0776447253822043,-0.0471094802297048,1.26523778783065e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,-0.0548659032884518,0.00685971213371228,-0.0683109390705278,-0.0414208675063757,1.36647509544769e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,-0.0535908557917099,0.00670403751323653,-0.0667307693176535,-0.0404509422657663,1.39918605081641e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,37437,-0.0599116123658426,0.00749668606784247,-0.0746051170588138,-0.0452181076728713,1.43719224485104e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,39913,-0.0237108818904961,0.00296791095565419,-0.0295279873635783,-0.0178937764174139,1.45113528475904e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37437,-0.0184939306477865,0.00231849325336276,-0.0230381774243775,-0.0139496838711955,1.62265502837237e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,-0.0369534848109029,0.00463558975807704,-0.0460392407367339,-0.0278677288850719,1.67015313148164e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,37382,-0.0829238505568405,0.0104055639324113,-0.103318755864367,-0.0625289452493143,1.72452378232127e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,-0.0593760037320241,0.00746383653750958,-0.0740051233455429,-0.0447468841185054,1.9087585275593e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,37437,-0.0348931073077563,0.00439361720474147,-0.0435045970290496,-0.026281617586463,2.14905675758613e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0316600709189153,0.00399350799052427,0.0238327952574877,0.0394873465803429,2.37524137208765e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,37306,-0.074338865207658,0.00938809462790103,-0.092739530678344,-0.055938199736972,2.59331729425366e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39858,-0.0406575084860238,0.00513818607614674,-0.0507283531952714,-0.0305866637767762,2.68010621794013e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,39749,-0.028748247225482,0.00364038136089674,-0.0358833946928396,-0.0216130997581244,3.04163310719083e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,39913,-0.0436924374844055,0.00553559953262885,-0.054542212568358,-0.032842662400453,3.13965644596473e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37039,-0.0573816875679618,0.00727021422363359,-0.0716313074462836,-0.04313206768964,3.18956694758804e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,0.0236372850636572,0.00299598754933918,0.0177651494669524,0.0295094206603619,3.22458268061203e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,0.0168199233100163,0.00213426983219307,0.0126367544389179,0.0210030921811148,3.46266363351008e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,40009,0.0178406641423972,0.00226469984938904,0.0134018524375947,0.0222794758471997,3.54520776307339e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37437,-0.0568448389107297,0.00721710849462246,-0.0709903715601897,-0.0426993062612697,3.62432801578426e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,-0.0171809740395398,0.00218415388278376,-0.021461915649796,-0.0129000324292836,3.93090192017554e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HLA_E,,39866,-0.0214646547342564,0.00273145883004564,-0.0268183140411458,-0.0161109954273669,4.13968092404417e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,39749,0.0328200340293225,0.00418252721190037,0.0246222806939978,0.0410177873646472,4.53321606113353e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,36543,-0.0191775425003183,0.00244529580527638,-0.02397032227866,-0.0143847627219765,4.76405643960524e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,37368,-0.0166953999672103,0.00213303645168787,-0.0208761514125185,-0.012514648521902,5.36433863992945e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40052,0.0192954833574824,0.00246690803486973,0.0144603436091377,0.0241306231058271,5.52982810463633e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39585,-0.0290513587535947,0.0037141265987227,-0.0363310468870911,-0.0217716706200982,5.53402615587623e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39866,0.0340652082095461,0.00436083644390473,0.0255179687794928,0.0426124476395994,5.99415690410177e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39931,-0.0982296812498243,0.0125765585355307,-0.122879735979464,-0.0735796265201843,6.04433425634806e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,39585,-0.0449175091538669,0.00575303383824094,-0.0561934554768191,-0.0336415628309146,6.19334603165873e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,37371,-0.0662173645348525,0.00848356240336478,-0.0828451468454475,-0.0495895822242575,6.36726823025021e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,39866,-0.0667385804646786,0.00857690191506525,-0.0835493082182064,-0.0499278527111507,7.62056712425454e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,-0.0414228416944629,0.0053251049957642,-0.0518600474861608,-0.0309856359027651,7.85170953445426e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,40009,-0.060224014297645,0.00775282751771265,-0.0754195562323618,-0.0450284723629282,8.44988132915523e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39826,-0.0500370475789621,0.00644665961019591,-0.0626725004149461,-0.0374015947429782,8.88507926160365e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,37043,-0.0578750960081108,0.00746107410399457,-0.0724988012519401,-0.0432513907642814,9.33785187899066e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,39477,-0.0425872122191009,0.005493293892929,-0.0533540682492418,-0.0318203561889601,9.55707850090862e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40052,-0.0241419843870576,0.00311556857355277,-0.030248498791221,-0.0180354699828942,9.82254910552976e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EZR,Ezrin,40009,-0.0185445422114245,0.00239342439379184,-0.0232356540232565,-0.0138534303995925,9.87815539620191e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,37388,-0.0474006008327325,0.00612330917384865,-0.0594022868134758,-0.0353989148519891,1.05607515347193e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,39453,0.0337043245174122,0.00435642040116276,0.0251657405311332,0.0422429085036912,1.08251400609994e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,-0.0700894510293304,0.00906017903092993,-0.087847401929953,-0.0523315001287077,1.0984150847258e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,39843,-0.029939456306438,0.00387506364469369,-0.0375345810500377,-0.0223443315628384,1.17370821389297e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,37249,-0.0850155542662545,0.0110076467725052,-0.106590541940365,-0.0634405665921443,1.21369460477358e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39908,0.0592996614696723,0.00768457343614674,0.0442378975348247,0.0743614254045199,1.26360454518116e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39830,-0.015052163761748,0.00195152456158798,-0.0188771519024604,-0.0112271756210356,1.30088375250626e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,-0.0860601512647867,0.0111673619450503,-0.107948180677085,-0.0641721218524882,1.37054518781587e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37135,-0.0501983792073697,0.00651640734979779,-0.0629705376129733,-0.037426220801766,1.41882436815549e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39477,-0.042004566572446,0.0054549021713902,-0.0526961748283708,-0.0313129583165212,1.43818625799133e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37021,-0.0282918430367671,0.00367554211791483,-0.0354959055878801,-0.021087780485654,1.48826702880753e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,39749,-0.038221527321179,0.00497395228301311,-0.0479704737958847,-0.0284725808464733,1.62741172465898e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40052,-0.0244648558724414,0.0031904709575792,-0.0307181789492967,-0.0182115327955862,1.8443966553076e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39908,0.034475224965834,0.00450352334598826,0.025648319207697,0.0433021307239709,2.04012500547424e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,39477,-0.0449359194171471,0.00586997028471569,-0.0564410611751899,-0.0334307776591044,2.04237800357377e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,-0.0488548613942028,0.00639051579844656,-0.061380272359158,-0.0363294504292475,2.2311532412915e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,37388,-0.0578830133095584,0.00757149518940396,-0.0727231438807902,-0.0430428827383266,2.23240300663953e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39667,0.0289283689790928,0.00379161555999473,0.0214968024815031,0.0363599354766824,2.48939953563346e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,39913,-0.0409329617717149,0.00536776177003734,-0.0514537748409881,-0.0304121487024417,2.56257450135036e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39931,-0.0790159790470332,0.0103646225528133,-0.0993306392505472,-0.0587013188435192,2.6039270575955e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,39789,-0.0570809917345363,0.00748733849709737,-0.0717561751888471,-0.0424058082802255,2.60426193228511e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39585,-0.0554535227363426,0.00728982473140129,-0.0697415792098891,-0.041165466262796,2.96425923477226e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39762,-0.0214703126102088,0.00282640064985974,-0.0270100578839339,-0.0159305673364837,3.215210050325e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39489,-0.0509723208357506,0.0067109856670747,-0.064125852743217,-0.0378187889282842,3.24282310599184e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,0.0265314782821827,0.00350247957317133,0.0196666183187669,0.0333963382455985,3.82857608733927e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,37385,-0.0729920595225523,0.00963874948459831,-0.091884008512365,-0.0541001105327396,3.88987817222177e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,40058,0.0297163539628741,0.00392829023857034,0.0220169050952762,0.0374158028304719,4.09568275169723e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,40058,-0.0323553311763188,0.00427900199186147,-0.0407421750803673,-0.0239684872722704,4.20008197343174e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,-0.0440064977615853,0.0058327450432357,-0.0554386780463273,-0.0325743174768433,4.82700933254188e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,37411,-0.0417728287997054,0.0055434573121907,-0.0526380051315991,-0.0309076524678116,5.17194238419892e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,39931,-0.0364158838535867,0.00483355200479328,-0.0458896457829816,-0.0269421219241919,5.18306899376739e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39788,0.0305318312771092,0.00405320489174296,0.022587549689293,0.0384761128649254,5.23387944630451e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,-0.049490383472501,0.00657520693034592,-0.062377789055979,-0.036602977889023,5.52686574502622e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,-0.0769700556619053,0.0102344387798368,-0.0970295556703854,-0.0569105556534252,5.79175941510882e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,37124,-0.0380430054571948,0.00505919515335171,-0.0479590279577641,-0.0281269829566254,5.84806582682029e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,39489,-0.0535474607620521,0.00712369832636492,-0.0675099094817273,-0.0395850120423768,5.9169932971726e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,39868,-0.0321617754969115,0.00428100435241478,-0.0405525440276444,-0.0237710069661785,6.0987455656829e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,36879,-0.0523406011441551,0.00697679939771908,-0.0660151279636845,-0.0386660743246257,6.68767451306176e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,-0.0602733456147667,0.00803490370041413,-0.0760217568675784,-0.044524934361955,6.70447902183483e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,37039,-0.0368019032573393,0.00490931802882606,-0.0464241665938384,-0.0271796399208402,6.98125985226654e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.019076848099285,0.00254694377463838,0.0140848383009937,0.0240688578975762,7.24090830485931e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,39477,-0.0735789365667508,0.00982827586498222,-0.092842357262116,-0.0543155158713857,7.4531847223618e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.0213425533888289,0.0028513578551515,0.015753891992732,0.0269312147849259,7.51923109744857e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,-0.057955668463093,0.00774572026410168,-0.0731372801807323,-0.0427740567454537,7.75368525980129e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37411,-0.0391884217419398,0.00523934917726545,-0.0494575461293801,-0.0289192973544995,7.9108197567505e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,-0.0526363208798666,0.0070383850420322,-0.0664315555622497,-0.0388410861974835,7.9117312488505e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,39972,-0.0507929300273771,0.00679313323364099,-0.0641074711653134,-0.0374783888894407,7.98851262076517e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,39749,-0.0462039919992678,0.00618393074958348,-0.0583244962684515,-0.0340834877300842,8.33286625985087e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,39858,0.0658067408672904,0.00880918018427031,0.0485407477061206,0.0830727340284602,8.41726909035767e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDK,Midkine,39843,-0.0376315930751989,0.00504180019254026,-0.0475135214525778,-0.02774966469782,8.83057210350212e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,-0.0443038050139063,0.00595518855978584,-0.0559759745910865,-0.032631635436726,1.06258944803532e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,-0.0279862793659189,0.0037619919709607,-0.0353597836290019,-0.0206127751028359,1.07390822340707e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,-0.041903641873219,0.00563504404867328,-0.0529483282086186,-0.0308589555378194,1.08914294740637e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39587,-0.0441518909462752,0.005937479793726,-0.0557893513419781,-0.0325144305505722,1.09016156583974e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,-0.0160395075448167,0.0021609997564732,-0.0202750670675042,-0.0118039480221292,1.22145939499568e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,39931,-0.0784837843355525,0.0105782937858096,-0.0992172401557394,-0.0577503285153656,1.23597940166129e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,-0.0419936766143377,0.00566033189485709,-0.0530879271282576,-0.0308994261004178,1.23976553573241e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,-0.0578944139367713,0.00780398972470842,-0.0731902337971998,-0.0425985940763429,1.24479982657344e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),37186,0.130115230007229,0.0175719158311569,0.0956742749781613,0.164556185036296,1.39308184081557e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,-0.0396896346255673,0.00536580343670335,-0.0502066093615059,-0.0291726598896287,1.47881441097193e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,37437,-0.0217851647519705,0.00294610739871813,-0.0275595352534581,-0.016010794250483,1.50185370703796e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,-0.0462189597349752,0.00625789333136364,-0.058484430664448,-0.0339534888055025,1.60515515176198e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,37149,0.022743213052089,0.00307970332965392,0.0167069945259674,0.0287794315782107,1.6168607099783e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,-0.0833013106216718,0.0113058915265023,-0.105460858013616,-0.0611417632297273,1.81722722268971e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37407,0.0106434464545976,0.0014444531208939,0.00781231833764555,0.0134745745715496,1.82547453504748e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37039,-0.0587787122481654,0.0079893901142791,-0.0744379168721524,-0.0431195076241783,1.99069252377196e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39489,-0.0424742732968532,0.00578219539182374,-0.0538073762648277,-0.0311411703288787,2.14787186471334e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,37124,-0.0213991132316262,0.00291279469641403,-0.0271081908365977,-0.0156900356266547,2.15201521828404e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,39489,0.0538779457116498,0.00733930563190609,0.0394929066731139,0.0682629847501858,2.22417228234593e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,39486,-0.0210681808917867,0.00287006871131806,-0.0266935155659702,-0.0154428462176033,2.23016687726425e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39885,0.0174205002630985,0.00237361617028423,0.0127682125693414,0.0220727879568556,2.2513529910601e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,39866,-0.0426500235460524,0.00581530379334218,-0.0540480189810031,-0.0312520281111017,2.33899055942548e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,37437,-0.0293660571469022,0.00400565544959621,-0.0372171418281108,-0.0215149724656936,2.41091679072847e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,39931,-0.0215911988433262,0.00294605990501329,-0.0273654762571523,-0.0158169214295002,2.43188961925331e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,-0.0752983231886749,0.0102752926743019,-0.0954378968303067,-0.0551587495470431,2.44505334106369e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,39856,0.0450946506546091,0.00615465742729571,0.0330315220971095,0.0571577792121087,2.46746640972913e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,37382,-0.0521347489102581,0.00711523227895739,-0.0660806041770146,-0.0381888936435016,2.48322341470209e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,37368,-0.0605691757567045,0.00827997487875419,-0.0767979265190627,-0.0443404249943463,2.71600669054803e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37124,-0.0303509132793478,0.00414998231387695,-0.0384848786145466,-0.022216947944149,2.75192343454095e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,37453,-0.0258444882210031,0.00353424519907904,-0.0327716088111981,-0.0189173676308082,2.76690452505774e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39477,-0.0338289108654505,0.00463415748960651,-0.0429118595450793,-0.0247459621858217,3.01841384743803e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36991,-0.0475810094560331,0.00652102037284279,-0.0603622093868049,-0.0347998095252612,3.12170420175873e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,39788,-0.0237801127778752,0.00326124384286352,-0.0301721507098877,-0.0173880748458627,3.20378451038153e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,-0.0560793758711566,0.00769626509397486,-0.0711640554553473,-0.0409946962869658,3.36025729502839e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,39984,-0.0430674724135779,0.00591620935821713,-0.0546632427556835,-0.0314717020714724,3.50319851706513e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,37043,-0.0343278068094858,0.0047152426400207,-0.0435696823839264,-0.0250859312350453,3.52270735563463e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,37445,-0.016284360310638,0.00223738099871085,-0.0206696270681113,-0.0118990935531648,3.56573577984491e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,40011,-0.041874482220872,0.00575510398400768,-0.053154486029527,-0.0305944784122169,3.59499197740391e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,-0.0268224132545984,0.0036880000255735,-0.0340508933047225,-0.0195939332044744,3.6816535962768e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,39866,-0.0479594392277101,0.00659878655174794,-0.060893060869136,-0.0350258175862841,3.8191932947771e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39866,-0.0314824082002028,0.00433383482674877,-0.0399767244606304,-0.0229880919397752,3.92158484883705e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,39846,-0.0269907339316488,0.0037187840277266,-0.0342795506259929,-0.0197019172373046,4.11074044485878e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40058,-0.04055072335468,0.00558764928956007,-0.0515025159622177,-0.0295989307471422,4.1307802815756e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39767,-0.0335953872074291,0.00463814324619769,-0.0426861479699766,-0.0245046264448816,4.58015209974471e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,-0.0678564435801284,0.00936693850944997,-0.0862156430586503,-0.0494972441016065,4.58321413857362e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,40009,0.0213183426650756,0.00294562289812567,0.0155449217847493,0.0270917635454019,4.78303487093191e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,37056,-0.0326820513191739,0.00451600714024136,-0.0415334253140469,-0.0238306773243008,4.84300584067417e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,-0.023826116363278,0.0032927023353377,-0.0302798129405399,-0.0173724197860162,4.87927006245919e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPARC,SPARC,39913,-0.0507972656634059,0.00702773564215647,-0.0645716275220326,-0.0370229038047793,5.11796752509614e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,40052,-0.0391104499986412,0.00541582035457975,-0.0497254578936175,-0.0284954421036649,5.36954407662748e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39835,-0.0318223461982699,0.00440844443258656,-0.0404628972861396,-0.0231817951104003,5.49301914579153e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,37415,-0.0321863363690269,0.00446174104918827,-0.0409313488254359,-0.0234413239126179,5.72782556142901e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,39985,-0.0514957807187018,0.00714155970316635,-0.0654932377369078,-0.0374983237004957,5.81270381265651e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39835,0.0124944029011395,0.00173359529224313,0.00909655612834296,0.015892249673936,5.96590777828085e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,40052,0.0218944782281481,0.00303953988059908,0.0159369800621739,0.0278519763941223,6.1394228862398e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,40011,-0.0192803513282351,0.00268047650611661,-0.0245340852802236,-0.0140266173762465,6.62204996096438e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,39805,-0.081640099427463,0.0113575980118724,-0.103900991530733,-0.0593792073241931,6.85870745297386e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,39788,0.0202890015510574,0.00282687410083231,0.0147483283134261,0.0258296747886887,7.42992844867253e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,39891,0.0199713208969661,0.00278555444546483,0.0145116341838551,0.0254310076100772,7.84969506289544e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,39931,-0.0465307956686581,0.00649096032560327,-0.0592530779068405,-0.0338085134304757,7.90909767158024e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,-0.0323721152394256,0.00452072683364131,-0.0412327398333625,-0.0235114906454886,8.37712926132122e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39858,-0.0213680818857606,0.00299037683749819,-0.027229220487257,-0.0155069432842641,9.34587641400704e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,39749,-0.046291968168024,0.00647917901974051,-0.0589911590467154,-0.0335927772893326,9.4089922577856e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,37437,-0.0460739341067668,0.00645176237436549,-0.0587193883605232,-0.0334284798530104,9.71604051409465e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,37208,-0.0196800652958412,0.00275791578371912,-0.0250855802319307,-0.0142745503597517,1.01157944777438e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39477,-0.0280290089288601,0.00393215025856491,-0.0357360234356473,-0.0203219944220729,1.06170379869188e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,40031,0.0289964091910968,0.00407133001348095,0.0210166023646741,0.0369762160175194,1.10772924029373e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,39619,-0.030100801497298,0.00422844639035406,-0.038388556422392,-0.0218130465722041,1.13697422634244e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0172586078422993,0.00242754278610148,0.0125006239815404,0.0220165917030582,1.21390086982488e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,39788,-0.0392042154031874,0.00551440779830196,-0.0500124546878593,-0.0283959761185156,1.21483640717578e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37411,-0.0454978349281617,0.00641526577047267,-0.0580717558382881,-0.0329239140180352,1.38621746830504e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37056,-0.0645362680911818,0.00910054603774491,-0.0823733383251618,-0.0466991978572017,1.39450978575131e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,39790,-0.0307082676599343,0.00433284951976217,-0.0392006527186681,-0.0222158826012004,1.42472605436881e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,39868,-0.0866373841458554,0.0122327831020154,-0.110613639025806,-0.0626611292659052,1.47580399732715e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,39749,-0.0236939525460928,0.00334621896155856,-0.0302525417107476,-0.017135363381438,1.49313157504815e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39836,-0.0598954173740453,0.00849433094312452,-0.0765443060225693,-0.0432465287255212,1.84617122898726e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,37388,-0.0580157883628649,0.00822836634880929,-0.0741433864065311,-0.0418881903191987,1.86649536848817e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40009,-0.0480969214052547,0.00682931330113918,-0.0614823754754875,-0.034711467335022,1.96127992066044e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40002,-0.0223827670579647,0.00317883295954311,-0.0286132796586692,-0.0161522544572602,1.98286504729616e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,-0.068468804655377,0.00972930113079348,-0.0875382348717322,-0.0493993744390218,2.05570105440829e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,40058,-0.0349729919670464,0.00497150220190421,-0.0447171362827787,-0.0252288476513142,2.07690554679897e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37411,-0.0437634652911141,0.00623743712073463,-0.055988842047754,-0.0315380885344742,2.38712538670802e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,37411,0.0315022513388208,0.00449227268555701,0.022697396875129,0.0403071058025125,2.45116981753954e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39477,-0.0236835209681624,0.00337897296695748,-0.030306307983399,-0.0170607339529257,2.49692835030424e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,-0.0382402194597303,0.00545949909080511,-0.0489408376777083,-0.0275396012417522,2.58069561335576e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,37043,0.0297932066853504,0.00425540248935636,0.021452617806212,0.0381337955644889,2.65943180830279e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39868,0.0543245008600928,0.00776072247406939,0.0391134848109168,0.0695355169092688,2.66260847736248e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,-0.0292050773793975,0.00417463619567407,-0.0373873643229187,-0.0210227904358763,2.73997999237938e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NBN,Nibrin,39587,-0.0358279199306748,0.00513579544052113,-0.0458940789940962,-0.0257617608672533,3.15546310163442e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37424,0.0131022893761238,0.00187894917273136,0.00941954899757034,0.0167850297546773,3.24151101763469e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37411,-0.0505738451315454,0.00725361473541803,-0.0647909300129647,-0.036356760250126,3.26409973343889e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,39453,-0.0312448879212169,0.00448848716286481,-0.040042322760432,-0.0224474530820019,3.51046544839242e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,37388,-0.0749915551006361,0.0107893485659238,-0.0961386782898467,-0.0538444319114255,3.80622112035799e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,37377,-0.0523736087078756,0.00754048855666165,-0.0671529662789325,-0.0375942511368188,3.93940730482926e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,37124,-0.0805504273833434,0.0116072340520962,-0.103300606125452,-0.0578002486412349,4.11259601540619e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,-0.0294078391398273,0.00424101388244074,-0.0377202263494111,-0.0210954519302435,4.24224111950285e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,37124,0.0226157775717157,0.00326154306277513,0.0162231531686764,0.029008401974755,4.27825815689442e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,39713,-0.0444700090689305,0.00642316874360135,-0.0570594198063891,-0.0318805983314718,4.5792984549893e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39841,-0.0672755395929885,0.00971916427104427,-0.0863251015642353,-0.0482259776217417,4.62419539783369e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,-0.023758138441803,0.00343257803623863,-0.0304859913928307,-0.0170302854907753,4.64363028499519e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,40024,-0.0474942049526752,0.00686224212103301,-0.0609441995098999,-0.0340442103954505,4.65016850654477e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,37368,-0.027379977442312,0.00395625031266187,-0.0351342280551293,-0.0196257268294948,4.69722034514427e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,39489,-0.0238556901749851,0.00345201866711328,-0.0306216467625271,-0.0170897335874431,5.01086094098106e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,-0.0278526810077939,0.00403334290925396,-0.0357580331099317,-0.0199473289056562,5.19036321838928e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37382,-0.0327183926721061,0.00474035572258253,-0.0420094898883679,-0.0234272954558443,5.35242808731192e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,-0.0258849816839807,0.00375669788537447,-0.0332481095393147,-0.0185218538286467,5.77288097820421e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,39858,0.0216395752381629,0.00314118148740847,0.0154828595228423,0.0277962909534835,5.8283256415821e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37043,-0.0710406819154644,0.010311092020618,-0.0912504222758757,-0.0508309415550531,5.84350407509576e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,37043,0.0449998343593373,0.00654704353119533,0.0321676290381944,0.0578320396804801,6.55522455398659e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,-0.0387157180768143,0.0056356216970417,-0.0497615366030161,-0.0276698995506126,6.67102837960953e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,37368,-0.0439615437996441,0.0064016891117001,-0.0565088544585763,-0.0314142331407119,6.8346841545507e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,-0.0191789659600289,0.0027952859428111,-0.0246577264079387,-0.0137002055121192,7.08089243983438e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37056,-0.0539913518099671,0.00786896997414148,-0.0694145329592844,-0.0385681706606498,7.12821229915948e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,37348,-0.0300814848699886,0.00438872588575653,-0.0386833876060714,-0.0214795821339058,7.47956890857046e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,37388,-0.0379218553900558,0.00553331968379017,-0.0487671619702845,-0.0270765488098271,7.52566471875156e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,39720,-0.0352948084496694,0.00515197628952284,-0.0453926819771342,-0.0251969349222046,7.61751414033609e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39962,-0.0286289427633826,0.00418045748707446,-0.0368226394380485,-0.0204352460887166,7.74461817082881e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,-0.0298739195517348,0.00436893725117688,-0.0384370365640415,-0.0213108025394281,8.3928272479745e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37411,-0.0523900475948487,0.00766347127561191,-0.067410451295048,-0.0373696438946493,8.47228213518849e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,-0.0535458351530156,0.00784345980380996,-0.0689190163684832,-0.0381726539375481,8.99645253489892e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,39477,-0.0317214193228941,0.00465643367082476,-0.0408480293177107,-0.0225948093280776,9.95004768113454e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,36942,0.0422374958933462,0.00622743674430847,0.0300317198745016,0.0544432719121908,1.23203648929307e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCN,Decorin,39585,0.0146551899424947,0.00216110153879376,0.010419430926459,0.0188909489585305,1.23297576660239e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,39882,-0.0420554851478479,0.00620479145659988,-0.0542168764027837,-0.0298940938929121,1.26184327940926e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELL,L-selectin,37453,0.0152860821485933,0.00226012347514724,0.0108562401373047,0.0197159241598819,1.40315876113885e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,-0.018930803408379,0.00279995689731242,-0.0244187189271114,-0.0134428878896467,1.41676905487698e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,39866,0.0284886479113574,0.00421618226750918,0.0202249306670394,0.0367523651556754,1.4575979317225e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,-0.0170533185235281,0.00252784057331384,-0.0220078860472232,-0.012098750999833,1.5697103200808e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,37445,0.0410560656750087,0.00608660699359912,0.0291263159675544,0.0529858153824629,1.58877102426965e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.0395922661085523,0.00588776189171107,-0.051132279416306,-0.0280522528007986,1.8220006870579e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37056,-0.0654753508492433,0.0097554378026823,-0.0845960089425006,-0.046354692755986,2.00260565657135e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,37056,-0.0306218306489794,0.0045668360827612,-0.0395728293711914,-0.0216708319267675,2.09228616663996e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,-0.0289986984202567,0.00432824020128308,-0.0374820492147715,-0.0205153476257418,2.16977437304319e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39757,-0.0178549412680578,0.00266638156963681,-0.023081049144546,-0.0126288333915697,2.20896310591413e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39858,-0.0223954032731655,0.00335022707930103,-0.0289618483485955,-0.0158289581977355,2.38980412505886e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,39713,0.031570026637705,0.00472468941382495,0.0223096353866081,0.0408304178888019,2.43677580235059e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,37056,-0.0279855613294268,0.00418781981089891,-0.0361936881587887,-0.0197774345000649,2.44151083849488e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,-0.0318419469820789,0.00477177004629311,-0.0411946162728134,-0.0224892776913444,2.60393782983441e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,37388,-0.0440716668530446,0.00661306712979591,-0.0570332784274446,-0.0311100552786446,2.76170712388726e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,39788,-0.0629181953828685,0.00946536293130539,-0.081470306728227,-0.0443660840375099,3.08414153351895e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39537,-0.0332059511678742,0.00500037501008451,-0.0430066861876398,-0.0234052161481086,3.22477134926849e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,37043,-0.0511091857878629,0.00771077337210957,-0.0662223015971976,-0.0359960699785281,3.52828429753782e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39913,-0.0224417611124116,0.00338990149585287,-0.0290859680442832,-0.0157975541805399,3.70132628911523e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37445,-0.0405284552907705,0.00612192281054451,-0.0525274239994378,-0.0285294865821033,3.72142943126987e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37388,-0.020602642963666,0.00311246579170389,-0.0267030759154056,-0.0145022100119263,3.742664161717e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,-0.0715389266714471,0.0108234560167882,-0.092752900464352,-0.0503249528785422,3.9975543487665e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,-0.0615883502458163,0.00936794854349635,-0.0799495293910692,-0.0432271711005635,5.03985827815397e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,-0.0409886078199922,0.00625484717052465,-0.0532481082742205,-0.0287291073657639,5.84555395355663e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,40030,-0.0728514998728719,0.0111195337488617,-0.0946457860206407,-0.051057213725103,5.86157633337858e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,37021,-0.0257074409445931,0.00392548194461526,-0.033401385556039,-0.0180134963331472,6.01307466002579e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39904,-0.0465750420841145,0.00711616646431443,-0.0605227283541708,-0.0326273558140582,6.1314248493706e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37411,-0.0242179649456653,0.00370096461991276,-0.0314718556006943,-0.0169640742906362,6.21767761408872e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,39477,-0.0189970793610061,0.0029097854357097,-0.0247002588149971,-0.0132938999070151,6.83951827860482e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,37021,-0.0438875864420174,0.00672256124058531,-0.0570638064735646,-0.0307113664104702,6.89136349302975e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,39868,0.0452273973205067,0.0069492085742912,0.0316069485148959,0.0588478461261174,7.82745356494518e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,37382,-0.0440999382699773,0.00677587683964043,-0.0573806568756725,-0.030819219664282,7.86474200895007e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,37388,-0.0245934521422289,0.00378132115395493,-0.0320048416039805,-0.0171820626804772,8.09980530840592e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,-0.0384440733942029,0.00591218672505701,-0.0500319593753147,-0.0268561874130912,8.13869673736382e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36874,-0.0348081915255557,0.00535551323406443,-0.045304997464322,-0.0243113855867894,8.35221665883279e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,37056,-0.0355661699190432,0.00547347170215211,-0.0462941744552613,-0.024838165382825,8.4364041186315e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,37411,-0.0440195904359297,0.00678067655310858,-0.0573097164800226,-0.0307294643918369,8.7702823025396e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,37056,-0.0207340305867768,0.00319814569019516,-0.0270023961395594,-0.0144656650339943,9.30294539880289e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37411,-0.0390780361514378,0.00603838307089029,-0.0509132669703828,-0.0272428053324929,1.00302350637966e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,37056,-0.0365400155545217,0.00564770557061452,-0.0476095184729261,-0.0254705126361172,1.01538711157446e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,-0.0410821660571608,0.0063558018907242,-0.0535395377629803,-0.0286247943513414,1.05751633951237e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,39808,-0.0667764616662038,0.010334697789157,-0.0870324693329516,-0.046520453999456,1.0675581317106e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,37422,-0.0299608666916556,0.00463693132769334,-0.0390492520939346,-0.0208724812893767,1.07312797951735e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,37453,-0.0194471579292625,0.00301029936865731,-0.0253473446918309,-0.0135469711666942,1.08120210214265e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39846,-0.0441608031897714,0.00684358325634916,-0.0575742263722158,-0.030747380007327,1.12902686635052e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,40052,-0.0358670697217587,0.00556032183681299,-0.0467653005219121,-0.0249688389216052,1.14613225500197e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,-0.0471348126811174,0.00730954154835604,-0.0614615141158952,-0.0328081112463395,1.16278884842557e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,37453,-0.0198144772031392,0.00307563136571871,-0.0258427146799479,-0.0137862397263305,1.21552057040088e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,39749,-0.0623746338789091,0.00969485787286623,-0.0813765553097269,-0.0433727124480913,1.28024561056693e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,37368,-0.0231494619973749,0.00360295782916875,-0.0302112593425456,-0.0160876646522041,1.36178227880364e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,37411,-0.0352766933745036,0.00549134412401558,-0.0460397278575741,-0.024513658891433,1.37124603247882e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,-0.0408690570085132,0.00636266746164715,-0.0533398852333416,-0.0283982287836848,1.372451137385e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,-0.0617904808207761,0.0096262225325521,-0.0806578769845782,-0.042923084656974,1.41054615209369e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39489,-0.0323550998280893,0.00504324120927702,-0.0422398525982722,-0.0224703470579063,1.44363020825198e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,37138,0.0135714093903105,0.00211738104561818,0.00942134254089887,0.0177214762397221,1.50906236753662e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,-0.0189610334518048,0.00296109433024269,-0.0247647783390805,-0.0131572885645291,1.56990346387511e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37043,-0.0383621533849978,0.00599371218841981,-0.0501098292743006,-0.0266144774956949,1.60217168885361e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,37437,-0.0647924563322506,0.0101243553525348,-0.0846361928232188,-0.0449487198412824,1.60835152202284e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,-0.0195812018861998,0.0030618636589468,-0.0255824546577355,-0.0135799491146641,1.65618076403683e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,39868,-0.0423464289642494,0.00662510910639747,-0.0553316428127884,-0.0293612151157104,1.68469565106328e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,-0.0488936501925241,0.00764989547136163,-0.0638874453163929,-0.0338998550686553,1.68892162521567e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,39788,-0.0572391112577055,0.00895717138927723,-0.0747951671806888,-0.0396830553347221,1.70146776805109e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,-0.0415000463467091,0.00650918388260387,-0.0542580467566127,-0.0287420459368055,1.88151466239535e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,39858,-0.0354613348090673,0.00556633760427435,-0.046371356513445,-0.0245513131046896,1.93337542518535e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39372,-0.0231185379896477,0.00363218755052156,-0.0302376255886699,-0.0159994503906254,2.0089496047382e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,-0.0257340315535495,0.0040432125661168,-0.0336587281831384,-0.0178093349239605,2.01919368715026e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39585,-0.0480634185377268,0.00755385520293301,-0.0628689747354755,-0.0332578623399781,2.03632572898079e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,39913,-0.0429598773820538,0.00676861473392848,-0.0562263622605536,-0.029693392503554,2.25555916283134e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37124,-0.0439789709319943,0.00694136069847899,-0.0575840379010131,-0.0303739039629754,2.4376660973828e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,39868,-0.0336546104099898,0.00532478762592254,-0.044091194156798,-0.0232180266631816,2.67847139286613e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,37382,-0.0617359659633536,0.00979572562577072,-0.0809355881898642,-0.042536343736843,3.02289295538392e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,39344,-0.0479628657439197,0.00763598368158072,-0.062929393759818,-0.0329963377280215,3.45019217656406e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F3,Tissue factor,39931,0.0170135976044661,0.00270994031538651,0.0117021145863085,0.0223250806226236,3.51263640140967e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39017,-0.0224302183793909,0.00357407598513595,-0.0294354073102573,-0.0154250294485244,3.57277728904599e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40058,-0.0424260404270236,0.00676309490084579,-0.0556817064326813,-0.0291703744213658,3.6275025274218e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,37039,-0.0826826658194264,0.0131872652944894,-0.108529705796626,-0.0568356258422271,3.72585452362013e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,39908,-0.0356049857430949,0.00568567877759146,-0.0467489161471742,-0.0244610553390157,3.89185452025664e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37437,-0.015002188500398,0.00239835523887658,-0.0197029647685961,-0.0103014122321999,4.08920953826108e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37453,0.0158741445510574,0.00253910788951133,0.0108974930876152,0.0208507960144996,4.17723617832844e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,39858,0.0119152113868906,0.00190709249434545,0.00817731009797353,0.0156531126758077,4.2669020859445e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,39749,0.0206684103237805,0.00330960446723671,0.0141815855679965,0.0271552350795644,4.34632739343884e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,37411,-0.0416789997655498,0.00667647174382519,-0.0547648843834472,-0.0285931151476524,4.42996390310472e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39585,-0.0327522101601761,0.00525156723069891,-0.0430452819323459,-0.0224591383880062,4.58452096593886e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37388,-0.0222805672218672,0.00357238803105444,-0.0292824477627339,-0.0152786866810005,4.59660540908927e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,39855,-0.0485400145978148,0.00778855957933273,-0.063805591373307,-0.0332744378223227,4.71391311197588e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,37043,-0.0333496718679871,0.00535191853515653,-0.0438394321968939,-0.0228599115390803,4.76514982311274e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,39858,-0.0450766901830828,0.00724108240257792,-0.0592692116921355,-0.0308841686740301,4.93148475298455e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,39715,-0.045147248375255,0.00725542290892738,-0.0593678772767527,-0.0309266194737573,5.01417926169603e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,39669,-0.0287048890469819,0.00461317832960818,-0.0377467185730139,-0.0196630595209499,5.02045030511158e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,37453,0.0188184973329331,0.00302901830643044,0.0128816214523295,0.0247553732135368,5.35879870856799e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,-0.0232600915466454,0.00374733221062385,-0.0306048626794681,-0.0159153204138226,5.52991455669524e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,37056,0.01647656215942,0.00265763667886388,0.0112675942688468,0.0216855300499932,5.82555114782127e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,39821,-0.0418934201764646,0.00676287310985378,-0.055148651471778,-0.0286381888811512,5.98583607737021e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,-0.0227615202808805,0.00367668200888288,-0.0299678170182909,-0.01555522354347,6.1353992658324e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,-0.0404435341022037,0.00653728391518888,-0.0532566105759739,-0.0276304576284335,6.29587981026525e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,39785,-0.0541772215418932,0.00876138881293572,-0.0713495436152472,-0.0370048994685392,6.41706896623583e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,-0.0415715544295316,0.00672223138601878,-0.0547471279461284,-0.0283959809129348,6.42487767086261e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,37043,-0.0250447499679152,0.00404992542354741,-0.0329826037980681,-0.0171068961377623,6.43424510570759e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,39477,-0.0251341193098472,0.00406550299097299,-0.0331025051721543,-0.0171657334475402,6.47488566880335e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,-0.0625963877694645,0.0101291834897477,-0.08244958740937,-0.042743188129559,6.5734344795178e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.0195508821156029,0.00316955178397076,0.0133385606190202,0.0257632036121856,7.06509865399295e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39477,-0.0275010744834491,0.00446876159282527,-0.0362598472053866,-0.0187423017615115,7.73628351488503e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39477,-0.0568287461791033,0.0092386136032738,-0.07493642884152,-0.0387210635166867,7.87629340683317e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37124,-0.0417627638152688,0.0068096429666313,-0.0551096640298662,-0.0284158636006715,8.87507677342128e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,40058,-0.0303600683825433,0.00495112040324507,-0.0400642643729036,-0.0206558723921829,8.8817107244033e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,40052,-0.0261606281307785,0.00426647537023444,-0.034522919856438,-0.017798336405119,8.89779446608688e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,39868,0.0207881024478191,0.00339164932814791,0.0141404697646493,0.027435735130989,9.03910112214451e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,39881,-0.0652766054925254,0.0106679415578064,-0.0861857709458259,-0.0443674400392249,9.6384858822755e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,39477,-0.059550245243545,0.00974523266700112,-0.0786509012708672,-0.0404495892162229,1.01546932906914e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,39858,-0.0546174802683862,0.0089386885000016,-0.0721373097283893,-0.037097650808383,1.01789649999495e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,37043,-0.0378945284148591,0.00620649995644858,-0.0500592683294983,-0.0257297885002199,1.05278841068401e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,37124,-0.0253581684719881,0.00415356670728205,-0.0334991592182609,-0.0172171777257152,1.05566938686062e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39913,0.0173908540294509,0.00284972625807393,0.011805390563626,0.0229763174952758,1.06727248237601e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,-0.0198470978381997,0.00325297892559179,-0.0262229365323596,-0.0134712591440398,1.07705690055524e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37382,-0.0292308150715069,0.00479629507658551,-0.0386315534216145,-0.0198300767213993,1.12793839136001e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,-0.0515418254119737,0.00845751685375446,-0.0681185584453324,-0.0349650923786149,1.12966169150445e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.0184052214549239,0.0030274098115979,0.0124714982241921,0.0243389446856558,1.23780116543457e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.0274983159282887,0.00452524910808949,0.0186288276764333,0.0363678041801441,1.2549808858264e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37437,-0.0283638028310768,0.00466863955926023,-0.0375143363672268,-0.0192132692949267,1.26993955615723e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,-0.0648050826476955,0.0106735838924242,-0.085725307076847,-0.0438848582185441,1.30075096568116e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37124,0.0171903192876777,0.00283724698139778,0.0116293152041381,0.0227513233712174,1.40852110309875e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,39496,-0.0227546407662729,0.00375712580990697,-0.0301186073536906,-0.0153906741788553,1.42392331100315e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,39882,-0.0555484479354396,0.00918736157705777,-0.0735556766264729,-0.0375412192444064,1.51610940607434e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37382,-0.0242081305912655,0.00401464562174764,-0.0320768360098909,-0.0163394251726401,1.68279906165781e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,39868,-0.0233240347685223,0.00386855739346004,-0.0309064072597039,-0.0157416622773406,1.68465424430279e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40030,0.0352261023944561,0.00584554418525084,0.0237688357913644,0.0466833689975477,1.71559207352245e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39866,-0.0680176824514288,0.0113030890242325,-0.0901717369389246,-0.0458636279639331,1.80860212605899e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39489,-0.0405980924284837,0.00674964726176518,-0.0538274010615435,-0.027368783795424,1.84071073968171e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,0.066314212303544,0.0110267494539369,0.0447017833738276,0.0879266412332604,1.85034647709867e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,40012,0.0269056874314473,0.00448712406256099,0.0181109242688277,0.0357004505940668,2.06292615621362e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,-0.026893695702134,0.00448525694617629,-0.0356847993166396,-0.0181025920876285,2.06578730256227e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,-0.0214564699408668,0.0035800599617399,-0.028473387465877,-0.0144395524158566,2.10827011521369e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,-0.0459891051914434,0.00767659730376932,-0.0610352359068313,-0.0309429744760556,2.14090066853824e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,-0.0400136421275102,0.00667971192510465,-0.0531058775007153,-0.0269214067543051,2.14887828626821e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,37388,-0.0127591211705136,0.00213184629850085,-0.0169375399155753,-0.00858070242545199,2.21849264795325e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,37039,-0.0251260282223238,0.00419951424436348,-0.0333570761412763,-0.0168949803033714,2.24636490881318e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39749,0.0214760365638712,0.00359385241395178,0.0144320858325257,0.0285199872952167,2.33899040542999e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,37257,0.0642034348438353,0.0107443268130341,0.0431445542902885,0.0852623153973821,2.35112764696073e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,39866,-0.0423055964329449,0.00709270482378283,-0.0562072978875592,-0.0284038949783306,2.50300715327527e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,39885,0.0192470635699235,0.00323053026546321,0.0129152242496156,0.0255789028902313,2.60904896435283e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,39931,0.017835341446274,0.00299801628892961,0.011959229519972,0.0237114533725761,2.75305204255441e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,37318,0.0168010291190535,0.00283303185190428,0.0112482866893212,0.0223537715487859,3.09597028268857e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,0.0417409899156902,0.0070391507751023,0.0279442543964897,0.0555377254348907,3.10640604577615e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,-0.0351896690249921,0.00593531570706344,-0.0468228878108364,-0.0235564502391477,3.12461927962294e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37056,-0.0295729443946705,0.00498860955106352,-0.039350619114755,-0.019795269674586,3.14126413682733e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,37411,-0.0448647060380528,0.0075798635276682,-0.0597212385522825,-0.0300081735238232,3.3186777812745e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,-0.0283069536110905,0.00479206216651295,-0.0376993954574559,-0.0189145117647251,3.56864881527112e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,37453,-0.0244503912027705,0.00414307721861655,-0.0325708225512589,-0.016329959854282,3.68778317303454e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,39866,-0.049537776238405,0.00841256516660941,-0.0660264039649594,-0.0330491485118506,3.97408178470861e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,37357,-0.0187597240156286,0.0031864161604305,-0.0250050996900723,-0.0125143483411848,4.01626830516496e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,40030,-0.0223348109874984,0.00379876939642834,-0.0297803990044979,-0.0148892229704988,4.19648273981818e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39866,-0.0209804989262498,0.003569307317549,-0.0279763412686458,-0.0139846565838537,4.23428830151088e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,39788,0.0448377734169717,0.00762870726034759,0.0298855071866904,0.0597900396472529,4.24811115860608e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37124,-0.0232522521498528,0.00395749492393508,-0.0310089422007655,-0.01549556209894,4.31688719887046e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37123,-0.0308248746703675,0.00525250058648706,-0.0411197758198822,-0.0205299735208529,4.49960431732477e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,-0.016411492667069,0.00279708927169751,-0.0218937876395961,-0.0109291976945419,4.51499430256244e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,37039,-0.0265722852985531,0.00453541303447582,-0.0354616948461257,-0.0176828757509805,4.77225128433186e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,-0.0275303709805629,0.00470756110450398,-0.0367571907453907,-0.0183035512157351,5.06767971382621e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,39856,-0.0249053495464241,0.00426077018155692,-0.0332564591022757,-0.0165542399905725,5.15591153330273e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,-0.0212724522979919,0.0036454079974188,-0.0284174519729327,-0.014127452623051,5.49178765350455e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,40009,-0.0370633387292031,0.00636427171704431,-0.04953731129461,-0.0245893661637963,5.86671828028869e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,37124,-0.0390501715184547,0.00670762169635533,-0.0521971100433112,-0.0259032329935983,5.95781148627329e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,37043,-0.0297155258121159,0.00510432584211135,-0.0397200044626542,-0.0197110471615777,5.96311001128882e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,39931,0.0371866924006565,0.00641396675372375,0.024615317563358,0.0497580672379551,6.84638755351081e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,40009,-0.0200180574141088,0.00345331809243969,-0.0267865608752906,-0.013249553952927,6.88693717173559e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,39489,-0.0359419728375177,0.00620827039595349,-0.0481101828135865,-0.0237737628614489,7.20063641433824e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37388,0.0380919255629975,0.00658004762831188,0.0251950322115062,0.0509888189144888,7.23756246422595e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,37445,-0.0359958709723909,0.00621923652625491,-0.0481855745638505,-0.0238061673809312,7.28763090429677e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39826,-0.0129395138011624,0.00223881335618234,-0.0173275879792798,-0.00855143962304502,7.62612714041484e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39913,-0.035433076158305,0.00613262684657094,-0.0474530247775841,-0.023413127539026,7.70870259524019e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,-0.0331823035003153,0.00574492025419111,-0.0444423471985298,-0.0219222598021007,7.7946433512996e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37124,-0.03080650590828,0.00533330586965473,-0.0412597854128033,-0.0203532264037568,7.8097785385099e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,37043,-0.0400456873811565,0.0069447153505113,-0.0536573294681587,-0.0264340452941543,8.28212183935701e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,-0.0251014239205088,0.00435587752601269,-0.0336389438714937,-0.0165639039695239,8.46524377312641e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39672,-0.0678809130136708,0.0117838058869752,-0.0909771725521422,-0.0447846534751993,8.54115018784621e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,37388,-0.0412494695561,0.00716758219093013,-0.055297930650323,-0.0272010084618769,8.85175293807986e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,39749,-0.0466783919468071,0.00811260132890144,-0.0625790905514539,-0.0307776933421603,8.88595250218127e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,-0.0214308076887927,0.0037246206147632,-0.0287310640937285,-0.0141305512838568,8.91872666005732e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,39489,-0.0388696454606551,0.00675802637291406,-0.0521153771515666,-0.0256239137697435,9.00414288371527e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,39866,-0.0279654755757035,0.00487025480864315,-0.037511175000644,-0.0184197761507629,9.52071079251992e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,37021,-0.0385378222755424,0.00672210450698757,-0.0517131471092381,-0.0253624974418468,1.00836215534862e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,36991,-0.0368252090355617,0.00642596672916084,-0.0494201038247169,-0.0242303142464064,1.02221875607148e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.01646540264894,0.00287816258361938,0.0108242039850461,0.022106601312834,1.07893784906099e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37437,-0.0615128470102005,0.0107655422275617,-0.0826133097762215,-0.0404123842441795,1.12758240723678e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,37445,-0.0393258330776436,0.00688254074620078,-0.0528156129401972,-0.0258360532150901,1.12763640922569e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,37039,-0.0281337046536487,0.00492681686660886,-0.037790265712202,-0.0184771435950953,1.15197615052913e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,40052,-0.0133769592490822,0.00234311480617752,-0.0179694642691902,-0.00878445422897429,1.15599580509218e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,37021,-0.0269024537395888,0.00471254115416232,-0.036139034401747,-0.0176658730774307,1.16304796714143e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,39587,-0.0526982789720256,0.0092400116095749,-0.0708087017267925,-0.0345878562172588,1.19643406423283e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,-0.0173432045995981,0.00304118933969168,-0.0233039357053938,-0.0113824734938024,1.20356340598377e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,39826,-0.0387382446909235,0.0067955712453298,-0.0520575643317699,-0.0254189250500771,1.21557899085066e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,-0.041120529579569,0.00722074018057302,-0.0552731803334921,-0.0269678788256458,1.26152001195753e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,37056,-0.0255361097057626,0.0044843215575932,-0.0343253799586452,-0.0167468394528799,1.26349456826054e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,-0.0484059509455749,0.00851436101411118,-0.0650940985332328,-0.031717803357917,1.32986119640076e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37039,-0.024794603295451,0.00436134174087428,-0.0333428331075646,-0.0162463734833374,1.3352051681095e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37437,-0.0514474997988987,0.00906040228221743,-0.0692058882720449,-0.0336891113257526,1.38843888076954e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,-0.0837736439463585,0.0147548353114152,-0.112693121156732,-0.0548541667359846,1.39319225732697e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,39477,-0.0250174214292566,0.00440802356063301,-0.0336571476080973,-0.0163776952504159,1.40798969313785e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,37382,-0.0385135924451076,0.00679368583887269,-0.0518292166892981,-0.0251979682009172,1.46546174334939e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNC,Tenascin,39931,0.0266034053747195,0.00469687565206066,0.0173975290966807,0.0358092816527584,1.50359712937333e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,-0.0501630818920084,0.00885888782729522,-0.067526502033507,-0.0327996617505097,1.51794475644194e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,-0.0169975239053573,0.00300926825314582,-0.0228956896815232,-0.0110993581291915,1.64687576154102e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,-0.0186276090569097,0.00329917607552891,-0.0250939941649464,-0.0121612239488731,1.66847827995888e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,-0.0591069293798508,0.0104717558900446,-0.0796315709243382,-0.0385822878353634,1.69140922364081e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,37388,-0.0259752376422579,0.00460332397453031,-0.0349977526323374,-0.0169527226521785,1.70749646877552e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,37124,-0.0303663667514955,0.0053929504467664,-0.0409365496271576,-0.0197961838758333,1.83067583514472e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37388,-0.0302563098157,0.00537412621680293,-0.0407895972006337,-0.0197230224307662,1.8379785120363e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39585,-0.0522541486691283,0.00928774641611336,-0.0704581316447105,-0.0340501656935461,1.87429326761364e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,37333,-0.0195555583184951,0.00348154002997956,-0.026379376777255,-0.0127317398597352,1.9822952550623e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37056,-0.0506047704282275,0.00901155860043161,-0.0682674252850735,-0.0329421155713816,1.99904947662172e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37043,-0.0308081361633769,0.00549560360289956,-0.0415795192250601,-0.0200367531016938,2.11260717020045e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,-0.0586448170989923,0.0104639829166354,-0.0791542236155976,-0.038135410582387,2.12368765794426e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40030,0.0313187161569074,0.00559062856104811,0.0203610841772532,0.0422763481365617,2.15342114164823e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39913,-0.0142563547548048,0.0025456067020833,-0.0192457438908881,-0.00926696561872154,2.17394304321921e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,39809,-0.0153082845815313,0.0027337884921737,-0.0206665100261918,-0.00995005913687086,2.18316151378516e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,39810,-0.0226384428233518,0.0040457139161578,-0.0305680420990211,-0.0147088435476826,2.23398165430142e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,39555,-0.0211514283694146,0.00378065300882464,-0.0285615082667109,-0.0137413484721183,2.24761105734978e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37265,-0.0308832978666963,0.0055203943137698,-0.0417032707216851,-0.0200633250117075,2.25719812785318e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,37124,-0.0161538707277448,0.00289387911168086,-0.0218258737866393,-0.0104818676688503,2.42318883930436e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,37445,0.0143408784221241,0.0025694655099696,0.00930472602258369,0.0193770308216645,2.43340285631728e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39866,-0.0260568333568172,0.00467169146254249,-0.0352133486234005,-0.016900318090234,2.47804282892309e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,-0.0278578585581398,0.00500731269281881,-0.0376721914360646,-0.0180435256802149,2.68708355153019e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,39403,-0.0471871531620175,0.00848859177813706,-0.0638247930471661,-0.0305495132768689,2.75961593870536e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,-0.0608646210967857,0.0109710919506204,-0.0823679613200017,-0.0393612808735696,2.93975602476022e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40030,-0.0298832021079263,0.00539121817761667,-0.0404499897360549,-0.0193164144797976,3.02083850267459e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,40040,-0.028976571633894,0.00523154668162032,-0.0392304031298698,-0.0187227401379182,3.09268450714063e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,-0.0362742108525003,0.00655099475122279,-0.0491141605648969,-0.0234342611401036,3.12290120384681e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,-0.030854800544897,0.00557247003372303,-0.0417768418109942,-0.0199327592787999,3.12611927936897e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,40030,-0.0236544205576559,0.00428607553757011,-0.0320551286112933,-0.0152537125040185,3.46372395131799e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,-0.0531942326937832,0.00963879206390228,-0.0720862651390317,-0.0343022002485347,3.46741958020193e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,-0.0371255055362252,0.00673168609048527,-0.0503196102735763,-0.023931400798874,3.55090443532373e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,-0.0491560589961656,0.00891460871866869,-0.0666286920847562,-0.0316834259075749,3.56995681315769e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,37039,-0.044662634842082,0.00810300742489761,-0.0605445293948813,-0.0287807402892827,3.61735695447408e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,37124,0.0116053914855921,0.00210961942521607,0.00747053741216864,0.0157402455590156,3.84253219978167e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,-0.0469237381685136,0.00853658213199174,-0.0636554391472174,-0.0301920371898098,3.93797154545078e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,-0.0105510970737499,0.00192073496598025,-0.0143157376070712,-0.00678645654042859,4.00619316467486e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37432,-0.0105571092190248,0.00192215970725138,-0.0143245422452375,-0.00678967619281211,4.03833464037972e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39825,-0.0151036990301411,0.00275203322983768,-0.020497684160623,-0.00970971389965929,4.12244075824716e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,-0.0309918528310299,0.00565064340375669,-0.042067113902393,-0.0199165917596668,4.20552529985823e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39788,-0.0327260260271546,0.00598079961589694,-0.0444483932743126,-0.0210036587799965,4.5208860547959e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,39931,-0.0506578023393035,0.00927492169777079,-0.0688366488669342,-0.0324789558116727,4.78320217574499e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37021,-0.0369889475495191,0.00678765436051122,-0.0502927500961211,-0.0236851450029172,5.14367343504767e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,40009,-0.0628155176841693,0.0115333162837993,-0.0854208176004159,-0.0402102177679226,5.21389842397765e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39832,-0.0194200335092099,0.00356588432750083,-0.0264091667911115,-0.0124309002273083,5.22575746216787e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39931,-0.0702950930672105,0.0129157010302277,-0.0956098670864568,-0.0449803190479641,5.32753139614144e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,-0.0534111198775533,0.00981893460650083,-0.0726562317062949,-0.0341660080488117,5.42023365948899e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,39858,-0.0349511374853179,0.00642548178285605,-0.0475450817797158,-0.0223571931909201,5.42275838250803e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,39771,-0.0304532119631783,0.00559913594517882,-0.0414275184157288,-0.0194789055106278,5.4397758157066e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,39587,-0.0434633704973541,0.00800211795049206,-0.0591475216803185,-0.0277792193143896,5.67175204233365e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,-0.0348744652264807,0.00642514878817695,-0.0474677568513075,-0.0222811736016538,5.79011622773308e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37411,-0.0366790464717182,0.00678459952505147,-0.0499768615408191,-0.0233812314026174,6.54587632138728e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,40009,-0.0119143479309845,0.00220736409199461,-0.016240781551294,-0.0075879143106751,6.85121309680911e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39868,-0.0434837190371656,0.00805667811568648,-0.0592748081439111,-0.0276926299304201,6.86421033502804e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37056,-0.031568794411585,0.00585600825067097,-0.0430465705829001,-0.0200910182402699,7.13365039851577e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,-0.0423425157128592,0.00785676140193068,-0.0577417680606433,-0.026943263365075,7.17533201139707e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,-0.0293400757029314,0.00545006819343743,-0.0400222093620688,-0.0186579420437941,7.41135703558294e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,39908,-0.0468664090707786,0.00870887397167873,-0.0639358020552689,-0.0297970160862883,7.49234817559971e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,36991,-0.0212479206672523,0.00395246767030378,-0.0289947573010477,-0.0135010840334569,7.75210189772687e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,39858,-0.0281021281966073,0.00522949949049044,-0.0383519471979685,-0.017852309195246,7.81868259080722e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39913,0.0125664433547504,0.0023393411459234,0.00798133470874055,0.0171515520007603,7.90462790669401e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39477,-0.03062010887743,0.00570184135071221,-0.0417957179248259,-0.0194444998300341,7.97685224052924e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,39788,-0.0482708805912939,0.00899052898279302,-0.0658923173975682,-0.0306494437850196,8.02480098537363e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,37124,-0.0296786831444244,0.00553267876519413,-0.0405227335242049,-0.0188346327646439,8.26503066630145e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39868,0.0150105183331373,0.00279970010434136,0.00952310612862825,0.0204979305376464,8.36906077460353e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,39720,0.0167473769857343,0.00312517866830853,0.0106220267958496,0.022872727175619,8.49216189934703e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,-0.0448407513642161,0.00837363007598669,-0.0612530663131501,-0.0284284364152822,8.69596539314809e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,-0.0136249224944094,0.00254547977579233,-0.0186140628549624,-0.00863578213385648,8.7893097228658e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39877,-0.02098361422798,0.00392275396772259,-0.0286722120047163,-0.0132950164512438,8.95551930691735e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,37382,-0.0318443126242837,0.0059567348068626,-0.0435195128457344,-0.020169112402833,9.14136860293059e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,39238,0.0164421146572336,0.00307685059784317,0.010411487485461,0.0224727418290062,9.23088695344468e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,39788,-0.0377830778100368,0.00707091296128777,-0.0516420672141608,-0.0239240884059128,9.24480237483302e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.0163809441605684,0.0030664045657318,0.0103707912117341,0.0223910971094027,9.31483463215828e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,-0.0307230580267467,0.0057598341671496,-0.04201233299436,-0.0194337830591335,9.73788600038342e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37437,-0.0261608717796394,0.0049046844318826,-0.0357740532661293,-0.0165476902931495,9.76922298475392e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,-0.0241356162752482,0.00452581852449019,-0.033006220583249,-0.0152650119672474,9.82656270414177e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,-0.0324077476725993,0.00608050752649812,-0.0443255424245356,-0.020489952920663,9.96663931631665e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,-0.0264879542673045,0.00496967146147696,-0.0362285103317993,-0.0167473982028096,9.99100242209246e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,39405,-0.0628786799369752,0.0118067264440439,-0.0860198637673013,-0.0397374961066492,1.01983662312588e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,37437,-0.0438825550541326,0.00824108110545214,-0.0600350740208188,-0.0277300360874465,1.0264429235834e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39713,-0.012509370248797,0.00235007716695296,-0.0171155214960248,-0.0079032190015692,1.03481610553523e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,37388,-0.0376772481832889,0.00707919275165131,-0.0515524659765255,-0.0238020303900524,1.04126697016963e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39585,-0.0182266332920381,0.00342506719752513,-0.0249397649991873,-0.0115135015848888,1.04303434307182e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,-0.0305102160302665,0.00573737894436135,-0.0417554787612147,-0.0192649532993183,1.0674490690656e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,40009,-0.0176263173765781,0.00331606726723983,-0.0241258092203682,-0.011126825532788,1.07821299350078e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,37043,-0.0625784479047956,0.0117730966345308,-0.0856537173084759,-0.0395031785011152,1.08171960328847e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,0.0313197278410356,0.00589878909579684,0.0197581012132737,0.0428813544687974,1.11401226729395e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39749,-0.0421339668413716,0.00794896683679012,-0.0577139418414802,-0.026553991841263,1.16991723079047e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,-0.026767878520092,0.00505877287950546,-0.0366830733639227,-0.0168526836762613,1.22994247216209e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,37056,-0.0260846564713134,0.00493458028008948,-0.0357564338202887,-0.016412879122338,1.26947340353662e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37411,-0.0632707354897776,0.0119840770637309,-0.0867595265346902,-0.0397819444448649,1.31489677866592e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,37056,-0.0177473886459952,0.00336197637339931,-0.0243368623378578,-0.0111579149541325,1.32054090844625e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,37411,-0.0253810712766311,0.00480864823314499,-0.0348060218135953,-0.0159561207396669,1.32462366345218e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37389,-0.0104771112786644,0.00198546010388355,-0.0143686130822762,-0.00658560947505264,1.33402710016402e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39487,-0.0255157035619886,0.00483848156295596,-0.0349991274253823,-0.016032279698595,1.35633839206648e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,40003,-0.031743175305232,0.00602028691272183,-0.0435429376541667,-0.0199434129562972,1.36162554007427e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,37445,0.075595603374528,0.014345318356898,0.0474787793950079,0.103712427354048,1.38732705053003e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39931,-0.0131095753068475,0.00248872284250788,-0.017987472078163,-0.00823167853553208,1.4000783210045e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39835,-0.0186638103612121,0.00354380765772394,-0.025609673370351,-0.0117179473520731,1.40776805870739e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,37437,0.017704482896004,0.00336515828676023,0.0111087726539539,0.024300193138054,1.45362249881661e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,40030,0.0238601591942541,0.00453779092982035,0.0149660889718062,0.032754229416702,1.47403694204764e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,37267,0.021712066817355,0.00412958137480992,0.0136180873227275,0.0298060463119824,1.48115492947718e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,40030,-0.0196174153658309,0.00373869607862996,-0.0269452596799456,-0.0122895710517162,1.56439192516972e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,39731,0.01503114522679,0.00286592936505094,0.0094139236712901,0.0206483667822898,1.58485227504118e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,37445,-0.0249049047316426,0.00474848788024235,-0.0342119409769176,-0.0155978684863676,1.58794657161864e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,39585,-0.0253549562603366,0.0048407166480739,-0.0348427608905614,-0.0158671516301117,1.64551201203646e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37021,-0.0324586651885603,0.00619753446619932,-0.044605832742311,-0.0203114976348096,1.6540872703334e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37382,-0.0339921653744267,0.00649947910147284,-0.0467311444133135,-0.0212531863355399,1.72054961772728e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,37388,-0.0717625635065356,0.0137236160999484,-0.0986608510624345,-0.0448642759506368,1.72848510847836e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,-0.0273953382009456,0.00524024021086827,-0.0376662090142474,-0.0171244673876438,1.73676136227407e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39489,-0.0251697580120719,0.0048167181603049,-0.0346105256062695,-0.0157289904178743,1.75918420434162e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,39456,-0.0477327447853612,0.00913519474041823,-0.0656377264765809,-0.0298277630941415,1.76257021644641e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39931,-0.014416623498877,0.00276245054601554,-0.0198310265690675,-0.00900222042868658,1.82344945529773e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,39858,-0.0136214001153463,0.00261265614290424,-0.0187422061554386,-0.00850059407525395,1.87494154521959e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,37043,-0.0477985686625454,0.00917364768625065,-0.0657789181275967,-0.0298182191974941,1.91254487993698e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,0.0172066616560599,0.00330420336288552,0.0107304230648042,0.0236829002473155,1.93776609815236e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0339886954811114,0.00652869286574652,-0.0467849334979746,-0.0211924574642482,1.95298476385345e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.0221222695881017,0.00425149241741081,0.0137893444499766,0.0304551947262269,1.98067497913735e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,40052,0.0141312034030851,0.0027219689926451,0.0087961441775007,0.0194662626286695,2.11087543953006e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37043,-0.0262231353508783,0.00505365395623121,-0.0361282971050915,-0.0163179735966651,2.14627536494606e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,37368,-0.0252183695633446,0.00486390204849144,-0.0347516175783879,-0.0156851215483014,2.19366903531932e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,37437,-0.0437749176952208,0.00844462995066641,-0.060326392398527,-0.0272234429919147,2.2058069762745e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,-0.0448092600027012,0.00864878409059553,-0.0617608768202684,-0.027857643185134,2.23957476819579e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,40009,0.0145349055730633,0.00280569779178423,0.0090357379011662,0.0200340732449604,2.23958672183147e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,40052,0.0120917300679129,0.00233639039945674,0.00751240488497767,0.0166710552508481,2.30153994613249e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,39858,0.0210432886379227,0.00407133494922791,0.013063472137436,0.0290231051384094,2.38633863916652e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,39788,-0.0149870068031439,0.00290071042212719,-0.0206723992305132,-0.00930161437577457,2.41180652588525e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,37437,0.0117833415084136,0.00228479271619738,0.00730514778466673,0.0162615352321604,2.54073599071193e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,40058,-0.0399765305778286,0.00776500200267031,-0.0551959345030624,-0.0247571266525948,2.6593978417244e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37013,-0.0440946985305776,0.0085692675890827,-0.0608904630051797,-0.0272989340559755,2.70393951219539e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.0151495839797859,0.00294954082911918,-0.0209306840048595,-0.00936848395471227,2.84169954738818e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,-0.0185887112214169,0.00362188165841964,-0.0256875992719194,-0.0114898231709144,2.90235532061837e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37056,-0.0452897901898555,0.00884421409745223,-0.0626244498208618,-0.0279551305588491,3.08465320717668e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,37382,-0.0404676453437267,0.00790280655576655,-0.0559571461930292,-0.0249781444944243,3.08640192758983e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,0.0250773194234966,0.00490916706422357,0.0154553519776184,0.0346992868693748,3.29656612004841e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37397,-0.0205610700721326,0.00402684039923121,-0.0284536772546258,-0.0126684628896394,3.33506813037034e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,-0.0167119852338625,0.00327609996542493,-0.0231331411660953,-0.0102908293016296,3.41395220711702e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,37043,-0.0460935183236679,0.0090376591767828,-0.0638073303101622,-0.0283797063371736,3.44075035753119e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,37368,-0.0165485936440567,0.00324575136813427,-0.0229102663255999,-0.0101869209625135,3.46913442758224e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39866,0.0175918682379794,0.00345979753526302,0.0108106650688639,0.0243730714070949,3.72456766943225e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,39788,0.00762847523621424,0.00150169359281481,0.00468515579429721,0.0105717946781313,3.81872114383012e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,-0.0480762500605689,0.00947300448193679,-0.066643338845165,-0.0295091612759728,3.91706344259462e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,37169,-0.0273809079999286,0.00540525232930272,-0.037975202565362,-0.0167866134344953,4.12542695379695e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,37453,-0.0167024037536153,0.00329831010742081,-0.0231670915641601,-0.0102377159430705,4.1608265251812e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37411,-0.0580714326745442,0.0114690888017501,-0.0805508467259744,-0.035592018623114,4.17470560715159e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39931,0.0142063119291481,0.00280681463846752,0.00870495523775172,0.0197076686205444,4.20863344001796e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,39858,-0.0389557342059559,0.00770254051416806,-0.0540527136137253,-0.0238587547981865,4.2944732618601e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,39858,-0.0167047972637191,0.00330311374586852,-0.0231789002056214,-0.0102306943218168,4.29963845900219e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,39836,-0.045382882155305,0.00898617312179509,-0.0629957814740234,-0.0277699828365866,4.45972510767518e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,39585,-0.0202637727362151,0.0040174217985821,-0.028137919461436,-0.0123896260109942,4.61038495147853e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,-0.0180485910921858,0.00358349195113695,-0.0250722353164143,-0.0110249468679574,4.8016633901988e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39477,-0.0256660577388793,0.00509672862040236,-0.035655645834868,-0.0156764696428907,4.8118409934429e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,-0.0250712835590814,0.00498856992443327,-0.0348488806109706,-0.0152936865071921,5.07992484066482e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39477,-0.0302294620400523,0.00602716846834595,-0.0420427122380103,-0.0184162118420942,5.34669092026754e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,37039,0.0156042933533751,0.00311237972939582,0.00950402908375928,0.0217045576229909,5.41090623789565e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39868,-0.0339433360749704,0.00679454842282039,-0.0472606509836983,-0.0206260211662424,5.92491299087206e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,-0.0386325137504492,0.00774182386271296,-0.0538064885213666,-0.0234585389795319,6.09801481023734e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,39248,-0.0146496939329718,0.00293612285538365,-0.0204044947295238,-0.00889489313641986,6.12062266308098e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,-0.0530909939544004,0.0106443658885598,-0.0739539510959777,-0.0322280368128231,6.18700842225301e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,37437,-0.0151647443528025,0.00304557859985813,-0.0211340784085245,-0.0091954102970806,6.46097070700117e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,-0.0323535188081553,0.00650349847358917,-0.04510037581639,-0.0196066617999205,6.6144061865913e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39811,-0.0443020482035634,0.00892233446033402,-0.0617898237458181,-0.0268142726613088,6.93043090383626e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,-0.034672093972718,0.00698615429978996,-0.0483649564003063,-0.0209792315451297,7.01391759597745e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,39455,-0.0430203689933367,0.00868382734763222,-0.0600406705946958,-0.0260000673919775,7.34348203422334e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,39793,-0.0394442032546439,0.00796887947208249,-0.0550632070199256,-0.0238251994893622,7.50563891568873e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,37345,-0.0436867686923133,0.00882773201875488,-0.0609891234490729,-0.0263844139355538,7.55699708373151e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39755,0.0114034642515652,0.00230914680295632,0.00687753651777078,0.0159293919853595,7.957034734574e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.0128685524892079,0.00261045100857989,0.00775206851239132,0.0179850364660245,8.3358212925277e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,-0.0205621084511375,0.00417322304419724,-0.0287416256177641,-0.0123825912845109,8.44218410522219e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37437,-0.0140694428295614,0.00285559308182111,-0.0196664052699308,-0.00847248038919201,8.44956463117109e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BSG,Basigin,40040,-0.00955257332389042,0.00194110947896591,-0.0133571479026636,-0.00574799874511724,8.68647155384935e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,39868,0.0172954761762477,0.00352138273858817,0.0103935660086149,0.0241973863438805,9.12471655034674e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,37021,-0.0192973560417184,0.00393217672304767,-0.0270044224188918,-0.011590289664545,9.33253147365886e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,37437,0.0148257845304949,0.00302229581657953,0.00890208472999897,0.0207494843309907,9.42834629379122e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37026,-0.0282541030049816,0.00576486573446207,-0.0395532398445273,-0.016954966165436,9.64434542466485e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,39788,-0.0289749952141016,0.0059191913227937,-0.0405766102067772,-0.0173733802214259,9.92209875193508e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,37342,-0.0471436531192664,0.00963473689070093,-0.0660277374250402,-0.0282595688134926,1.00411182930299e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,-0.0483131956110346,0.00987613966719679,-0.0676704293587403,-0.0289559618633289,1.01006522475486e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,37388,-0.0184111856863903,0.00377721146662904,-0.0258145201609832,-0.0110078512117974,1.10445241656601e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPART,Spartin,37124,-0.0380723441926999,0.0078135206420796,-0.0533868446511759,-0.0227578437342239,1.11398868912241e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,39788,0.0141487714292031,0.00290415531756717,0.00845662700677144,0.0198409158516347,1.11589246087476e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,39477,-0.0281013903930304,0.00577696058872633,-0.039424233146934,-0.0167785476391268,1.15929202895308e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,37437,-0.0260330809452993,0.0053545531518995,-0.0365280051230223,-0.0155381567675762,1.17590422489039e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,39686,-0.0243858962604834,0.0050185327481428,-0.0342222204468433,-0.0145495720741235,1.19008742196229e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37437,-0.0162766900077074,0.00335527527830917,-0.0228530295531934,-0.00970035046222143,1.24157360059554e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,-0.0227823914854392,0.00469780541147471,-0.0319900900919297,-0.0135746928789488,1.24874364363899e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37365,-0.0203132885694469,0.00419077893830556,-0.0285272152885258,-0.012099361850368,1.26647851309265e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,37021,-0.0367828357953869,0.007589215340603,-0.0516576978629688,-0.021907973727805,1.26948907026628e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,-0.0173839209265946,0.00358818121156039,-0.024416756101253,-0.0103510857519363,1.27930760269064e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,39985,-0.0337171359809063,0.00696573164089599,-0.0473699699970624,-0.0200643019647501,1.30758207366869e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39892,0.0170094984211802,0.00351703275860288,0.0101161142143186,0.0239028826280419,1.33492284450704e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C3,Complement C3,36816,-0.0223489744403089,0.00462147457259817,-0.0314070646026013,-0.0132908842780164,1.34070026424143e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37411,-0.0333238221040991,0.00689491672313129,-0.0468378588814365,-0.0198097853267618,1.35896746145981e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,37124,-0.0358913525939748,0.00743307368234702,-0.0504601770113749,-0.0213225281765746,1.39029505790463e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,37088,0.0148737783525634,0.00308349237260523,0.00883013330225718,0.0209174234028697,1.42504856008324e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,37340,-0.0227865283927249,0.00472655384470281,-0.0320505739283424,-0.0135224828571074,1.44427968489503e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,39587,-0.0549516640509184,0.0114065855101374,-0.0773085716507878,-0.0325947564510491,1.46695068687758e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,-0.0519520294723821,0.0107966425283925,-0.0731134488280314,-0.0307906101167327,1.5114194052484e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,37388,-0.0481088347795636,0.0100102266762507,-0.0677288790650149,-0.0284887904941122,1.55658766186825e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,40030,0.0212336914870953,0.0044201517568479,0.0125701940436734,0.0298971889305172,1.57048824426887e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,-0.0142335468270193,0.00296653513416552,-0.0200479556899837,-0.00841913796405485,1.61657902482356e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,37453,-0.0263930882740137,0.00550155179929455,-0.037176129800631,-0.0156100467473964,1.62453626054347e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,37039,-0.0326839597479014,0.00681486192443149,-0.0460410891197872,-0.0193268303760157,1.63650523698467e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,39477,-0.0180531094930645,0.00376841343853955,-0.025439199832602,-0.010667019153527,1.67778249591097e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,39866,-0.0178773483807587,0.00373553969744839,-0.0251990061877575,-0.0105556905737598,1.71873421461704e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,39866,-0.0156810201912389,0.00327692293652561,-0.0221037891468291,-0.00925825123564867,1.72266183890196e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,37411,-0.0366727410870303,0.00766857450076386,-0.0517031471085274,-0.0216423350655331,1.75201973657085e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,-0.0240741001621905,0.00503435062921123,-0.0339414273954445,-0.0142067729289365,1.75418093161226e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,37368,-0.0187539960156316,0.00392206418792146,-0.0264412418239576,-0.0110667502073055,1.75683852935388e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,39477,-0.0251798029205918,0.00526708514645503,-0.0355032898076436,-0.0148563160335399,1.7636968265887e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,-0.0190978735637295,0.00399628073652609,-0.0269305838073206,-0.0112651633201383,1.78092488713862e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,-0.0167761070511994,0.00351430170851351,-0.0236641383998859,-0.00988807570251295,1.82847889043805e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,39868,-0.0268140346459452,0.00562036210046239,-0.0378299443628515,-0.0157981249290389,1.85047024642468e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,39673,-0.0158230947391986,0.00331796794987634,-0.0223263119209562,-0.00931987755744098,1.868756389972e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,-0.0209458081802091,0.00439258477058292,-0.0295552743305516,-0.0123363420298666,1.87285980957547e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,37437,-0.0266077316113364,0.00560101438642806,-0.0375857198087354,-0.0156297434139374,2.04970982544171e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,36961,-0.0264196959892509,0.00556168578490819,-0.0373206001276709,-0.0155187918508309,2.05266072208208e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,37382,-0.049120010581205,0.0103582406273299,-0.0694221622107715,-0.0288178589516385,2.13653204802984e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.00740990319969193,0.00156335471355244,0.00434572796112915,0.0104740784382547,2.15806502219886e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37056,-0.0431947684660677,0.0091142621784368,-0.0610587223358039,-0.0253308145963316,2.16749391924424e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,39749,-0.0166995344716776,0.00352562037626799,-0.0236097504091628,-0.00978931853419231,2.19187220617008e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,39868,-0.0165252396335284,0.00348957937601553,-0.0233648152105188,-0.00968566405653795,2.20284032710281e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,-0.0295037974133055,0.00623331474473332,-0.0417210943129828,-0.0172865005136282,2.23190231928677e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,37388,-0.0439684080350745,0.00929289371631645,-0.0621824797190547,-0.0257543363510942,2.25230773058592e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,39747,-0.0107665123292662,0.002276565140485,-0.0152285800046168,-0.00630444465391562,2.27254450288376e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,37411,-0.0275910357035322,0.00583841055419817,-0.0390343203897606,-0.0161477510173037,2.31539455103755e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,39397,0.0305149156040187,0.00645784024704345,0.0178575487198135,0.0431722824882239,2.31844362116094e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,-0.0392952755101032,0.00832761574492414,-0.0556174023701545,-0.0229731486500518,2.3939785660893e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,-0.0181463690083746,0.00384640358632313,-0.025685320037568,-0.0106074179791813,2.40497464373285e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.02752441712992,0.00584182219345368,-0.0389743886290892,-0.0160744456307508,2.47864192364437e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,39866,-0.0313299383301247,0.00665816320603162,-0.0443799382139467,-0.0182799384463027,2.55372002049751e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,39858,0.0110214961413908,0.00234675160222362,0.0064218630010325,0.0156211292817491,2.66868547205185e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,36962,-0.0264908424633983,0.00564704738739886,-0.0375590553427001,-0.0154226295840965,2.74491476229337e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,40058,-0.0213690448825621,0.00456024571571972,-0.0303071264853728,-0.0124309632797515,2.80942504753392e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37043,-0.0433807208172877,0.00926512730512936,-0.0615403703353413,-0.0252210712992342,2.86711226389456e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37021,-0.0561694476803141,0.0119986355558714,-0.0796867733698219,-0.0326521219908062,2.87878847814968e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,40058,-0.0256909116447643,0.00549655960628797,-0.0364641684730887,-0.0149176548164399,2.97770592687273e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,39858,0.0221584202332472,0.00475208260455173,0.0128443383283258,0.0314725021381685,3.14324927036215e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39374,-0.0571458163872717,0.0122555109760559,-0.0811666179003412,-0.0331250148742021,3.14433204049911e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,39749,-0.0471514461898299,0.010116416625803,-0.0669796227764038,-0.027323269603256,3.17411467062379e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,37453,0.0103515119199,0.0022213478291134,0.0059976701748377,0.0147053536649622,3.1918962535216e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,39868,-0.0596856729032929,0.0128195624778721,-0.0848120153599222,-0.0345593304466636,3.25272642581018e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39931,0.0153102585216638,0.00329545046792303,0.0088511756045347,0.021769341438793,3.41320209574865e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,37382,-0.0387842321102214,0.00834897947778559,-0.0551482318866812,-0.0224202323337616,3.42641681466951e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,37056,-0.0268425643645379,0.00578019558863579,-0.0381717477182641,-0.0155133810108118,3.45217340219961e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37430,-0.0223632618516433,0.0048175748642199,-0.0318057085855143,-0.0129208151177723,3.48257863964059e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39788,-0.048934968260591,0.0105452364274945,-0.0696036316584803,-0.0282663048627017,3.5036878992383e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,-0.0399743446140001,0.00861827397428827,-0.0568661616036052,-0.0230825276243951,3.54603021234315e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37411,-0.0419674033502133,0.00904977313730916,-0.0597049586993392,-0.0242298480010874,3.56119508305573e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,39587,-0.0199322202956693,0.00429885208680478,-0.0283579703858067,-0.0115064702055319,3.56970595105682e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39931,-0.017518732452839,0.00378390316157036,-0.024935182649517,-0.0101022822561611,3.68875521695466e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39868,-0.0335514713229676,0.00725750322202655,-0.0477761776381397,-0.0193267650077956,3.81176347204637e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,-0.0361008478166353,0.00781510364495323,-0.0514184509607436,-0.0207832446725269,3.8845262007963e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39949,0.00931103604160805,0.00201688648314893,0.00535793853463615,0.01326413354858,3.93208854922139e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.0123223781738277,0.00267271815613602,0.00708385058780114,0.0175609057598543,4.04917979596197e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAX,Protein max,39489,-0.0484374016322811,0.0105233777374911,-0.0690632219977638,-0.0278115812667985,4.20052613776481e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39931,-0.0209092810508582,0.00454677695492899,-0.029820963882519,-0.0119975982191974,4.28369640791657e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39862,-0.0121355123912446,0.00263978204995837,-0.017309485209163,-0.00696153957332616,4.31555571684482e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,37073,-0.0302272399131224,0.0065751765513179,-0.0431145859537055,-0.0173398938725393,4.32227046257369e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,37124,-0.0319456086576553,0.00694946062916635,-0.0455665514908214,-0.0183246658244893,4.32891728180917e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,37043,-0.0237999833030073,0.00518847274090785,-0.0339693898751867,-0.013630576730828,4.53611315586651e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36991,-0.0352307424823087,0.00768715998233013,-0.0502975760476757,-0.0201639089169416,4.624368016344e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,39587,0.015127151558702,0.00330311574294779,0.0086530447025243,0.0216012584148797,4.69301679558544e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,37162,-0.0103650790287475,0.00226455401571025,-0.0148036048995396,-0.00592655315795539,4.75746008499149e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,-0.0289033470122389,0.006325712083015,-0.0413017426949483,-0.0165049513295295,4.93288237229993e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,37445,0.0109024729752217,0.00238795838348346,0.00622207454359407,0.0155828714068492,5.02430294133496e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,37388,-0.0385168456737504,0.00843820691662778,-0.0550557312303408,-0.0219779601171599,5.04911295543483e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37411,-0.0225240519140361,0.00493690182009001,-0.0322003794814125,-0.0128477243466597,5.10194909764885e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37382,0.0226755560789714,0.00497508401900727,0.0129243914017171,0.0324267207562256,5.21393078726152e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,-0.0195783913371416,0.00429640538950199,-0.0279993459005655,-0.0111574367737177,5.22988954238721e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,39777,-0.0128778786060549,0.00282743873488158,-0.0184196585264228,-0.00733609868568701,5.28724947752597e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,39585,-0.0383812155144988,0.00844717535326462,-0.0549376792068974,-0.0218247518221001,5.56934196401809e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37422,-0.0110792607305836,0.00243886293359912,-0.0158594320804379,-0.00629908938072937,5.59914379655286e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,39419,-0.031116519314205,0.00685424943374711,-0.0445508482043493,-0.0176821904240606,5.67455420497677e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,40009,-0.024094092929317,0.00530884356927205,-0.0344994263250902,-0.0136887595335438,5.70693179186659e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,-0.0230948056690623,0.00509611846823255,-0.0330831978667981,-0.0131064134713265,5.89732417711284e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,37021,-0.0269951290992789,0.00596919021875675,-0.0386947419280421,-0.0152955162705157,6.16735638038536e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,39862,0.00997255505947935,0.00221098116536145,0.00563903197537091,0.0143060781435878,6.51453288763774e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37043,-0.039476766657415,0.00875170951810544,-0.0566301173129017,-0.0223234160019283,6.51570400880985e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,36991,0.0405575890497956,0.00899982881425346,0.0229179245738588,0.0581972535257324,6.64799912891807e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,37088,-0.0468156430381417,0.0103916935223881,-0.0671833623420225,-0.0264479237342609,6.69092815867879e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,39456,-0.0315901315802465,0.00701631606371683,-0.0453421110651315,-0.0178381520953615,6.76831023278765e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39931,-0.0116972367625731,0.00260115495833238,-0.0167955004809045,-0.00659897304424158,6.94210126775838e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,39913,-0.0282108920463028,0.00629882932014921,-0.0405565975137952,-0.0158651865788103,7.5598747704882e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,39858,-0.0202297417587732,0.00451815591096945,-0.0290853273442733,-0.0113741561732731,7.60681468374394e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,-0.0523119594359711,0.0116850407786442,-0.0752146393621138,-0.0294092795098284,7.62848113167781e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,39615,-0.033424252201479,0.00746836333381365,-0.0480622443357538,-0.0187862600672042,7.67866458767006e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,37021,0.0185394818978359,0.00414873968978366,0.0104079521058599,0.0266710116898118,7.9352458944777e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37043,-0.0359479381947709,0.00805903894000723,-0.051743654517185,-0.0201522218723567,8.24168561544411e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37169,-0.0339256675070047,0.00761746283048022,-0.0488558946547459,-0.0189954403592635,8.5102477832599e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,36962,-0.0220528475694657,0.00495408192308331,-0.031762848138709,-0.0123428470002224,8.59970018165075e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39913,-0.0371072699583555,0.00835162447937831,-0.053476453937937,-0.020738085978774,8.92568380994686e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,-0.0356619385798358,0.0080321026640688,-0.0514048598014106,-0.019919017358261,9.07207324672101e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39453,-0.0293021425096659,0.00660517078586483,-0.0422482772499609,-0.0163560077693708,9.21693251823459e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,36874,-0.0358314546665157,0.00807650780124441,-0.0516614099569548,-0.0200014993760767,9.21825428291641e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37324,-0.027116622584123,0.00612964089647054,-0.0391307187412052,-0.0151025264270407,9.77175335116341e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,39846,-0.0168906374698912,0.00381891781572459,-0.0243757163887114,-0.00940555855107097,9.80341637671007e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLU,Clusterin,37453,0.0140791670670271,0.00318475333671899,0.00783705052705787,0.0203212836069963,9.90972187601318e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,37043,-0.0229618603613817,0.00519803262349049,-0.0331500043034231,-0.0127737164193404,1.00685232006534e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37043,-0.014762387294553,0.00334221838730987,-0.0213131353336804,-0.00821163925542569,1.00904423187082e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,39489,-0.0294624430506108,0.00667247550677446,-0.0425404950438888,-0.0163843910573329,1.01444023786706e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,37368,-0.0314042059088226,0.00712159987720265,-0.0453625416681398,-0.0174458701495054,1.04307943909635e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,39587,-0.0290666733110021,0.00659536406198255,-0.0419935868724879,-0.0161397597495163,1.05439296344709e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,39862,-0.0108970300893635,0.00247613797911902,-0.0157502605284368,-0.00604379965029023,1.0854179975209e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,39750,-0.029002982700153,0.00659530428076237,-0.0419297790904472,-0.0160761863098587,1.10206167691205e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,39776,-0.0170554443964705,0.0038833940198886,-0.0246668966754522,-0.00944399211748889,1.13094179145117e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,39788,-0.0575871322153476,0.0131144909384677,-0.0832915344547442,-0.031882729975951,1.13501925951627e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,39812,-0.0208779902356241,0.00475644979071142,-0.0302006318254185,-0.0115553486458297,1.14390978992493e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,37169,-0.0147150319999032,0.00335451155982613,-0.0212898746571624,-0.00814018934264396,1.16000420585941e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,40009,-0.0117705870335522,0.00269345844102822,-0.0170497655779675,-0.00649140848913692,1.24985068862441e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39732,-0.0170986559224322,0.00391528256011661,-0.0247726097402608,-0.00942470210460364,1.26671218882602e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37368,-0.0190934972584654,0.004372946822934,-0.0276644730314161,-0.0105225214855148,1.27322460381755e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,39892,-0.016361791310931,0.00375094727974298,-0.0237136479792272,-0.00900993464263477,1.29658253965366e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,-0.0388199787054545,0.00891260569856567,-0.0562886858746432,-0.0213512715362658,1.33660082253922e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",37453,-0.00709236724566764,0.00162860945489792,-0.0102844417772676,-0.00390029271406772,1.34126212793705e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,-0.0326650999732788,0.00750529866900356,-0.0473754853645258,-0.0179547145820318,1.35569347144058e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,39931,-0.0180962703198577,0.00416487461748352,-0.0262594245701254,-0.00993311606958998,1.4014694496013e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,37347,-0.0121425095528224,0.00279534797767748,-0.0176213915890702,-0.00666362751657451,1.41044456843787e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,-0.0486098169712903,0.0112082700941851,-0.0705780263558932,-0.0266416075866874,1.45347021751613e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,40052,-0.0384679525329538,0.00887808360253812,-0.0558689963939285,-0.0210669086719791,1.4803663426402e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40003,-0.0259316955405197,0.00598509363764724,-0.0376624790703083,-0.0142009120107311,1.48172626089953e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,-0.0393832602904594,0.00909773300657788,-0.0572148169833521,-0.0215517035975668,1.50927379328381e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37339,-0.0208443047959296,0.00482235161870274,-0.030296113968587,-0.0113924956232722,1.55423079222303e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,-0.020420409005646,0.00472674686454075,-0.0296848328601459,-0.0111559851511461,1.57041507493457e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37382,-0.0251968858599529,0.00583765344971275,-0.0366386866213899,-0.013755085098516,1.59816752993288e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,0.00871412894743549,0.00201968001845679,0.00475555611126018,0.0126727017836108,1.61052506587724e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37368,-0.0219913494126884,0.00510088870027216,-0.0319890912652218,-0.011993607560155,1.63464111915728e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,39749,-0.0623047833958168,0.0144561233368532,-0.090638785136049,-0.0339707816555846,1.642936448131e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,-0.0140586170790716,0.00327145068696948,-0.0204706604255317,-0.00764657373261136,1.74079313975078e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,-0.0141678262170012,0.00330161146753591,-0.0206389846933716,-0.00769666774063079,1.78764626089941e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,0.0111212517706622,0.0025954891986853,0.00603409294123899,0.0162084106000854,1.84171587067064e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37388,0.0256073785727325,0.00598580204030611,0.0138752065737326,0.0373395505717325,1.89859015001325e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,0.0114909935431267,0.00268950555730596,0.00621956265080702,0.0167624244354464,1.94370989774795e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,0.0127003567558573,0.00297663622727674,0.00686614975039486,0.0185345637613197,1.99786184897458e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,39931,-0.0325263337711729,0.00762950183016392,-0.0474801573582942,-0.0175725101840516,2.02641035801948e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,37037,-0.0181984470338724,0.00427649054431441,-0.0265803685007286,-0.00981652556701614,2.10059178474375e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,-0.0315838450090042,0.00742783747691424,-0.0461424064637561,-0.0170252835542523,2.13013462949415e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,-0.0402410583426239,0.00946652750357392,-0.0587954522496288,-0.021686664435619,2.14363697621309e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37382,-0.0215107987922598,0.00506138372178302,-0.0314311108869545,-0.0115904866975651,2.15219110643832e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37169,-0.0284962966049758,0.00670630170236499,-0.0416406479416112,-0.0153519452683404,2.16012823576022e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39868,-0.0124969555355765,0.00294417949178604,-0.0182675473394771,-0.00672636373167585,2.20186833488875e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37368,-0.0252341267755142,0.00596623645696097,-0.0369279502311577,-0.0135403033198707,2.35766579105209e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,39477,-0.0246004671604009,0.00581861040152858,-0.0360049435473969,-0.0131959907734049,2.37230792026184e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,37388,0.0156515000532461,0.00370286677392444,0.00839388117635423,0.022909118930138,2.38529983008307e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,37445,-0.0387626907621262,0.00917583088164523,-0.0567473192901509,-0.0207780622341016,2.41104136062437e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,39587,0.0125004124392617,0.00295950973272772,0.00669977336311538,0.0183010515154081,2.41556301067871e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,-0.0267960216114791,0.00635105249507057,-0.0392440845018174,-0.0143479587211407,2.46565272772581e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,39866,-0.0277095593143375,0.0065880957477767,-0.0406222269799799,-0.0147968916486952,2.61339459891578e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,37368,-0.0275147522994053,0.00654198377973062,-0.0403370405076773,-0.0146924640911333,2.61753510334662e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39788,-0.0237503215229056,0.0056516014246222,-0.0348274603151651,-0.0126731827306461,2.65532625827339e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,0.0127803659095336,0.00304161016461934,0.00681880998687973,0.0187419218321875,2.6622254724435e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,39804,-0.0194523759164528,0.00463443419339493,-0.0285358669355068,-0.0103688848973987,2.71511271621236e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,37420,0.0149674127584667,0.00356588611999363,0.0079782759632792,0.0219565495536542,2.71730591571586e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37039,-0.0255750981147347,0.00609436297210873,-0.0375200495400678,-0.0136301466894016,2.72827567620489e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,-0.0411164774829292,0.00980413097881981,-0.060332574201416,-0.0219003807644424,2.76077773811058e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,39587,-0.0330521689095993,0.00789647985347005,-0.0485292694224006,-0.017575068396798,2.85854316378837e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37388,-0.0272374373551695,0.00651187185750568,-0.0400007061958806,-0.0144741685144584,2.89838465083825e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,39866,-0.0324934503501894,0.00778432872884356,-0.0477507346587228,-0.017236166041656,3.00597750500352e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAT,Catalase,37252,-0.0220174517336991,0.00528494499064729,-0.0323759439153678,-0.0116589595520304,3.11839339750174e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,39718,-0.0188260110516984,0.00452445633860682,-0.0276939454753678,-0.00995807662802908,3.18604855804197e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PI3,Elafin,39594,-0.0219675511424864,0.00528519211533997,-0.0323265276885527,-0.01160857459642,3.24964012110509e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,39826,-0.010889706536424,0.0026265560152443,-0.0160377563263028,-0.00574165674654515,3.4007799119084e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37043,-0.0305411731204584,0.0073672908844629,-0.0449810632540057,-0.0161012829869111,3.41179600492702e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,-0.0103488055756132,0.00250131691294168,-0.0152513867249788,-0.00544622442624747,3.5314119589952e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37368,-0.0139765362286077,0.00338028098592502,-0.0206018869610207,-0.00735118549619465,3.57525604429747e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,37021,-0.0248293111858152,0.0060088815358069,-0.0366067189959967,-0.0130519033756337,3.61685055121175e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37382,-0.0364747833520457,0.00883696223925353,-0.0537952293409826,-0.0191543373631088,3.68887319330467e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.0281774249874858,0.00682973280929422,-0.0415637012937025,-0.0147911486812692,3.71813368823883e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,39839,-0.0389911441685889,0.00945421864363065,-0.057521412710105,-0.0204608756270728,3.73897433775688e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,39970,-0.0247414684464364,0.00600313621665264,-0.0365076154310755,-0.0129753214617972,3.78421953631139e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,37382,-0.0138178691971838,0.00336153521912041,-0.0204064782266598,-0.00722926016770782,3.96991424133946e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,39489,-0.0321358622893609,0.0078198785969439,-0.047462824339371,-0.0168089002393509,3.98523663061406e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,37124,-0.0236558625107229,0.0057597385608195,-0.0349449500899291,-0.0123667749315167,4.03049234876207e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,37388,0.0171772568668919,0.00418910603233175,0.00896660904352165,0.0253879046902621,4.14742162677356e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,-0.0350757839165338,0.00855979608554793,-0.0518529842442077,-0.0182985835888599,4.19639480704943e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,40058,-0.0262992726304859,0.00642638916639911,-0.0388949953966282,-0.0137035498643436,4.2902318306504e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLPS,Colipase,39836,0.0281916384654017,0.00689925663449526,0.014669095461791,0.0417141814690125,4.40665731895122e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,-0.0115415603988855,0.0028289660787141,-0.0170863339131651,-0.00599678688460585,4.53424567333566e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,36991,-0.0177159052494039,0.00434345413910231,-0.0262290753620445,-0.0092027351367634,4.55438752363043e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,36654,-0.0502431021205546,0.0123186251494674,-0.0743876074135108,-0.0260985968275984,4.55764820624964e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39862,-0.0209667636855184,0.00514897693771227,-0.0310587584834345,-0.0108747688876024,4.68303836558704e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,37095,-0.0578325159913529,0.0142126444993124,-0.0856892992100051,-0.0299757327727007,4.74712184713788e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,37039,-0.0279321341656721,0.00686446520700618,-0.0413864859714042,-0.01447778235994,4.74719694651631e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,40058,-0.0181990215224266,0.00447739398158124,-0.0269747137263258,-0.00942332931852735,4.83324996349128e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,-0.0118340801733349,0.00291234105511932,-0.0175422686413687,-0.00612589170530099,4.85902667710291e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,-0.0172387014330832,0.00424384228906692,-0.0255566323196543,-0.00892077054651199,4.89248456282203e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37437,0.0138595318534529,0.00341353399450041,0.0071690052242321,0.0205500584826737,4.93118806476141e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,37124,-0.0350967788742393,0.00865682322188041,-0.0520641523891249,-0.0181294053593537,5.05863022298188e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,-0.0293533340512287,0.00725116389776162,-0.0435656152908415,-0.015141052811616,5.18803828141502e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,37382,-0.0134624437430194,0.00332693881472738,-0.0199832438198851,-0.00694164366615374,5.22791966318931e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,39568,-0.0168186871883643,0.00416103210321696,-0.0249743101106695,-0.00866306426605902,5.32609628394698e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,39857,0.0236629959936271,0.00585615642940195,0.0121849293919993,0.0351410625952549,5.35400097981253e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAYN,Layilin,39713,-0.0129825546810846,0.00322008571498719,-0.0192939226824595,-0.00667118667970969,5.56238877970267e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39477,-0.0207404543743625,0.00514721430867228,-0.0308289944193602,-0.0106519143293649,5.61718172900177e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,39868,-0.0267924147679706,0.00664957583322354,-0.0398255834010887,-0.0137592461348524,5.62275947980927e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.0283869315128932,0.00705243416720435,-0.0422097024806137,-0.0145641605451726,5.72051848258252e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39868,-0.0251622047376962,0.00625166487255561,-0.0374154678879052,-0.0129089415874872,5.72665382545402e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,39908,-0.0233850886167096,0.00582665132068027,-0.0348053252052429,-0.0119648520281763,6.01043782887105e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,36991,-0.0221059662004539,0.00550821863470926,-0.0329020747244841,-0.0113098576764238,6.02158507687985e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,39739,-0.0232328187773507,0.00580009009803388,-0.0346009953694971,-0.0118646421852043,6.21430495022205e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,37064,0.0135336653323138,0.0033885265478484,0.00689215329853094,0.0201751773660967,6.53289020920203e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,-0.0222929153682023,0.00558243510849003,-0.0332344881808428,-0.0113513425555619,6.54199908119278e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGN,Mimecan,39858,-0.0157147066747193,0.00393626594949714,-0.0234297879357337,-0.00799962541370489,6.57310346222958e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,-0.028806901581006,0.00721889690411373,-0.0429559395130689,-0.0146578636489431,6.62372110505633e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36991,-0.0398111467720937,0.00997681470132175,-0.0593657035866843,-0.020256589957503,6.63296014758624e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36593,0.0434610771823193,0.0108916626491165,0.0221134183900509,0.0648087359745877,6.63574508396492e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37056,-0.0344325846957721,0.00863674015730315,-0.0513605954040863,-0.0175045739874579,6.7343326091145e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,39587,-0.0331317772877917,0.0083151722744171,-0.0494295149456492,-0.0168340396299342,6.79281283299626e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,39788,-0.021545814146991,0.00540750146006913,-0.0321445170087265,-0.0109471112852555,6.79431994059194e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,-0.0108035265056445,0.00271244375378675,-0.0161199162630665,-0.00548713674822249,6.84216778581523e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,-0.0472570530783728,0.0118670905440783,-0.0705165505447663,-0.0239975556119794,6.86394317752707e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,39489,-0.0290114583398047,0.00730163186890412,-0.0433226568028567,-0.0147002598767526,7.12065608874304e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39822,-0.0112625274811641,0.00283618829021873,-0.0168214565299929,-0.00570359843233542,7.18828908274209e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,39868,-0.027453350990109,0.00692179087901992,-0.0410200611129881,-0.01388664086723,7.33390412032542e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,39866,-0.0270732407016698,0.00682692781310609,-0.0404540192153577,-0.0136924621879818,7.35130995924596e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,37124,-0.0433486356660337,0.0109321030498066,-0.0647755576436546,-0.0219217136884128,7.37007418359347e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,39908,0.0120851042679164,0.00305727445971961,0.00609284632686596,0.0180773622089668,7.75402481278011e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,37388,-0.0258938578639098,0.0065525545752417,-0.0387368648313835,-0.0130508508964361,7.79858756679046e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37124,-0.0471626731457016,0.0119599777540048,-0.0706042295435511,-0.0237211167478521,8.07560174012266e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37021,0.0109997736086185,0.00278962739249453,0.00553210391932925,0.0164674432979078,8.08524711273115e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,-0.0133699818456804,0.00339387671036345,-0.0200219801979928,-0.00671798349336806,8.20194120947388e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,37376,-0.0249913503812768,0.0063575059444425,-0.0374520620323841,-0.0125306387301695,8.50152804886915e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.0124822153348578,0.00317618903719269,0.00625688482196013,0.0187075458477555,8.53325647719335e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,-0.018472525732178,0.00470961754380575,-0.0277033761180372,-0.00924167534631868,8.81407013112763e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGMN,Legumain,39931,-0.0140337462137754,0.00358098716596837,-0.0210524810590734,-0.00701501136847735,8.93002378812535e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,39881,-0.024908293246611,0.00637463728181738,-0.0374025823189731,-0.012414004174249,9.36758945479236e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,39913,0.0106955253789416,0.00274086256283737,0.0053234347557804,0.0160676160021029,9.5692395648353e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,37187,-0.00974862047345409,0.00250166191779401,-0.0146518778323304,-0.00484536311457782,9.79255350381658e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,39967,0.0159089849144219,0.00408615610048987,0.00790011895746173,0.023917850871382,9.92531159895998e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37124,-0.032254710666019,0.00829021130427055,-0.0485035248223893,-0.0160058965096487,0.000100444522794804
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37021,-0.0270563775093113,0.00695721565261196,-0.0406925201884307,-0.0134202348301918,0.000101166949538542
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,39913,-0.0281413626586533,0.00726325040206823,-0.042377333446707,-0.0139053918705996,0.000107274403722427
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,39477,-0.0187145322205316,0.00483495146455548,-0.0281910370910603,-0.00923802735000287,0.000108975372105066
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,40034,-0.00896495775489622,0.00231831276990462,-0.0135088507839093,-0.00442106472588317,0.000110605422866998
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,37287,-0.0386212551572349,0.00998762795226459,-0.0581970059436736,-0.0190455043707963,0.000110743003560858
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,-0.0106998704343108,0.00276856193324938,-0.0161262518234796,-0.00527348904514206,0.000111725246249035
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.0132603321834435,0.00343603066863589,0.00652571207291716,0.0199949522939698,0.000114206988850206
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,-0.0327756440277073,0.00849849316607228,-0.0494326906332089,-0.0161185974222056,0.000115416730153975
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,39585,-0.0141758316230274,0.00368060388103765,-0.0213898152298612,-0.00696184801619358,0.000117863901847892
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,39952,0.0151063510751335,0.00393704087704558,0.00738975095612416,0.0228229511941428,0.000125031891317945
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,39858,-0.0147202152756176,0.00383680243933044,-0.0222403480567052,-0.00720008249452992,0.000125236656958974
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,-0.0169689425668746,0.0044291589461707,-0.0256500941013692,-0.00828779103238004,0.000128118191153923
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37124,0.00938755276957508,0.00245060501075677,0.00458436694849181,0.0141907385906583,0.000128363620322494
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,-0.0381795246655789,0.0099691561808192,-0.0577190707799845,-0.0186399785511733,0.000128843587577397
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,39489,-0.0196196597715889,0.00512522935886471,-0.0296651093149637,-0.00957421022821408,0.000129663475330933
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,37169,-0.0283304331897748,0.00741267272779575,-0.0428592717362545,-0.0138015946432951,0.000133034584598339
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37388,-0.0109575039355323,0.00287078299877728,-0.0165842386131357,-0.00533076925792878,0.00013573871777348
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,39858,-0.00914641371134938,0.00240236704097465,-0.0138550531116597,-0.00443777431103906,0.000141044565271934
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,39587,-0.0252034083199532,0.0066275549572231,-0.0381934160361104,-0.0122134006037959,0.000143598061319409
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39788,-0.0170267447015752,0.00447816169282612,-0.0258039416195144,-0.00824954778363595,0.000143967450116613
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,37169,0.0125286976294461,0.00329848082409748,0.00606367521421501,0.0189937200446771,0.000146325828452401
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40052,-0.0118652167352645,0.00312510377069697,-0.0179904201258306,-0.00574001334469847,0.000147144349548383
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,39836,-0.0335733473164714,0.00884332142360521,-0.0509062573067376,-0.0162404373262052,0.000147317512437472
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,37220,-0.0125193071941802,0.00330295869256668,-0.0189931062316109,-0.0060455081567495,0.000151107743844528
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,39434,0.0343176642335767,0.00906331123397886,0.0165535742149781,0.0520817542521752,0.000153396107759894
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,39831,-0.00998056433177028,0.00263873905569318,-0.0151524928809289,-0.00480863578261164,0.000155937859034053
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39585,-0.0423160816869012,0.0111894144963346,-0.064247334099717,-0.0203848292740853,0.000156277306985824
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,-0.0201401613575613,0.00532998176831673,-0.0305869256234621,-0.00969339709166053,0.000158354514880424
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,39858,-0.00933801967588146,0.00247241470696506,-0.014183952501533,-0.00449208685022994,0.000159378558835898
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,37437,-0.0272208541332289,0.00720759926325179,-0.0413477486892025,-0.0130939595772554,0.000159605543561511
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,39531,-0.0223663973089804,0.00592788128757981,-0.0339850446326368,-0.0107477499853239,0.000161835295383954
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37039,-0.0231632905834464,0.00615143815672182,-0.0352201093706212,-0.0111064717962716,0.00016693306993135
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,-0.0288917223883383,0.00767845678621181,-0.0439414976893135,-0.0138419470873632,0.000168704022653676
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,-0.0256395902919531,0.00681427551774675,-0.0389955703067367,-0.0122836102771694,0.000168751322932549
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,39489,-0.02309536104034,0.00615127468532025,-0.0351518594235677,-0.0110388626571123,0.000174272027110335
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,0.0108321484671389,0.00288625590919039,0.00517508688512577,0.0164892100491521,0.00017547626691875
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,39749,0.00460334949507369,0.00122722524109805,0.00219798802252151,0.00700871096762587,0.000176740458265385
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,39754,-0.0225253534471768,0.00600787881443237,-0.0343007959234643,-0.0107499109708894,0.000177955863470502
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,39489,-0.0164559077625806,0.00438946448984298,-0.0250592581626728,-0.00785255736248833,0.000178212391670054
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,-0.044876641402131,0.0119721079910757,-0.0683419730646394,-0.0214113097396226,0.000178568036585894
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,39617,-0.0260467504846841,0.00695218376867136,-0.03967303067128,-0.0124204702980882,0.000179917787528593
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,39858,-0.0455544704480858,0.0121766385228514,-0.0694206819528745,-0.0216882589432971,0.000183829641414805
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39585,-0.0197337600606034,0.00527604568640577,-0.0300748096059587,-0.00939271051524808,0.000184485831263115
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,36962,-0.0134717139524277,0.00360429369373354,-0.0205361295921454,-0.00640729831270993,0.000186512097929598
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37043,-0.0288799891712535,0.00773111956962238,-0.0440329835277133,-0.0137269948147936,0.000188094523075851
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,37056,0.0200417283909411,0.00536757284839814,0.00952128560808079,0.0305621711738015,0.000189365420143803
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,37382,-0.0168646553191112,0.00452481923465009,-0.0257333010190254,-0.00799600961919707,0.000194450679054852
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37039,-0.0180092341266003,0.00483618250790037,-0.0274881518420851,-0.0085303164111156,0.000197022731993054
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37388,-0.0143158175676942,0.00384675595272329,-0.0218554592350319,-0.00677617590035657,0.000198821471186242
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,-0.0157014318728624,0.00422096639073303,-0.0239745259986991,-0.00742833774702566,0.000200150158272607
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,-0.0418044334612077,0.0112545263951366,-0.0638633051956754,-0.0197455617267401,0.000204350764764688
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39489,-0.0272687400433994,0.00735769329915432,-0.0416898189097419,-0.012847661177057,0.000211157145844086
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,37043,-0.0153844281494194,0.00415171596702662,-0.0235217914447915,-0.00724706485404718,0.000211787796723096
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,37453,-0.00906987709910053,0.00244975504251206,-0.0138713969824242,-0.00426835721577689,0.000214447069238409
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37437,0.00924889828844493,0.00249857683510745,0.00435168769163433,0.0141461088852555,0.000215035236152222
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,39908,-0.0106740402777826,0.0028868972930853,-0.0163323589722298,-0.00501572158333541,0.000218536810437535
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37021,-0.0260612419185899,0.00704820189808659,-0.0398757176388396,-0.0122467661983402,0.000218555113297377
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,-0.0302507743416219,0.00819075715046825,-0.0463046583565397,-0.0141968903267042,0.000222114812460891
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39489,-0.0141220530348403,0.00382567340140597,-0.021620372901596,-0.00662373316808459,0.000223790035423185
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37362,-0.0149830542609194,0.00406205740830859,-0.0229446867812042,-0.00702142174063453,0.000226431327287721
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,-0.0140533481914904,0.00381048220165228,-0.0215218933067289,-0.00658480307625196,0.000226855409799744
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,-0.0133151380072463,0.00361164793968058,-0.0203939679690202,-0.00623630804547234,0.000228050459536402
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37043,-0.0193225566682829,0.00524111624896064,-0.0295951445162457,-0.00904996882032,0.000228069678232957
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39867,-0.0348943770689198,0.00948462551563212,-0.0534842430795588,-0.0163045110582809,0.000234875126397295
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,39715,-0.0258970944098435,0.0070416967401715,-0.0396988200205796,-0.0120953687991073,0.000236144526979895
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,-0.0253794267646967,0.00690507927075232,-0.0389133821353713,-0.0118454713940222,0.000238328958602253
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37382,-0.0184044249054155,0.00500894778411931,-0.0282219625622894,-0.00858688724854169,0.00023941460356894
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39489,-0.0236804754248458,0.00645763479497828,-0.0363374396230032,-0.0110235112266884,0.000246177730611888
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,-0.0322174274373878,0.00879008799098613,-0.0494459998997206,-0.014988854975055,0.000248087618930619
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37411,0.0164723074613272,0.00449936714172958,0.0076535478635372,0.0252910670591171,0.00025216078792082
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37056,0.0158042943469275,0.00431881880970373,0.00733940947990822,0.0242691792139468,0.000253789920311195
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.0130111474434798,0.00357025351338692,0.00601345055724148,0.0200088443297182,0.000269103067980379
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39721,-0.02129466832766,0.0058549941712106,-0.0327704569032328,-0.00981887975208722,0.000276695934172761
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37437,-0.0223406827632714,0.00614264767313423,-0.0343802722026145,-0.0103010933239283,0.000276875295611315
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39928,-0.0291479723045331,0.00805148578904323,-0.0449288844510578,-0.0133670601580084,0.00029528260567531
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,-0.0347441493224376,0.00959779357882999,-0.0535558247369444,-0.0159324739079309,0.000295497328804255
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,39749,-0.0120807412239558,0.00333845445103151,-0.0186241119479776,-0.00553737049993409,0.000297048154948362
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,39866,-0.0235381171750287,0.00651524834617133,-0.0363080039335245,-0.0107682304165329,0.000303866841772701
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39788,-0.0166729154848406,0.00461901482148662,-0.0257261845349544,-0.00761964643472682,0.000307579427217119
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,40058,-0.0125039172026621,0.00347163722099361,-0.0193083261558096,-0.00569950824951463,0.000317046083327025
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37169,-0.0126364312286611,0.0035104608254324,-0.0195169344465086,-0.00575592801081357,0.000319803265191505
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,0.00847494507560863,0.00235821989284832,0.00385283408562592,0.0130970560655913,0.000326880770837694
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,-0.0131061277984409,0.00364671361710145,-0.0202536864879598,-0.00595856910892207,0.000326884150529206
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0174314178213132,0.00485427132736558,-0.0269457896229498,-0.0079170460196767,0.000330469590964922
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39868,0.0140043191716796,0.00390008141685599,0.00636015959464184,0.0216484787487173,0.000330681371671583
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,-0.0220085927472262,0.00613873543669585,-0.03404051420315,-0.00997667129130232,0.000338037754062608
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,37169,0.0131726500382329,0.00368681499814434,0.00594649264187003,0.0203988074345958,0.000354286541850827
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,37021,-0.0221524534181139,0.00620051228169476,-0.0343054574902356,-0.00999944934599214,0.000354607157279373
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,-0.0172811748930269,0.00483757522888224,-0.0267628223416361,-0.0077995274444177,0.000355115643120112
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37437,-0.0114377252824769,0.00320199583823767,-0.0177136371254227,-0.0051618134395311,0.000355408199091642
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39868,-0.0233776490304933,0.00657919882449349,-0.0362728787265005,-0.010482419334486,0.000381573009546224
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,37039,-0.0155137736504928,0.00437250430746293,-0.0240838820931201,-0.00694366520786542,0.000389474174517876
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39864,0.0141677009404202,0.00399738494110027,0.00633282645586364,0.0220025754249767,0.000394865581058886
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39617,-0.010356403795562,0.00292231065010844,-0.0160841326697745,-0.00462867492134942,0.000395381970551798
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,0.00921539944420345,0.00260367403969589,0.00411219832639951,0.0143186005620074,0.000402444731220535
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,-0.029374344671098,0.00830873010704435,-0.0456594556809049,-0.013089233661291,0.000408371199247546
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,37021,0.0111006606208426,0.00314627187079843,0.00493396775407764,0.0172673534876075,0.000419830094821843
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,39477,-0.0240243173617385,0.00681127908109401,-0.0373744243606827,-0.0106742103627942,0.000421283875305704
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,37368,-0.0148919027966775,0.00422206923647233,-0.0231671585001632,-0.00661664709319171,0.000421440459697747
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,-0.0259457899735585,0.00735873088068793,-0.0403689024997068,-0.0115226774474101,0.00042354348758634
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37169,-0.0251454776166649,0.00713219292364428,-0.0391245757470077,-0.0111663794863221,0.000423896048799654
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,-0.0354672063019191,0.010063405019036,-0.0551914801392298,-0.0157429324646085,0.0004256688666983
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37021,-0.0347887195793522,0.00987898702280871,-0.0541515341440573,-0.0154259050146471,0.000430586958942813
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37169,-0.0197057996514555,0.00559790520542544,-0.0306776938540894,-0.00873390544882168,0.000432647168586838
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,36962,0.0108896734904051,0.00310286547780397,0.00480805715390936,0.0169712898269009,0.000450365998289654
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,-0.0149218662650642,0.00427349515885641,-0.0232979167764228,-0.00654581575370565,0.000481484617601608
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,39829,-0.0232513051556628,0.00667967597192625,-0.0363434700606383,-0.0101591402506874,0.000501060833113051
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,39788,-0.0262761320536911,0.0075583083341237,-0.0410904163885735,-0.0114618477188086,0.000509440205731167
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,39738,-0.0166839643528907,0.00480470999513678,-0.0261011959433588,-0.0072667327624226,0.000517164347396157
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,39866,-0.0107939028209934,0.00311240944520294,-0.0168942253335912,-0.00469358030839565,0.000525683282908858
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,39563,-0.0170657011047395,0.00492479220947122,-0.0267182938353031,-0.00741310837417588,0.000531127634006304
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,40030,0.0207867370493262,0.00600394175984166,0.00901901120003657,0.0325544628986159,0.000537200501435002
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,-0.0256665012227203,0.00741395295543315,-0.0401978490153692,-0.0111351534300713,0.00053799053312989
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,37411,0.0121997746488461,0.00352663938996704,0.00528756144451068,0.0191119878531815,0.000543206455412462
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,-0.0234757038341779,0.00678660745552695,-0.0367774544470107,-0.0101739532213451,0.000543662829281131
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.0164787670846698,0.00476584587431803,0.00713770917100647,0.0258198249983331,0.000546522191216829
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,39559,-0.0187210085440275,0.00541976778874321,-0.0293437534099642,-0.00809826367809083,0.000553367294033063
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37368,-0.0167954034066917,0.00486548406018078,-0.026331752164646,-0.00725905464873735,0.000558256320106071
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37388,-0.0366230329168895,0.0106699823575991,-0.0575361983377837,-0.0157098674959953,0.000600182149253489
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,39859,-0.0323851794462771,0.00944267849531204,-0.0508928292970887,-0.0138775295954655,0.000605861798039917
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37169,-0.0202342876059547,0.00590587308210147,-0.0318097988468736,-0.00865877636503585,0.000614097508837063
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,39587,-0.0166191658885039,0.00485480927999111,-0.0261345920772865,-0.00710373969972133,0.000620376416833281
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39477,-0.020544404804081,0.00600239086544881,-0.0323090909003607,-0.00877971870780138,0.000621606662540546
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,-0.00958332511386901,0.00280350786664116,-0.0150782005324857,-0.00408844969525233,0.000631963838875473
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,39421,-0.0157457131635328,0.00461217114660798,-0.0247855686108845,-0.0067058577161812,0.000641920066468508
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,37056,-0.0140529556601874,0.00412156981102802,-0.0221312324898023,-0.00597467883057246,0.000652499528887966
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,-0.0129067494895754,0.00379339710750897,-0.020341807820293,-0.00547169115885782,0.00066983788708368
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,37437,0.0112252832887801,0.00330674407855029,0.00474406489482152,0.0177065016827387,0.000689096347839913
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,40042,-0.0109400178168597,0.00323049108839348,-0.0172717803501109,-0.00460825528360843,0.000709619188894742
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,37388,-0.0154025916146488,0.00455021489353959,-0.0243210128059864,-0.00648417042331118,0.000713739978479022
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,0.00949262761534165,0.00280978194272168,0.00398545500760717,0.0149998002230761,0.000730783430096606
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37021,0.014017111119742,0.0041587419906625,0.00586597681804345,0.0221682454214405,0.000752429288229823
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,39725,0.01652818159012,0.00490648494840694,0.00691147109124239,0.0261448920889976,0.000757197650717602
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37169,-0.0249737262350068,0.00741967386798823,-0.0395162870162638,-0.0104311654537499,0.000765159025451961
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37445,-0.00895128937622871,0.00266770223184231,-0.0141799857506396,-0.00372259300181779,0.000794586114341584
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,37388,0.0125166787861785,0.00373068320025952,0.00520453971366985,0.0198288178586872,0.000795649442688594
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,39913,-0.0184851865421871,0.00551715227028135,-0.0292988049919385,-0.00767156809243564,0.000808534410034535
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,-0.0207233726569738,0.00619095390621903,-0.0328576423131631,-0.0085891030007845,0.000818065808644738
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39444,0.00944122821761907,0.00282280103641522,0.00390853818624524,0.0149739182489929,0.000825864329753064
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37021,-0.0147667405618423,0.0044161890076258,-0.0234224710167889,-0.00611101010689577,0.000828775286788234
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,37056,-0.0178049950324681,0.00532535224841912,-0.0282426854393695,-0.00736730462556661,0.000829768716481112
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,39489,-0.0236997900822708,0.00708928184426567,-0.0375947824970315,-0.00980479766751014,0.00083058953037882
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37382,-0.0253310088815347,0.00759681597559796,-0.0402207681937067,-0.0104412495693627,0.00085705908742725
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,37249,0.010433809716724,0.00313176101720494,0.00429555812300235,0.0165720613104457,0.000865785322532881
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,39991,-0.0127793586490136,0.00383767455896505,-0.0203012007845851,-0.00525751651344215,0.000870486558124183
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,37437,-0.0155126104165955,0.00465990586440457,-0.0246460259108284,-0.00637919492236253,0.000874049092478226
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,37411,-0.0170238752948371,0.00511741112073761,-0.0270540010914828,-0.00699374949819139,0.000881280125316204
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,39489,-0.0123350604766683,0.00370994267531168,-0.0196065481202792,-0.00506357283305744,0.000886647461730511
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,37021,0.0158714095353684,0.00478629727310629,0.00649026688008007,0.0252525521906567,0.000915596598312466
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,39709,0.00915157320793192,0.00276042126503762,0.00374114752845818,0.0145619988874057,0.000917564473169365
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,-0.00992839979525055,0.00299494195114309,-0.015798486019491,-0.00405831357101008,0.000918648995439247
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,-0.0178239611259184,0.00537713806530371,-0.0283631517339137,-0.00728477051792317,0.000919242245311138
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,37364,-0.0186824004154101,0.00563597369544382,-0.0297289088584799,-0.00763589197234017,0.000919342197919151
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37411,-0.0420285574474696,0.012731482874962,-0.0669822638823951,-0.0170748510125442,0.000965376523495643
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,-0.0201409639944879,0.00611168351142653,-0.0321198636768839,-0.00816206431209188,0.000985111862837598
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,39788,-0.0272584806037478,0.00829450007715887,-0.0435157007549792,-0.0110012604525164,0.00101720804050156
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,39866,-0.0129370172638856,0.00394506677300593,-0.0206693481389773,-0.00520468638879402,0.00104290871599054
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.0121573493844431,0.00371124894096166,0.00488330146015827,0.019431397308728,0.00105588740831597
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37021,-0.0120059251859203,0.0036654787003477,-0.0191902634386018,-0.00482158693323881,0.00105783582950346
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36962,0.00981581385753902,0.00299714543974581,0.00394140879563723,0.0156902189194408,0.00105915929108594
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,37382,-0.0187360395092022,0.00573043502189626,-0.0299676921521189,-0.00750438686628556,0.00107981586613158
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,39868,0.0124122083528405,0.00379719589266444,0.00496970440321818,0.0198547123024628,0.00108239042303989
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.0106137892521136,0.00325200381849225,0.00423986176786879,0.0169877167363584,0.00110220806644929
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39858,0.010813898710131,0.00331657769508106,0.00431340642777217,0.0173143909924899,0.00111425175954946
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,37021,-0.0396099210764462,0.0121505426482999,-0.063424984667114,-0.0157948574857783,0.00111722732393279
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LXN,Latexin,39682,0.0217415863426377,0.00667558756864468,0.00865743470809411,0.0348257379771813,0.00112881301856809
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,39866,-0.0172492194721396,0.00530117145357655,-0.0276395155211496,-0.00685892342312956,0.00114088326465025
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,0.00990719093573541,0.00304533950218221,0.00393832551145828,0.0158760563600125,0.00114389918197844
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,37333,-0.0157364694540848,0.00483937435015781,-0.0252216431803941,-0.00625129572777551,0.0011497601805506
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,39900,-0.0162987534562952,0.00501401878804685,-0.026126230280867,-0.00647127663172334,0.00115384363423587
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,37437,-0.0216422930619927,0.00666087083882688,-0.0346975999060934,-0.00858698621789201,0.00116024368060687
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39931,-0.0285552980008486,0.0087979071677303,-0.0457991960496,-0.0113113999520972,0.0011740528358095
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,37056,-0.0209255089975241,0.00646680333704564,-0.0336004435381336,-0.00825057445691467,0.00121586433784761
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,37169,0.0136612882563282,0.00422353746600976,0.00538315482294912,0.0219394216897074,0.00122127368384621
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,39947,0.00823073860763979,0.00254592823529181,0.00324071926646784,0.0132207579488117,0.00122786163210832
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37124,-0.0170748203711999,0.00528268675314528,-0.0274288864073647,-0.00672075433503516,0.00123131262673077
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,-0.0143284017030226,0.00443614583882088,-0.0230232475471116,-0.0056335558589337,0.00124120500734575
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,37021,0.0118055584810123,0.00366086512234213,0.00463026284122172,0.0189808541208029,0.00126368302202269
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39489,-0.0130488309137026,0.00404948681326095,-0.020985825067694,-0.00511183675971111,0.00127407887765647
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWC2,Brorin,39684,-0.0123780690012234,0.00384513641305641,-0.0199145363708139,-0.00484160163163278,0.00128830709897488
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,37388,0.00973475477894609,0.00302542639384734,0.00380491904700531,0.0156645905108869,0.00129551069921518
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,37368,-0.0123479864210794,0.0038392412320114,-0.0198728992358217,-0.00482307360633705,0.00130180304701203
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,39713,-0.024499751382768,0.00762444906307008,-0.0394436715463854,-0.00955583121915063,0.00131474966019318
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,37124,-0.030812685693042,0.00959058134982273,-0.0496102251386945,-0.0120151462473894,0.00131758619756125
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37325,0.00862148889781192,0.00268974494102615,0.00334958881340065,0.0138933889822232,0.00135227885616028
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,39901,-0.00940229803274795,0.00294075104756292,-0.0151661700859713,-0.00363842597952463,0.00139016755955339
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,39489,-0.00930151237111091,0.00291222370673204,-0.0150094708363057,-0.00359355390591612,0.00140616197127822
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39866,0.0130583481081357,0.00409338518309217,0.00503531314927501,0.0210813830669963,0.00142492977266633
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,37437,-0.0169991086283172,0.00532939262348854,-0.0274447181703548,-0.0065534990862797,0.00142749264755573
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,-0.0193669814516552,0.0060757990378596,-0.03127554756586,-0.00745841533745037,0.0014381096941957
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,-0.0233298342351606,0.0073285274517307,-0.0376937480405528,-0.00896592042976845,0.00145823821698091
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,-0.0326661069676383,0.0102615963026518,-0.0527788357208357,-0.0125533782144409,0.00145926866744896
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,-0.0301544643663269,0.00948492521489563,-0.0487449177875223,-0.0115640109451315,0.00147965243899159
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,-0.0148661613366865,0.00467826422868605,-0.0240355592249112,-0.00569676344846187,0.00148732720824896
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39822,0.0149839629112932,0.00471879220561355,0.00573513018829068,0.0242327956342958,0.00149924337791862
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,0.011665460240226,0.00367390994074364,0.00446459675636841,0.0188663237240835,0.00150069772839339
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,40009,0.00980108583107709,0.00308891898761228,0.00374680461535702,0.0158553670467972,0.00151164310735222
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,39822,-0.0128637594337897,0.00405945787653166,-0.0208202968717918,-0.00490722199578769,0.00153339030188513
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,36962,0.0112977887529506,0.0035687354551529,0.00430306726085093,0.0182925102450503,0.00155028309395459
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.00889314244809863,0.00281130985855429,0.00338297512533221,0.014403309770865,0.00156258984519544
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40030,-0.0121787555590921,0.00385217988015178,-0.0197290281241896,-0.00462848299399463,0.00157236162132103
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,-0.0105131901433071,0.00332658659289443,-0.0170332998653802,-0.00399308042123403,0.00157867779405369
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36991,0.0106938966644105,0.00338504921502216,0.0040592002029671,0.017328593125854,0.00158585877035665
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37021,-0.0160064360902218,0.00506702621973943,-0.0259378074809111,-0.00607506469953251,0.00158701788235849
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,39489,-0.0162699241525613,0.00515130051608809,-0.0263664731640939,-0.00617337514102862,0.00158933680002598
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,39477,0.0177751548840342,0.00563564641794907,0.00672928790485406,0.0288210218632144,0.00161322316849145
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,39393,0.0217927470796421,0.0069260362556692,0.00821771601853049,0.0353677781407538,0.00165551469178953
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,37043,-0.00959315186863087,0.00305225517784309,-0.0155755720172033,-0.00361073172005842,0.00167612646286551
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.0113519162932066,0.00361658252948068,0.00426341453542446,0.0184404180509887,0.00169985372535197
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,37106,0.0113737227675738,0.00362394574268345,0.00427078911191424,0.0184766564232334,0.00170192524987962
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,37445,0.00711367961184766,0.00226748719774751,0.00266940470426255,0.0115579545194328,0.00170903605237986
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,37056,0.00840626989534358,0.00268949756349947,0.00313485467088462,0.0136776851198025,0.00177833025924518
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,-0.0295592429637109,0.00947824460246427,-0.0481366023845409,-0.0109818835428809,0.00182012198309134
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39919,-0.0103250289221341,0.00331263390368508,-0.0168177913733569,-0.00383226647091138,0.00183108454858656
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,37021,0.0221517832375954,0.0071154271353761,0.00820554605225829,0.0360980204229326,0.00185464180786112
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,-0.0156324752104099,0.00503733444422873,-0.0255056507210982,-0.00575929969972158,0.00191765548559189
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,37299,0.00881548118150186,0.00284428853082814,0.00324067566107871,0.014390286701925,0.00194338135067579
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,37388,-0.00847015990644133,0.0027360650164168,-0.0138328473386183,-0.0031074724742644,0.00196720118768833
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,37056,0.00809716681946494,0.00261726730549365,0.00296732290069739,0.0132270107382325,0.00198057925614545
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,39585,-0.0143293941396797,0.00463532322731507,-0.0234146276652173,-0.0052441606141422,0.00199598754078038
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,39477,-0.0224654049870373,0.00726795342547045,-0.0367105937009594,-0.0082202162731152,0.00199819763195347
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37021,-0.0117153272471549,0.00379199349664062,-0.0191476345005706,-0.00428301999373933,0.00200918171248852
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENG,Endoglin,40052,0.00522354801598017,0.00169103153445541,0.00190912620844756,0.00853796982351277,0.00201190837690302
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37388,-0.0137094612911995,0.00444226236738897,-0.0224162955312818,-0.0050026270511171,0.00203180172693472
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,39701,0.0193898149429137,0.00628960465100251,0.00706218982694873,0.0317174400588786,0.00205390892020261
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,37056,0.00855785365310651,0.00277591631074803,0.00311705768404038,0.0139986496221726,0.00205421531797037
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.0107277817183383,0.00348009962616115,0.00390678645106245,0.0175487769856141,0.00205540291436399
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,-0.0147507863330815,0.00479378519184469,-0.0241466053090971,-0.00535496735706595,0.00209467945115943
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36962,-0.022741834006904,0.00740101054434187,-0.0372478146738141,-0.00823585333999396,0.00212495008597819
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,37453,-0.0222011020789434,0.00725194636730881,-0.0364149169588686,-0.0079872871990181,0.00220735207822351
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,37072,-0.0133997468355446,0.0043780251909564,-0.0219806762098192,-0.00481881746127007,0.00221275901060652
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FST,Follistatin,39908,0.015645508444933,0.00513112188982464,0.00558850954087667,0.0257025073489893,0.00229871420448143
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,40052,0.00813685641407672,0.00267528482373508,0.00289329815955596,0.0133804146685975,0.00235785678693924
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37405,-0.01869117957027,0.00614896328553747,-0.0307431476099234,-0.00663921153061654,0.00237243308277314
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39477,-0.0121534937441311,0.00400145099031724,-0.0199963376851529,-0.00431064980310928,0.00239124134159401
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,-0.00795950860537343,0.00262107380618298,-0.0130968132654921,-0.00282220394525478,0.0023953823508992
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39826,0.0164964299383041,0.00543858319147359,0.00583680688301588,0.0271560529935924,0.00242346205441829
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,0.0131559412603358,0.00433843820278105,0.00465260238288498,0.0216592801377867,0.00243064836442677
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,37021,-0.0242720418556654,0.00801093126654505,-0.0399734671380937,-0.0085706165732371,0.00245137769045764
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,39477,0.0253706396888726,0.00838402055466582,0.00893795940172756,0.0418033199760176,0.00248157641815466
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,-0.0267133261333637,0.00883020847304827,-0.0440205347405383,-0.00940611752618912,0.00248853360850535
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,-0.0127393739285407,0.0042112611816211,-0.0209934458445181,-0.00448530201256335,0.00249037800849365
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,0.0115373299918957,0.00381638059763892,0.00405722402052342,0.019017435963268,0.00250591028703567
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,37249,-0.018346370883692,0.00608824676971716,-0.0302793345523377,-0.00641340721504641,0.0025881457072214
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,0.0147944643389471,0.00491468316398458,0.00516168533753732,0.0244272433403569,0.00261432236357568
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36962,0.00789368693576628,0.00262550297748077,0.00274770109990397,0.0130396727716286,0.00264737709327803
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,37430,0.0327479013065207,0.0109018672516933,0.011380241493202,0.0541155611198395,0.00267046620418907
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36962,-0.0184214475750285,0.00614175416413745,-0.0304592857367379,-0.00638360941331915,0.00271038974740264
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37453,0.00527374238528119,0.00176027904646694,0.00182359545420599,0.00872388931635638,0.00274067149778933
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,39868,-0.0260227688742284,0.00871006362874049,-0.0430944935865598,-0.00895104416189707,0.00281541877762669
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,39477,-0.015507391070952,0.00519574184150302,-0.0256910450802979,-0.00532373706160606,0.00284356745309027
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HLA_DRA,,39799,0.0105523230559859,0.00354565434170606,0.00360284054624207,0.0175018055657298,0.00292350669319229
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,-0.0216079704417949,0.00726720380741444,-0.0358516899043272,-0.00736425097926261,0.00295004051046378
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,37453,-0.00551520096868049,0.00185497660701887,-0.00915095511843747,-0.0018794468189235,0.00295237281384442
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,37430,-0.0112123425143382,0.00377161830171331,-0.0186047143856963,-0.00381997064298007,0.00295595580747823
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,37056,0.0124756579916476,0.00419670875117329,0.00425010883934791,0.0207012071439472,0.00295702459915966
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,-0.0136969565282979,0.00460982697555818,-0.0227322174003919,-0.00466169565620382,0.00297123643310061
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,37169,-0.0157645060838375,0.00530879063664791,-0.0261697357316675,-0.00535927643600764,0.00298807166126548
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37021,-0.0188794686362171,0.00636067653319576,-0.0313463946412808,-0.00641254263115342,0.00300133392057335
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,36971,-0.0290797676879124,0.00980278339606366,-0.0482932231441971,-0.00986631223162757,0.00301772547813331
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,37056,-0.0347673564976954,0.0117516331330134,-0.0578005574384016,-0.0117341555569892,0.00309675973677515
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,-0.0140817151556601,0.00476444631785762,-0.023420029938661,-0.00474340037265913,0.00312534097833212
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,39858,0.00990162441554078,0.00336411135419371,0.00330796616132112,0.0164952826697604,0.00325188914956395
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,39931,0.0170211514042328,0.00578446068358362,0.00568360846440889,0.0283586943440567,0.00325970448107371
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37000,-0.0118263085189353,0.00401962000923408,-0.0197047637370341,-0.00394785330083648,0.00326515538250168
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,-0.0143512485397227,0.00488276412569579,-0.0239214662260864,-0.00478103085335894,0.00329654434752232
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,39558,-0.0124127177425923,0.00422709889977969,-0.0206978315861604,-0.00412760389902408,0.00332460711854803
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39868,0.00514609267295525,0.00175491363119173,0.00170646195581946,0.00858572339009104,0.00336839473126319
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,39585,-0.0131082526005495,0.00447564123925428,-0.0218805094294879,-0.00433599577161115,0.00340762995376898
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37039,0.0094044768959286,0.00321166068444098,0.00310962195442427,0.0156993318374329,0.00341482639124114
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37388,-0.0203645451708109,0.00697051659431673,-0.0340267576956717,-0.00670233264595015,0.00348897158810757
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,36962,0.0174070507392239,0.00596225357435463,0.00572103373348884,0.029093067744959,0.00351142928436988
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,36991,0.00823558254910473,0.00282181462874312,0.00270482587676822,0.0137663392214412,0.00352270098769676
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37056,-0.0161453611251766,0.00554311483244787,-0.0270098661967744,-0.00528085605357873,0.00358933759048457
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,-0.0122529663036528,0.00420962957703088,-0.0205038402746333,-0.00400209233267224,0.00361126746595505
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37362,-0.0206759394825537,0.00711577378261201,-0.0346228560964732,-0.00672902286863413,0.00367087773189846
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,-0.0192662175239431,0.00663073836449536,-0.032262464718354,-0.00626997032953221,0.00367152699528017
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,39868,-0.00692356668735168,0.00238478119300165,-0.0115977378256349,-0.00224939554906845,0.00369840454856022
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,37388,-0.017147267554678,0.00591110114721591,-0.0287330258032212,-0.00556150930613483,0.00372741597754616
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39453,-0.012100304129179,0.00417696135124224,-0.0202871483776138,-0.00391345988074424,0.00377375406038492
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40052,0.00913803757720015,0.0031547131919082,0.00295479972106009,0.0153212754333402,0.00377699116172038
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,37021,0.0157220167906211,0.00542810135755689,0.00508293812980954,0.0263610954514326,0.00378078419160171
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,40009,-0.00724556611120269,0.00250169776741376,-0.0121488937353336,-0.00234223848707172,0.00378146654301387
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,39788,-0.0120674031814891,0.00417261428850274,-0.0202457271869545,-0.00388907917602375,0.00383256767145942
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,39796,-0.00928338779356759,0.00321454346268065,-0.0155838929804217,-0.00298288260671351,0.00388303682076673
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,37124,-0.0217042706004942,0.00752497565983305,-0.036453222893767,-0.00695531830722148,0.00392919024676417
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",39489,-0.0155383399018897,0.00538805921166786,-0.0260989359567587,-0.00497774384702066,0.00393385516325385
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,37411,-0.0178871210426135,0.00620793433048022,-0.0300546723303547,-0.00571956975487226,0.00396619590185846
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37124,-0.0254610414229971,0.00883671702002115,-0.0427810067822385,-0.00814107606375561,0.00396700772214082
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,39818,-0.0115411559203835,0.00400749999392428,-0.0193958559084751,-0.0036864559322919,0.00398344192084423
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,37043,-0.00809779402151521,0.00281406097526368,-0.013613353533032,-0.0025822345099984,0.00401332807254312
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,36962,0.0104113766341311,0.0036197393623985,0.00331668748383,0.0175060657844321,0.00403044263717637
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,0.00886001887956655,0.00308077901734014,0.00282169200557987,0.0148983457535532,0.00403521286334615
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37021,-0.0195047234387467,0.00678816194012994,-0.0328095208414014,-0.00619992603609206,0.00406801600790541
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,39587,-0.0163303446766211,0.0056871576512626,-0.0274771736730958,-0.00518351568014643,0.00409149180667481
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSPN,Persephin,39866,-0.027032345284496,0.00941542105690604,-0.0454865705560318,-0.00857812001296016,0.00409619817749964
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,37021,0.0132743425871153,0.00462629041826861,0.0042068133673088,0.0223418718069217,0.00412000358867371
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.0108186926522235,0.00377390858407904,0.00342183182742855,0.0182155534770184,0.00415329984125499
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,-0.0251640656317364,0.00877880047109186,-0.0423705145550765,-0.00795761670839637,0.0041575572166942
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,-0.0152437199419023,0.00532483858783967,-0.0256804035740681,-0.00480703630973658,0.00420634156571081
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39587,-0.00874488651546863,0.00305991034301997,-0.0147423107877878,-0.00274746224314948,0.00427028396858125
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37368,-0.0111620393979837,0.00391158007054715,-0.0188287363362562,-0.00349534245971133,0.00432942246390993
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37056,0.0123698533498016,0.00433605936452352,0.00387117699533548,0.0208685297042677,0.00434050500412803
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,37368,-0.0116729384908751,0.00409719536572985,-0.0197034414077056,-0.00364243557404454,0.00439221969517957
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39720,0.00938908959314018,0.00329645970491476,0.00292802857150725,0.0158501506147731,0.00440190826091165
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,-0.0239712357229734,0.0084172318622584,-0.0404690101729999,-0.00747346127294691,0.00440783784737833
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,39788,0.00591711640159505,0.00207997416150193,0.00184036704505127,0.00999386575813883,0.00444955776479672
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,39489,-0.0138691951112629,0.00487971607904333,-0.0234334386261878,-0.00430495159633797,0.00448594939103369
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37021,-0.0130206256586195,0.00458108595549537,-0.0219995541313904,-0.00404169718584856,0.00448642030774622
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,37056,-0.0148871713721626,0.00524277396539233,-0.0251630083443316,-0.00461133439999361,0.0045244858311107
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37039,-0.0191050102370795,0.00675522413349312,-0.032345249538726,-0.00586477093543297,0.00468836596279624
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37169,0.00783525375171676,0.00277118189602823,0.00240373723550142,0.0132667702679321,0.00469969620317177
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.019738499717587,0.00699928789583118,0.0060198954417579,0.0334571039934161,0.00480722487736071
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.0131618064673185,0.00467895451220338,0.00399105562339989,0.0223325573112371,0.00491551241876126
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40038,-0.0146834417907836,0.00522064563956465,-0.0249159072443303,-0.00445097633723692,0.00492062196075055
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,-0.0338071956048382,0.0120334849886691,-0.0573928261826297,-0.0102215650270467,0.0049689737553549
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,-0.0132434052138882,0.00471453392135023,-0.0224838916997346,-0.00400291872804172,0.00497576347409972
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,36991,-0.0237784113763883,0.00847123216262642,-0.0403820264151361,-0.00717479633764054,0.00500851164774683
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,37043,-0.00854725158007756,0.00304714531416812,-0.0145196563958471,-0.00257484676430805,0.00503897841277725
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,37056,0.0096044178739693,0.00342581292005197,0.00288982455066745,0.0163190111972712,0.00506180933756416
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39477,-0.0146234978664661,0.00522014655255993,-0.0248549851094836,-0.00439201062344863,0.0050950666714793
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.0104663878209813,0.00373819710712155,0.00313952149102304,0.0177932541509395,0.00512009793899029
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,-0.0074096271459536,0.00265114564867251,-0.0126058726173517,-0.00221338167455549,0.00519805427493028
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,37382,-0.0168613458870172,0.00603308171815572,-0.0286861860546024,-0.00503650571943197,0.00520026120043782
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,39477,-0.0226286427409792,0.00809806220890846,-0.0385008446704398,-0.00675644081151867,0.0052071075249263
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,37021,0.0145431916397664,0.00520612468495085,0.00433918725726274,0.0247471960222701,0.00522200135972246
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,37169,0.00811213220641914,0.00290517802037345,0.00241798328648717,0.0138062811263511,0.00524092684098296
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37437,-0.0198692855651096,0.00714489900142202,-0.0338732876078967,-0.0058652835223224,0.00542822883013467
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37411,-0.0107251442809668,0.00386204866379148,-0.0182947596619981,-0.00315552889993552,0.00549282559709279
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,40009,-0.00826110326417985,0.00298786146998665,-0.0141173117453537,-0.00240489478300602,0.0057006893299489
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39931,0.00752076821657934,0.0027220459733329,0.00218555810884685,0.0128559783243118,0.00573536947432277
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,40030,-0.00739507489005142,0.00268935376134981,-0.0126662082622971,-0.00212394151780579,0.00597053534331177
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,-0.0169620022362697,0.00616861818348334,-0.029052493875897,-0.00487151059664233,0.00597242573027419
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37043,-0.01569944951887,0.00571428979987435,-0.0268994575266237,-0.00449944151111627,0.00601511189607716
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,37043,-0.0200332460903289,0.00729662931934352,-0.0343346395562422,-0.00573185262441555,0.00604917983499802
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,-0.00767007601321506,0.00279937406649331,-0.0131568491835419,-0.00218330284288816,0.00615358849167431
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,39587,0.010881883877626,0.00397817700407497,0.00308465694963904,0.0186791108056129,0.00623753770778892
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37021,0.0130462338225185,0.00478567061429353,0.00366631941850314,0.0224261482265338,0.00641716863787398
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,40002,-0.0073141383179271,0.00268650720940978,-0.0125796924483703,-0.00204858418748392,0.00648506582507089
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,39344,-0.016236156854078,0.00598443647429497,-0.0279656523436962,-0.00450666136445989,0.00667380045786991
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37368,-0.00787545279255065,0.00290558372941615,-0.0135703969022063,-0.00218050868289499,0.00672759006570375
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,0.0155998296461032,0.00577291079188567,0.00428492449400729,0.0269147347981991,0.00689609276483911
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,39489,-0.0115176053980355,0.00426280427853988,-0.0198727017839737,-0.00316250901209735,0.00690220837008634
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36991,0.016268062701321,0.00603859687643879,0.00443241282350099,0.028103712579141,0.00706870006521353
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,39480,-0.0298481390936486,0.0110919908839599,-0.05158844122621,-0.00810783696108728,0.00713218763903534
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,0.00901760485636621,0.00335163187736369,0.00244840637673338,0.015586803335999,0.00714325855686518
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37124,-0.0340130244784071,0.0126785077511356,-0.0588628996706329,-0.0091631492861813,0.00731142425971406
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.00733329702831878,0.00273388983017776,0.00197487296117037,0.0126917210954672,0.00731773117356624
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,39866,0.0103563096006477,0.00386177599647497,0.00278722864755679,0.0179253905537387,0.0073313763186778
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37368,-0.0147402641438371,0.00550238707447328,-0.0255249428098048,-0.00395558547786951,0.00739571308385119
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,-0.00924715441913563,0.00345941718326497,-0.016027612098335,-0.00246669673993629,0.0075244459676962
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,39931,0.00536754610133899,0.0020134445293327,0.0014211948238469,0.00931389737883108,0.00768701880513522
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,37411,-0.0215068739889258,0.00807706272707688,-0.0373379169339965,-0.00567583104385512,0.00776057962660393
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,37021,0.0114167437569093,0.00430045421463748,0.0029878534962198,0.0198456340175987,0.00794565245414935
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,39866,0.0131756587592665,0.00496685691140508,0.00344061921291253,0.0229106983056204,0.00799259005541347
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,39885,0.00841444787674428,0.00317737495065674,0.00218679297345706,0.0146421027800315,0.00809915877070414
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,39815,-0.0157277778977995,0.005953997956911,-0.0273976138933451,-0.00405794190225395,0.0082608311360927
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39689,0.011194982866664,0.00424199050125134,0.00288068148421137,0.0195092842491166,0.00832110192114883
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,39477,-0.019511165427019,0.00739404413552576,-0.0340034919326495,-0.00501883892138856,0.00832905302304356
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36991,0.0100228434170418,0.00379977341646518,0.00257528752077005,0.0174703993133136,0.00835570312314634
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37382,-0.0260871401345384,0.00991386245827277,-0.0455183105527531,-0.0066559697163238,0.00851353720749111
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,37039,-0.0131105765288454,0.0049838022726559,-0.022878828983251,-0.00334232407443985,0.00853240446293111
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40058,-0.0194722385276451,0.00740789314289661,-0.0339917090877224,-0.00495276796756772,0.0085823138207859
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,37056,0.0122413239909631,0.00465794296397207,0.00311175578157779,0.0213708922003483,0.00859743768527711
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40009,-0.0119776922499596,0.00455803565532516,-0.0209114421343969,-0.00304394236552224,0.00860155059025853
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,40014,-0.0245420592313536,0.00936779311029944,-0.0429029337275405,-0.00618118473516673,0.00880549375281948
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,40058,-0.0220126754605402,0.00841248998233056,-0.0385011558259081,-0.00552419509517232,0.00888756541691127
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39587,-0.0170834769415549,0.00652986605530767,-0.0298820144099579,-0.00428493947315184,0.00889977846191062
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37437,-0.0155072142110829,0.00592913128401127,-0.027128311527745,-0.00388611689442081,0.00892143393480257
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,-0.0229120564927485,0.00876844207807624,-0.040098202965778,-0.00572591001971912,0.00898471172579927
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,36962,-0.00945597696892854,0.00362014908653276,-0.0165514691785328,-0.00236048475932432,0.00901061929453563
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,-0.00934857758484981,0.00359052470386724,-0.0163860060044296,-0.00231114916527001,0.00923320794370122
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,-0.00896457524251834,0.00345929517066925,-0.0157447937770301,-0.00218435670800662,0.00956607209878053
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39391,-0.0151036332861796,0.00583115057461396,-0.0265326884124229,-0.0036745781599362,0.00960199516900571
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,40030,-0.0154304731130152,0.00595872731804146,-0.0271095786563764,-0.0037513675696539,0.00961852149132116
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37382,-0.0205208113127775,0.00793808676545174,-0.0360794613730629,-0.0049621612524921,0.00974522104960742
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39749,-0.0107158989077268,0.00414716421014418,-0.0188443407596093,-0.00258745705584417,0.00977757044099314
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,36962,0.0120778705258724,0.00468051351275337,0.00290406404087578,0.021251677010869,0.00987770224762414
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37382,-0.0294648135746125,0.0114339272080032,-0.0518753109022987,-0.00705431624692634,0.00997774547615632
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39788,-0.0187752256747378,0.00728903905508105,-0.0330617422226967,-0.00448870912677898,0.0100093042771026
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,39868,0.00674064655290397,0.00261801016833237,0.00160934662297253,0.0118719464828354,0.0100409871210639
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,-0.01047203958107,0.00406773768787558,-0.0184448054493062,-0.00249927371283389,0.0100518138391082
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,-0.0105752541436638,0.00412995556546496,-0.0186699670519751,-0.00248054123535243,0.0104595409439585
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39971,-0.0058620671722354,0.00229019383116627,-0.0103508470813213,-0.00137328726314951,0.0104871684486627
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,35640,-0.0259133690866211,0.010126303490297,-0.0457609239276031,-0.00606581424563904,0.0105092831322941
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,-0.0184062577855453,0.00719411561432782,-0.0325067243896279,-0.00430579118146281,0.0105229740827257
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.00815526933093542,0.00318940962279236,-0.0144065121916085,-0.00190402647026239,0.0105694370391571
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,-0.00685984377554769,0.00268615221760752,-0.0121247021220584,-0.00159498542903696,0.010666860122562
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.0123996126272519,0.00487011252920644,-0.0219450331844965,-0.00285419207000723,0.0109038365319603
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,37124,-0.0215934041015606,0.00849734234723745,-0.038248195102146,-0.00493861310097523,0.0110587171571753
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,37039,-0.0148657427424648,0.0058571594811206,-0.0263457753254612,-0.00338571015946842,0.0111587339232832
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,37437,0.0126554631860748,0.00499159104655756,0.00287194473482195,0.0224389816373276,0.0112444153015045
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,36991,0.0121270057750587,0.00478543238718491,0.00274755829617633,0.0215064532539412,0.0112835531854195
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,39908,-0.00648994067700807,0.00257358430500575,-0.0115341659148193,-0.00144571543919679,0.011686806946427
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,37021,0.00882784496065597,0.00350107042134194,0.00196574693482576,0.0156899429864862,0.0116982636223775
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39862,-0.0739245331507551,0.0293237304340274,-0.131399044801449,-0.0164500215000614,0.0117124919317563
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39585,-0.0132293774732755,0.00526102428175007,-0.0235409850655056,-0.00291776988104532,0.0119266088570923
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,37021,0.00852113406825986,0.0033911018552581,0.00187457443195398,0.0151676937045657,0.0119898436971181
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39991,-0.00636887725373256,0.00253555693316149,-0.0113385688427291,-0.00139918566473604,0.0120205222502459
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40052,0.00634951334908186,0.00252791987957414,0.00139479038511654,0.0113042363130472,0.0120229231503126
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,39478,-0.0139309576157836,0.00557207902046578,-0.0248522324958965,-0.00300968273567063,0.0124247201424865
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,36962,0.00648160332761712,0.00259354130565781,0.00139826236852781,0.0115649442867064,0.0124619169983351
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39866,0.0114837987008106,0.00459637113417548,0.00247491127782665,0.0204926861237945,0.0124837578629601
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,39913,0.00673269262975297,0.00269606583617696,0.00144840359084612,0.0120169816686598,0.0125267604016025
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,-0.00663899368299142,0.00267378585533997,-0.0118796139594578,-0.00139837340652507,0.0130385394787093
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39990,0.00996121484815653,0.00401404970127363,0.00209367743366021,0.0178287522626528,0.0130899721578568
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,-0.0117628314781475,0.00474601794921437,-0.0210650266586076,-0.00246063629768728,0.0132054668599194
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,37056,0.00852448514082265,0.00343984485084135,0.00178238923317362,0.0152665810484717,0.013218611739761
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,39477,-0.010926322248765,0.0044144855602021,-0.0195787139467611,-0.00227393055076885,0.0133301742992671
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,-0.0120546386463939,0.00487684162620248,-0.0216132482337508,-0.00249602905903707,0.0134533174422264
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,39985,0.00740575526882826,0.0029997231824527,0.00152629783122097,0.0132852127064356,0.0135664967484339
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,39703,-0.0112009720393882,0.00453702609836898,-0.0200935431921914,-0.00230840088658503,0.0135674858492217
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,-0.0225918771593643,0.00917690941858395,-0.0405786196197889,-0.00460513469893978,0.0138362004035379
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,-0.00771064434061579,0.00313519556042684,-0.0138556276390524,-0.00156566104217919,0.0139303819253296
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,37124,-0.00915008241733896,0.00372096532405691,-0.0164431744524905,-0.00185699038218742,0.0139427523731596
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37043,-0.0237746258209777,0.00968038531140804,-0.0427481810313375,-0.00480107061061796,0.0140637402936314
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,0.0137861794629453,0.00561761574051763,0.00277565261153071,0.0247967063143598,0.0141367676329765
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,-0.0134004690990509,0.00546126047538542,-0.0241045396308063,-0.00269639856729548,0.0141490690340072
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,40058,-0.00653422726249098,0.00266742608495051,-0.011762382388994,-0.00130607213598798,0.0143105174164226
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,39520,-0.0218492782267585,0.00892382766527095,-0.0393399804506896,-0.00435857600282748,0.0143593193813882
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,36931,0.00987975001035488,0.00404957483034103,0.00194258334288646,0.0178169166778233,0.0147126412800892
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F2,Prothrombin,37453,0.0035828459770758,0.00146897835018525,0.000703648410712715,0.00646204354343889,0.0147404580404743
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,-0.00583878905596489,0.00240293761446909,-0.0105485467803243,-0.00112903133160546,0.0151158777984947
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.00874431807884756,0.00360098953012836,0.00168637859979598,0.0158022575578991,0.0151803291619886
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,39489,-0.00946865820356191,0.00389987256807584,-0.0171124084369906,-0.00182490797013326,0.0151960507065461
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37388,-0.00531903389617797,0.00219320437405409,-0.00961771446932398,-0.00102035332303195,0.0153115212262497
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,39687,-0.0139197911054859,0.00574460855195117,-0.0251792238673102,-0.00266035834366165,0.0153996105019216
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,0.0125538633050698,0.00519283033313488,0.00237591585212544,0.0227318107580142,0.0156394111262782
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40030,0.0144643948045365,0.00598546847270713,0.00273287659803057,0.0261959130110425,0.0156778564050488
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37382,-0.0233224157836488,0.0096525210686391,-0.0422413570781815,-0.0044034744891162,0.0156966292800588
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,37411,-0.00884106105860214,0.00366310979902383,-0.0160207562646889,-0.00166136585251543,0.0158115822057399
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39794,0.00623905210593173,0.00259089135101618,0.00116090505794,0.0113171991539235,0.0160483170225527
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALLD,Palladin,37056,0.00980075754245168,0.00407304995395053,0.00181757963270865,0.0177839354521947,0.0161310951137566
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,39868,-0.0162767579909613,0.00676739263585111,-0.0295408475572294,-0.00301266842469308,0.0161760344580505
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,37437,-0.00636104461473386,0.00264639447525266,-0.0115479777862291,-0.00117411144323864,0.0162449794068508
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,39913,-0.00681080979316058,0.00283546348785781,-0.0123683182293619,-0.00125330135695928,0.0163165808608534
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,-0.0122712283257335,0.0051176510737519,-0.0223018244302872,-0.00224063222117982,0.0165044383657467
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,39866,0.0141112514777174,0.00590713023372861,0.00253327621960933,0.0256892267358255,0.0169126870289645
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37388,-0.0571131090200528,0.0239149830247235,-0.103986475748511,-0.0102397422915947,0.0169460170733019
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,36962,-0.0174734191371057,0.00732479539872348,-0.0318300181186037,-0.00311682015560769,0.0170692879375461
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.00599524059014937,0.00251490935308682,0.00106601825809922,0.0109244629221995,0.0171426825284985
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,37039,-0.0220242394022188,0.0092623895947009,-0.0401785230078326,-0.00386995579660506,0.0174297858959206
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39749,-0.0111752010717288,0.00471566828008491,-0.0204179109006952,-0.0019324912427624,0.0178094791422605
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39477,-0.00831117135594157,0.00351730703385858,-0.0152050931423044,-0.00141724956957875,0.0181429855430731
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,39477,-0.00836187106087475,0.00355586756153423,-0.0153313714814819,-0.00139237064026765,0.0187067313436593
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,39585,-0.0117793954743677,0.00501666884140827,-0.0216120664035279,-0.00194672454520746,0.0188842459346915
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37411,-0.00829391230000158,0.00353237581300205,-0.0152173688934856,-0.00137045570651756,0.0188903426397475
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,36962,0.0105258223757489,0.00449792001869891,0.00170989913909905,0.0193417456123988,0.0192907539339496
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,-0.0213904728687752,0.00914228448022155,-0.0393093504500094,-0.00347159528754093,0.0193121506897712
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,39764,-0.015756385845371,0.00676242520046508,-0.0290107392382826,-0.00250203245245944,0.0198191045372722
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,-0.0188074814641636,0.00808399115673454,-0.0346521041313633,-0.0029628587969639,0.0200041182958241
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39585,-0.0142149171249393,0.00611217279950716,-0.0261947758119733,-0.00223505843790524,0.0200486375401372
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,0.00967366199190937,0.00416544271784609,0.00150939426493104,0.0178379297188877,0.0202286373287651
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,-0.00740229830539963,0.00319190428612158,-0.0136584307061979,-0.00114616590460133,0.0204052068205689
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,36962,0.0148070730186021,0.00639345965083994,0.00227589210295582,0.0273382539342484,0.0205751594038166
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",40030,-0.0169442207674287,0.00732724941097637,-0.0313056296129424,-0.00258281192191506,0.0207629654400916
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,37445,0.0142048230094649,0.00614257597925586,0.0021653740901234,0.0262442719288064,0.0207639758299925
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,39585,-0.0119395355072026,0.00516494431013681,-0.0220628263550707,-0.00181624465933442,0.0208099238261314
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,39585,-0.0173102885471162,0.00749997653632311,-0.0320102425583095,-0.00261033453592295,0.0210095079033313
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,37289,-0.0099756417809893,0.00432720384717193,-0.0184569613214463,-0.00149432224053233,0.0211631507109807
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,0.0117214956010047,0.00508648472117201,0.00175198554750757,0.0216910056545019,0.0212134849611471
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,39489,-0.00750238956992748,0.00325994929972608,-0.0138918901973906,-0.00111288894246436,0.0213831234619063
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,36703,0.016152100210796,0.00701945681508811,0.00239396485322327,0.0299102355683687,0.0214049106327938
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,37043,-0.00528091956171223,0.00229720134874214,-0.00978343420524683,-0.000778404918177627,0.0215290669519107
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37388,-0.0105865541125354,0.00460729639583703,-0.019616855048376,-0.00155625317669483,0.0215894925816319
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39489,-0.00881101280731075,0.00384008341703495,-0.0163375763046993,-0.00128444930992224,0.0217758641572908
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,39490,-0.00967431993655838,0.00422257119155976,-0.0179505594720155,-0.00139808040110126,0.0219710506951336
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,37124,-0.00749760029116153,0.00327430521474161,-0.0139152385120551,-0.00107996207026798,0.022046836913441
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,0.00792386504084207,0.00346341296543155,0.00113557562859623,0.0147121544530879,0.0221604690714551
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37388,-0.00745834995321316,0.00327012942555316,-0.0138678036272974,-0.00104889627912896,0.0225786819865793
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39477,-0.0107258536536753,0.0047101387569086,-0.0199577256172161,-0.00149398169013441,0.0227886876729494
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,39868,-0.00761468887459556,0.00334727336971901,-0.0141753446792448,-0.0010540330699463,0.0229255122598481
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,37169,0.00767200924845699,0.00337569937569952,0.00105563847208594,0.014288380024828,0.0230591143665351
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,39456,-0.0140397045673164,0.00620326195160807,-0.0261980979924682,-0.00188131114216457,0.0236322597911893
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,37021,0.0111893048699426,0.00494690109666266,0.00149337872048379,0.0208852310194014,0.0237209573533531
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,37056,0.0153673036200823,0.00679918708048387,0.0020408969423339,0.0286937102978307,0.0238270678114576
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,-0.00861581537045802,0.00382649438118494,-0.0161157443575805,-0.00111588638333554,0.0243597968818842
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,-0.0118738685755009,0.00527424593423257,-0.0222113906065968,-0.0015363465444051,0.0243834430828418
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37039,0.00827442462156216,0.00367885575588354,0.00106386734003041,0.0154849819030939,0.0245172141854262
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERVV_1,,37021,0.010824327721816,0.00481995630460479,0.00137721336479064,0.0202714420788414,0.0247377352951455
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,39587,0.00629702348425054,0.00280687783438512,0.000795542928855703,0.0117985040396454,0.0248832008181998
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,39477,-0.0174367932301978,0.00778726693250452,-0.0326998364179067,-0.00217375004248899,0.0251607274991324
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,-0.0123841813920501,0.00553245421473953,-0.0232277916529396,-0.00154057113116066,0.0252072262120643
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37039,0.00971006942703921,0.00434147825866361,0.00120077204005854,0.0182193668140199,0.0253303742528989
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37247,0.00180743134727094,0.000808597769422542,0.000222579719202755,0.00339228297533912,0.0254162956082199
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39477,-0.0171394617238893,0.00768110776856195,-0.0321944329502707,-0.00208449049750785,0.0256701782218602
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,-0.0332629024502956,0.0149169838268343,-0.0625001907508908,-0.00402561414970036,0.025770032472578
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,-0.0144312024994932,0.00647716778694232,-0.0271264513619002,-0.0017359536370863,0.0258964126161288
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,37453,-0.00593550975530557,0.00266436722010044,-0.0111576695067024,-0.000713350003908706,0.0259143527669987
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,0.00658254410591735,0.00295847087038314,0.000783941199966393,0.0123811470118683,0.0260988221205932
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,39455,-0.0169618660051265,0.00763656909831024,-0.0319295414378145,-0.00199419057243841,0.0263559913806783
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,40052,0.0042863671989514,0.00193746315882181,0.000488939407660652,0.00808379499024215,0.0269556595270669
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,-0.017529781255123,0.00793673184557639,-0.0330857756724527,-0.00197378683779326,0.0272106579510672
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,39720,0.0101271535697872,0.00458789284121167,0.00113488360101231,0.0191194235385621,0.027302841921195
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,0.013488188539857,0.00613974737073173,0.0014542836932228,0.0255220933864912,0.0280475875874502
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,40030,0.00634882797901018,0.00289393312734062,0.000676719049422569,0.0120209369085978,0.0282610513704899
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37037,-0.013212393894468,0.00603294716527765,-0.0250369703384122,-0.00138781745052382,0.0285388229067123
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,39791,-0.0234851539217471,0.0107327381066823,-0.0445213206108445,-0.00244898723264973,0.0286710270097888
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37043,-0.0135599748362459,0.00619966612273599,-0.0257113204368084,-0.00140862923568338,0.0287446673580734
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,0.0107880224989048,0.00493882373811057,0.00110792797220813,0.0204681170256015,0.0289525490245508
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,40009,-0.0144110821992277,0.00660490147050435,-0.0273566890814162,-0.00146547531703911,0.0291329814269546
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,-0.00796236654460799,0.00365268853248486,-0.0151216360682783,-0.000803097020937656,0.0292851341665726
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,37056,-0.00851571907287886,0.00391313093001649,-0.0161854556957112,-0.00084598245004653,0.0295586816899484
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,37382,-0.00916764087161934,0.004218222549346,-0.0174353570683375,-0.000899924674901185,0.0297718724631427
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,37453,-0.00561681901711916,0.00258611862516248,-0.0106856115224376,-0.000548026511800699,0.0298796207533737
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37021,0.00822726062949288,0.00379497280269011,0.000789113936220256,0.0156654073227655,0.0301813699576933
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,37124,-0.0244725435188477,0.0113249635713726,-0.046669472118738,-0.00227561491895743,0.0307179747443668
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,0.00742788230282118,0.00345215585773259,0.000661656821665311,0.0141941077839771,0.0314419634255086
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37382,0.0100184116113546,0.0046570050429252,0.000890681727221232,0.019146141495488,0.0314736316865907
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00484140708648536,0.00225288502443078,0.000425752438601039,0.00925706173436969,0.0316540404128488
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,37388,-0.0081485159799236,0.00380303311119574,-0.0156024608778673,-0.00069457108197994,0.032160122366255
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,37368,0.0119219565229224,0.00557925984846624,0.000986607219928614,0.0228573058259163,0.0326293430501663
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37056,0.00623922820283335,0.00292200302262728,0.000512102278483882,0.0119663541271828,0.0327583618984206
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,-0.00481136647967499,0.00225713178458745,-0.00923534477746639,-0.00038738818188358,0.0330528436485999
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,37021,0.00755199947141857,0.00354802207321024,0.0005978762079265,0.0145061227349106,0.0333133659234882
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,39587,-0.00607762932282454,0.00285589881290437,-0.0116751909961171,-0.000480067649531966,0.0333445575405698
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,36962,0.00935607752704729,0.00440017444747817,0.000731735609990071,0.0179804194441045,0.0334971824866388
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37021,-0.0119649444289195,0.00564739269791192,-0.0230338341168269,-0.00089605474101216,0.0341373032874245
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,39587,-0.0101465818204191,0.00479017487639731,-0.0195353245781578,-0.000757839062680362,0.0341731833679695
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,37056,0.00909310606569112,0.00429724664906653,0.000670502633520711,0.0175157094978615,0.0343608678707011
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,-0.0121044274838775,0.00574634265496111,-0.0233672590876013,-0.000841595880153718,0.0351801393750371
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39818,-0.0230914133897578,0.0109643906772428,-0.0445816191171537,-0.00160120766236197,0.0352167081209353
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,39866,-0.0121417290473594,0.00576669703480539,-0.023444455235578,-0.000839002859140842,0.0352641224074874
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,37056,0.00459299188890937,0.00218323222330027,0.000313856731240841,0.0088721270465779,0.0354184512217664
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,-0.00986091424505266,0.00468948066737973,-0.0190522963531169,-0.000669532136988386,0.0355015864488923
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,40011,-0.0111827632692446,0.00532535732003179,-0.0216204636165069,-0.00074506292198228,0.0357523595966377
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,37437,0.0106218045766755,0.0050670007408456,0.00069048312461816,0.0205531260287329,0.0360766565061832
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,0.00619264046424674,0.00295975413720022,0.000391522355334298,0.0119937585731592,0.0364290082136266
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37056,0.010014751681136,0.00479029392531761,0.000625775587513491,0.0194037277747585,0.036579963662562
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37169,-0.00915021025296978,0.00438806379828,-0.0177508152975986,-0.000549605208340973,0.0370656159686402
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,0.00854732301741154,0.0041002448032917,0.000510843202959802,0.0165838028318633,0.0371223037107905
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCT,Secretin,37039,-0.00922369362670932,0.00442601812120649,-0.017898689144274,-0.0005486981091446,0.0371820155645005
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,36962,0.0101892012234677,0.00489263877774109,0.000599629219095168,0.0197787732278402,0.037310933437133
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,0.00953941221654555,0.0045893158313506,0.000544353187098367,0.0185344712459927,0.0376721962652784
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37169,-0.0148259657280057,0.00713519131763395,-0.0288109407105682,-0.000840990745443125,0.0377408991505784
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,36991,0.0200259001883105,0.00964068820599435,0.0011301513045616,0.0389216490720594,0.0377999823521489
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,37039,0.00719350515939007,0.00346803367226866,0.000396159161743495,0.0139908511570366,0.0380771716383157
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,37235,0.00709381254630038,0.00342177331977555,0.000387136839540309,0.0138004882530604,0.0381784241293618
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,-0.0211630346916265,0.0102135429045657,-0.0411815787845752,-0.00114449059867781,0.038276295232934
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39477,-0.0110431456456722,0.0053312861887489,-0.02149246657562,-0.000593824715724315,0.0383392240928501
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,37411,-0.0062140149964619,0.00300455304356209,-0.0121029389618436,-0.000325091031080207,0.0386401988028704
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00655039948773681,0.0031688053933411,0.000339540916788243,0.0127612580586854,0.0387362452342247
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,39868,-0.0158479940359852,0.00767817238927842,-0.0308972119189709,-0.000798776152999449,0.0390307522279271
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,0.0116472810236672,0.00565587636184372,0.000561763354453548,0.0227327986928809,0.0394828980982067
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39477,-0.00964111954543086,0.00468652523702547,-0.0188267090100008,-0.000455530080860942,0.0396835629779855
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,-0.0183962642608576,0.00897168785837762,-0.0359807724632777,-0.000811756058437439,0.0403372476526185
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,-0.0097838387781968,0.00477696294648502,-0.0191466861533074,-0.00042099140308615,0.0405671100869214
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,36962,0.00843070770364814,0.00412407805348832,0.000347514718811032,0.0165139006884853,0.0409473393997554
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40034,0.0113259814723075,0.00556313817646199,0.000422230646441996,0.022229732298173,0.0417768676651448
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39587,0.00735475185025987,0.00362280907012179,0.000254046072821154,0.0144554576276986,0.0423607268053059
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37366,-0.0179471582873916,0.00884285782678406,-0.0352791596278883,-0.000615156946894794,0.0424203012875263
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,37382,-0.00728896502489291,0.00359417092594845,-0.0143335400397519,-0.000244390010033953,0.0425802006289588
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,39489,-0.00956289140733292,0.00472116033082525,-0.0188163656557504,-0.000309417158915436,0.0428290715072725
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,37056,-0.0128327122287033,0.00633571988981648,-0.0252507232127436,-0.000414701244663026,0.0428408053778411
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36962,0.00665801975791555,0.00328948264579127,0.000210633772164666,0.0131054057436664,0.0429870611720877
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,37056,0.0119010422638836,0.00588467882127708,0.000367071774180531,0.0234350127535867,0.0431574964957249
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,37124,-0.00569524821741353,0.00281946826205989,-0.0112214060110509,-0.000169090423776148,0.0434063098559198
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,37368,-0.0162653113312841,0.00805765431341575,-0.0320583137855789,-0.000472308876989198,0.0435468502499644
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37124,-0.00737271192112432,0.00365240674589961,-0.0145314291430876,-0.000213994699161072,0.0435499308374647
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,-0.00736824070735225,0.00365921606795002,-0.0145403042005343,-0.000196177214170222,0.0440700983307077
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37021,0.0074152759831212,0.0036908921552244,0.000181127358881372,0.014649424607361,0.0445496530294474
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39868,-0.0065234459131822,0.00326108989895954,-0.0129151821151429,-0.000131709711221491,0.0454752159421915
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,37368,-0.0161061316564653,0.00806182005585062,-0.0319072989659326,-0.000304964346998126,0.0457553020083869
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",37169,-0.00920376188415044,0.00461906653433796,-0.0182571322914528,-0.000150391476848036,0.0463301648023162
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,39691,0.00940777492656483,0.00475472853992857,8.85069883048446e-05,0.0187270428648248,0.0478767276732011
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,40030,0.0116695537356699,0.0059012493827999,0.000103104945382087,0.0232360025259577,0.048005288859295
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39788,-0.00408764726767115,0.00206949178369661,-0.0081438511637165,-3.14433716258004e-05,0.0482634010775503
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,39720,0.02472674577086,0.0125461097172315,0.000136370725086352,0.0493171208166337,0.0487561586211388
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,-0.0106481509209626,0.00540541793439222,-0.0212427700723713,-5.35317695538017e-05,0.0488697413926098
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,-0.0171366270078033,0.00872998937467004,-0.0342474061821566,-2.58478334500163e-05,0.0496717575807329
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,37021,0.007948540563056,0.00405306285779188,4.53736178391076e-06,0.0158925437643281,0.0498861401862004
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,37437,0.00513082069864607,0.00262198817691857,-8.27612811433141e-06,0.0102699175254065,0.0503863281553813
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,37311,0.0140700204928391,0.00720920420811455,-6.00197550653936e-05,0.0282000607407436,0.0509975785086324
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,-0.00710363455584783,0.00364773030289447,-0.014253185949521,4.59168378253274e-05,0.0515031091396304
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37220,-0.0108510699579348,0.00557750889127114,-0.0217829873848262,8.08474689566324e-05,0.0517352062534158
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.00776931712990371,0.00399397198161811,-5.88679540677838e-05,0.0155975022138752,0.0517648730686839
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,39587,-0.00960963985175707,0.00494048988325468,-0.0192930000229362,7.37203194220975e-05,0.0517833486061554
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.00659444003420561,0.00339193829843271,-5.37590307225005e-05,0.0132426390991337,0.0518946215476219
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,37411,-0.0116643659117591,0.00600280151726174,-0.0234298568855921,0.000101125062073935,0.0520182722841072
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,40012,0.00567195586633526,0.00291913650201743,-4.95516776189021e-05,0.0113934634102894,0.052030461903393
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,37021,0.0160922307606413,0.00830389188012247,-0.000183397324398715,0.0323678588456813,0.052655041567468
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,39903,0.010543771711722,0.00545706341730368,-0.000152072586193246,0.0212396160096372,0.0533606909919412
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,37169,0.00767852353661701,0.003980732095784,-0.000123711371119637,0.0154807584443537,0.0537617277744891
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39585,0.0063809540576169,0.00330889443212376,-0.000104479029345658,0.0128663871445795,0.053820291074337
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,39315,-0.00668424256998264,0.00346705119977283,-0.0134796629215374,0.000111177781572114,0.0538817550584508
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,-0.0232249814579332,0.012076543537846,-0.0468950067921114,0.000445043876244982,0.0544791759854642
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,39990,-0.00887257415833663,0.00462516250802271,-0.0179378926740612,0.000192744357387883,0.055087192706219
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,39695,0.00504184543005153,0.00263155913571285,-0.000116010475945664,0.0101997013360487,0.055393814685459
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37357,-0.0069294480774546,0.00362079276670624,-0.0140262019001988,0.000167305745289639,0.055667729955531
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40009,-0.00443555105588949,0.00232409636108642,-0.00899077992361887,0.000119677811839898,0.0563436034651731
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,-0.0139845249473582,0.00734204848455661,-0.0283749399770892,0.000405890082372727,0.0568379719816511
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,37056,0.00524561202227337,0.00275714903126406,-0.000158400079004186,0.0106496241235509,0.0571211236241645
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37043,-0.00460538670352018,0.00242557977332828,-0.0093595230592436,0.000148749652203244,0.057629087686126
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,39788,-0.0163521731805135,0.00862806637012922,-0.0332631832659668,0.000558836904939776,0.0580799807484932
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,39699,0.0127631608089627,0.00674647364194386,-0.000459927529247266,0.0259862491471727,0.0585322620672352
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,0.00691618349199667,0.00366174696418824,-0.000260840557812276,0.0140932075418056,0.0589451465904218
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,-0.0108806398044055,0.00576817121989552,-0.0221862553954007,0.000424975786589727,0.059269844289809
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,0.00769280740698078,0.0040822616754316,-0.000308425476865164,0.0156940402908267,0.0595265517256936
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,-0.0132598708095236,0.00704210418661397,-0.027062395015287,0.000542653396239757,0.0597296864090242
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37021,0.00617296427772931,0.00328012890673589,-0.000256088379473038,0.0126020169349317,0.0598679286706589
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,-0.0157927389919421,0.00839628680606534,-0.0322494611318302,0.000663983147945909,0.0600014552050208
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,0.0117883131579976,0.00628600817111525,-0.000532262857388255,0.0241088891733835,0.0607700116533678
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,37388,0.00502324230496211,0.00268682623037248,-0.000242937106567946,0.0102894217164922,0.0615634540692898
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,-0.00874283231269341,0.00467881501556115,-0.0179133097431933,0.000427645117806448,0.0617007263089107
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,40030,0.00463819473614065,0.00248486723497822,-0.000232145044416664,0.00950853451669796,0.0619788402622216
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,39587,0.0088255286874396,0.00473599067637427,-0.00045701303825397,0.0181080704131332,0.0624102773145657
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00560080494730858,0.0030076941929475,-0.000294275670868531,0.0114958855654857,0.0625993110040503
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,37056,-0.00795345578592121,0.00427671900007472,-0.0163358250260677,0.000428913454225235,0.0629488464457323
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,37169,-0.013530565203461,0.00728026632620823,-0.0277998872028291,0.000738756795907108,0.0631163968749755
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,37021,-0.00714368884176792,0.00384565972300405,-0.0146811818988559,0.000393804215320026,0.0632484773531791
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,-0.0089029935074661,0.00480044185376944,-0.0183118595408542,0.000505872525922003,0.0636723452027324
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,39587,-0.00802482236820499,0.00432848366803246,-0.0165086503575486,0.000459005621138627,0.0637640296255508
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,39889,0.0054657136887381,0.00294996998805969,-0.000316227487858887,0.0112476548653351,0.0639289461048208
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,37271,-0.0116921104455174,0.00631342066808522,-0.0240664149549644,0.000682194063929657,0.0640556241234418
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.00656598193713272,0.00355814178772868,-0.000407975966815486,0.0135399398410809,0.0650098331930756
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,39587,0.00524974688692932,0.00284792002684187,-0.000332176365680736,0.0108316701395394,0.065295012245956
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,-0.00719425544050577,0.0039145683941205,-0.014866809492982,0.000478298611970413,0.0661078703490905
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,-0.00982520770612536,0.00534923085125092,-0.0203097001745772,0.000659284762326446,0.0662685498453021
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,0.00466723433317429,0.00255020619588195,-0.000331169810754335,0.00966563847710292,0.0672509208636339
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,37437,-0.00982971880417566,0.00537304625959293,-0.0203608894729778,0.00070145186462648,0.0673541605143721
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,-0.00497588687502966,0.00272180404068282,-0.010310622794768,0.00035884904470866,0.0675449466586403
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,37056,0.00869255254845425,0.00476090517056505,-0.000638821585853242,0.0180239266827617,0.0679000724010723
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,37388,-0.0175844092689181,0.00963809655449816,-0.0364750785157345,0.00130625997789828,0.0681032308266595
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,37056,-0.00517399250666085,0.00283617661441105,-0.0107328986709065,0.000384913657584806,0.0681317031169413
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,-0.00575548984285184,0.00315695235258803,-0.0119431164539244,0.000432136768220712,0.0683045149071234
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37021,0.00603689432620189,0.00331283757901889,-0.000456267328675136,0.0125300559810789,0.0684362617765821
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,-0.00485993063211404,0.00266732434502246,-0.0100878863483581,0.000368025084129974,0.0684699958905927
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,-0.0157310697517272,0.00864730081275876,-0.0326797793447343,0.00121763984128,0.068905498897358
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36991,0.0126355835101745,0.00695166780527288,-0.000989685388160376,0.0262608524085093,0.0691429638941569
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,39587,0.00731740214279184,0.00402696807852597,-0.000575455291119057,0.0152102595767027,0.0692208850089966
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,0.00586113147755002,0.00323015065306776,-0.00046996380246279,0.0121922267575628,0.0696224908537789
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.00705765248774593,0.00389465123599136,-0.000575863934797134,0.014691168910289,0.0699873766232845
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,37411,-0.00497309883778465,0.00274468207773703,-0.0103526757101492,0.00040647803457993,0.0700232471360475
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,0.0153292784918765,0.00848833275133363,-0.00130785370073742,0.0319664106844904,0.0709497124466631
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37056,0.0108608283586054,0.00601566624827722,-0.000929877488017903,0.0226515342052288,0.0710311362028198
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,39866,-0.0116767923729636,0.00647128445522414,-0.0243605099052029,0.00100692515927567,0.0711872504919489
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,37388,0.0130831298786663,0.00725281231460778,-0.00113238225796492,0.0272986420152976,0.0712739397075714
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,37124,-0.00652293177558157,0.00362450658655743,-0.0136269646852341,0.000581101134070997,0.0719347797847081
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C2,Complement C2,39908,-0.00424746486212286,0.00236120826776357,-0.00887543306693945,0.000380503342693736,0.0720608336943878
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,0.011541922684388,0.00641790037083748,-0.00103716204245349,0.0241210074112294,0.0721331567353275
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,37368,-0.0112611250143724,0.00627379925050147,-0.0235577715453553,0.00103552151661047,0.0726848003340121
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,37411,-0.0124494371899112,0.00693951936148075,-0.0260508951384134,0.00115202075859109,0.0728368463757831
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,0.0112089424265019,0.00626350259406509,-0.00106752265786571,0.0234854075108695,0.073546664575767
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,39992,0.00754795897048542,0.00422501443184545,-0.000733069315931659,0.0158289872569025,0.0740382325043313
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,39587,-0.0110735426669618,0.00621026357543918,-0.0232456592748226,0.00109857394089901,0.0745887388001183
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36962,0.00457009977691573,0.00256328554998424,-0.000453939901053386,0.00959413945488484,0.0746245869799026
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40002,0.00832359969598292,0.00467317219233058,-0.000835817800985008,0.0174830171929509,0.074907480166458
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,39173,-0.00375424396936878,0.00210950199420304,-0.00788886787800674,0.000380379939269184,0.0751477482993054
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',37021,-0.00761876550864463,0.00428475696084978,-0.0160168891519102,0.000779358134620945,0.0754090137050236
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39788,-0.00958897423825053,0.00539320081336104,-0.0201596478324382,0.000981699355937102,0.0754270942058479
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,37380,-0.00452295262254142,0.00255237192635307,-0.00952560159819344,0.000479696353110602,0.0764073477508847
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,0.00992193840147004,0.0056230100446699,-0.00109916128608296,0.020943038089023,0.0776669767519607
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,37043,-0.0152206581110907,0.00862700807166892,-0.0321295939315618,0.00168827770938035,0.07770409737292
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,39489,-0.00789803181737431,0.00448204675263894,-0.0166828434525466,0.000886779817798012,0.0780637615718622
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,-0.010823852579842,0.00615136206440287,-0.0228805222260717,0.0012328170663876,0.0784970729117908
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39489,-0.0248457193916403,0.0141222638147386,-0.052525356468528,0.00283391768524737,0.0785410738353784
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39477,-0.00713072230209451,0.00405396224706502,-0.0150764883063419,0.000815043702152925,0.0786053562168138
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BSND,Barttin,36962,0.00592595459004768,0.00337248125051538,-0.000684108660962467,0.0125360178410578,0.0789156414545746
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,-0.00800046679238368,0.00455923588537935,-0.0169365691277272,0.000935635542959853,0.0793197442816692
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.00695956314213043,0.00397914227413151,-0.0147586819994282,0.000839555715167339,0.0803124484274528
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37368,0.00899315048526126,0.00514809587237823,-0.00109711742460008,0.0190834183951226,0.0806793735288525
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,37169,-0.00752256184859702,0.00431769078929883,-0.0159852357956227,0.000940112098428676,0.0814851716420357
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,0.00562125677227332,0.0032281201843939,-0.000705858789138717,0.0119483723336854,0.0816435827039969
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,39779,-0.00505346465859778,0.00290262581873246,-0.0107426112633134,0.000635681946117834,0.0817033141437727
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,39866,-0.00977320264502131,0.00562208181142028,-0.0207924829954051,0.00124607770536244,0.082166613981691
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPL,Periplakin,37056,-0.00558134928823248,0.00321068826110376,-0.0118742982799959,0.000711599703530895,0.0821697789778432
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,36991,-0.0192541881035444,0.0111621752245589,-0.0411320515436798,0.00262367533659105,0.0845601119944432
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,-0.00634152441740896,0.00367959207712167,-0.0135535248885674,0.000870476053749518,0.0848334260836396
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39587,-0.0115964963214657,0.0067306098657916,-0.0247884916584173,0.00159549901548581,0.0849174382083432
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,0.00329787580186865,0.00191655158499145,-0.000458565304714594,0.00705431690845188,0.0853218298892818
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,37039,-0.0113176758612211,0.00659235765246224,-0.0242386968600471,0.00160334513760487,0.086041540012484
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,-0.0115947214146287,0.0067545884166631,-0.0248337147112883,0.00164427188203101,0.0860807592824263
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,36962,0.00513880990989302,0.00300025185405125,-0.000741683724047433,0.0110193035438335,0.0867743164435862
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,0.00705917033338434,0.00412479495460518,-0.0010254277776418,0.0151437684444105,0.0870310269619222
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37388,0.00673069193515085,0.00393783734438786,-0.000987469259849349,0.0144488531301511,0.0874302448568599
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,37437,-0.016884229656385,0.00988340837977948,-0.0362557100807528,0.00248725076798279,0.0875959849792679
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,0.00604951816711331,0.00354183277111537,-0.000892474064272803,0.0129915103984994,0.0876563104875285
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MB,Myoglobin,40052,-0.00878684696503131,0.00517620538874847,-0.0189322095269783,0.0013585155969157,0.0896126907906175
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39585,0.00541498561581203,0.00319037400304718,-0.000838147430160436,0.0116681186617845,0.089661888461481
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,36931,0.0134164507872769,0.00790586940633652,-0.00207905324914263,0.0289119548236965,0.0897159150119725
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,-0.00971661683514478,0.00574923988265432,-0.0209851270051472,0.00155189333485768,0.0910376370128584
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,36962,0.0101079326855103,0.00598130688344994,-0.00161542880605156,0.0218312941770722,0.0910669686842113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.00515038173660357,0.0030477587169083,-0.0111239888217438,0.000823225348536693,0.0910685239656433
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,36991,0.0127101496869558,0.00753532887167574,-0.00205909490152864,0.0274793942754402,0.091676879327807
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,0.00929978839917746,0.00551378073498932,-0.00150722184140161,0.0201067986397565,0.091695351386256
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37043,0.00989912507745127,0.00587471033327395,-0.00161530717576568,0.0214135573306682,0.0920044187009697
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,-0.0112838498971926,0.00669711805858608,-0.0244102012920213,0.00184250149763611,0.0920349736591676
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.00676972564083133,0.00402067388970162,-0.00111079518298385,0.0146502464646465,0.0922537394962493
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,37368,-0.0089994593877315,0.00534519361782445,-0.0194760388786674,0.00147712010320442,0.0922715618712576
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,-0.0100947320370284,0.00601569031603786,-0.0218854850564626,0.00169602098240585,0.093353665740578
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36991,-0.00729104669421136,0.00435405978554173,-0.0158250038738732,0.00124291048545044,0.0940483597616751
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,39862,0.00585643887802442,0.00350966960070821,-0.00102251353936368,0.0127353912954125,0.0952047054002349
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.00783735530454342,0.00469729361759843,-0.0170440507950363,0.0013693401859495,0.095243599243699
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,37368,-0.00843820666613235,0.00506433257061005,-0.0183642985045281,0.00148788517226335,0.0956961530739993
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,0.0103243996536748,0.00619876988563846,-0.00182518932217654,0.0224739886295262,0.0958256398613794
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39456,-0.00845686269489857,0.00511269429325529,-0.0184777435096789,0.00156401811988179,0.0981291055969353
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,-0.0202516177932082,0.0122483437381608,-0.0442583715200034,0.00375513593358696,0.0982656686916784
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,37083,-0.0136096594091689,0.00827252202660991,-0.0298238025813244,0.00260448376298648,0.0999596647210459
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.00602531146782909,0.00366509008604861,-0.00115826510082618,0.0132088880364844,0.100201055331857
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,37348,0.00951239914493231,0.00580055469971367,-0.00185668806650649,0.0208814863563711,0.101046788969265
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C7,Complement component C7,37149,0.00525384684597762,0.00321139993944632,-0.00104049703533717,0.0115481907272924,0.101863494001424
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,39892,0.00730321197702528,0.00446489265157633,-0.00144797762006433,0.0160544015741149,0.101922626510936
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,39587,0.00796870830502351,0.00487300619299787,-0.00158238383325231,0.0175198004432993,0.102011290800287
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,39489,0.00610349145311324,0.00374869004076323,-0.0012439410267827,0.0134509239330092,0.10350974719417
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39962,-0.00482844407900353,0.00296810995605586,-0.010645939592873,0.000989051434865942,0.103804674776794
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,39780,0.0108876544644276,0.00669574144077478,-0.00223599875949096,0.0240113076883462,0.103957411149323
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.00554390287460145,0.00341138174944404,-0.00114240535430888,0.0122302111035118,0.10416031754615
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39585,-0.0100202259487019,0.00617847508905332,-0.0221300371232464,0.00208958522584259,0.104867091369724
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,39775,-0.00542277036725686,0.00335147660470028,-0.0119916645124694,0.00114612377795569,0.105677191785681
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,37437,0.00755821086238923,0.00469048477017309,-0.00163513928715003,0.0167515610119285,0.107117497416177
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,37382,-0.0183447337087725,0.0113933968751435,-0.0406757915840537,0.00398632416650877,0.107395050916553
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39477,0.00795567339994835,0.00494526958790875,-0.0017370549923528,0.0176484017922495,0.107692516135711
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,39585,-0.020174939645087,0.0126100623841502,-0.0448906619180213,0.00454078262784737,0.109639084268161
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39866,-0.00530308510483954,0.00331691131028636,-0.0118042312730008,0.00119806106332172,0.109884297875913
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,37021,-0.00963713420644771,0.0060319393035243,-0.0214597352413553,0.00218546682845993,0.110137280470082
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,39858,0.00810746636916827,0.00508202214838338,-0.00185329704166315,0.0180682297799997,0.110659797600598
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,-0.00707289650869327,0.00444297808649098,-0.0157811335582156,0.00163534054082904,0.111420694129932
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,39587,0.00534552185198133,0.00338139411606582,-0.00128201061550768,0.0119730543194703,0.11392940758368
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,36991,0.00537435851302229,0.00340265083966882,-0.00129483713272861,0.0120435541587732,0.114254158089406
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37056,-0.0102452836766536,0.00649269547450245,-0.0229709668066784,0.00248039945337124,0.114596294735356
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,-0.0112147825177863,0.00711553188927157,-0.0251612250207586,0.00273165998518596,0.115026997501001
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,0.00829874906745969,0.00526741072550486,-0.00202537595452983,0.0186228740894492,0.115167754883294
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37411,-0.00440738531975873,0.00280212187348221,-0.00989954419178386,0.00108477355226639,0.115771286242706
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TTN,Titin,37021,-0.0107621311229376,0.00685352971716749,-0.0241950493685859,0.0026707871227107,0.116368240251508
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,0.00682975961347352,0.00435226115877594,-0.00170067225772733,0.0153601914846744,0.11661524899158
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,37043,-0.00937252677391393,0.00600054352799731,-0.0211335920887887,0.0023885385409608,0.11832464297603
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,39844,-0.0193980924699202,0.0124450899859342,-0.0437904688423513,0.00499428390251089,0.119088518154345
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37388,0.00416925512602867,0.00268229045428801,-0.00108803416437582,0.00942654441643317,0.120121060751585
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,0.00521731171289595,0.00335992147936122,-0.00136813438665205,0.0118027578124439,0.120493252311661
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.0063451286820332,0.0040902425523927,-0.0143620040847229,0.00167174672065649,0.120857634260225
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,39913,-0.012097766268853,0.00783253326938224,-0.0274495314768422,0.00325399893913623,0.122474025489959
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,-0.00954379103777224,0.00618741171509817,-0.0216711179993647,0.00258353592382017,0.122987676551151
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,0.00608730084940866,0.00396726063957114,-0.00168853000415077,0.0138631317029681,0.124958537195997
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.00832053289187064,0.00542381969668216,-0.0189512194973677,0.00231015371362639,0.125031571199558
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,37056,0.0155598768383096,0.0102050066586308,-0.00444193621260674,0.035561689889226,0.127350492668537
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.00355368814552452,0.00233087949854968,-0.00101483567163286,0.0081222119626819,0.127375618145183
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VIM,Vimentin,39585,-0.0177885762132226,0.0116753420511051,-0.0406722466333887,0.0050950942069434,0.127628235778729
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,37391,0.00362316443054788,0.00237875513051909,-0.00103919562526954,0.00828552448636529,0.1277483836465
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37056,-0.00452384171494259,0.0029705016216513,-0.0103460248933791,0.00129834146349396,0.1278022300148
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,-0.00377421869430452,0.00248207365613401,-0.00863908306032717,0.00109064567171813,0.128385796978146
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,39984,-0.00931391194353544,0.00615668228261941,-0.0213810092174695,0.0027531853303986,0.130346643043883
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,0.0049050523347974,0.00325028252541975,-0.00146550141502531,0.0112756060846201,0.131293282215792
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,37368,0.0163967778116635,0.0108654723778895,-0.00489954804899987,0.0376931036723269,0.131303827012467
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,37411,-0.00382492586984522,0.00253470378010802,-0.00879294527885694,0.0011430935391665,0.131316262864723
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36991,0.00931028581509141,0.00617656730275232,-0.00279578609830313,0.021416357728486,0.131743485973957
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,0.00479565262939992,0.0031817006318059,-0.00144048060893963,0.0110317858677395,0.13176779096433
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39749,-0.00345651498514465,0.00229392788912426,-0.00795261364782821,0.00103958367753891,0.13187907782246
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.00380456427735526,0.00253030705107392,-0.00115483754274963,0.00876396609746014,0.132709080955046
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,39908,0.0123145255033648,0.00822581123787017,-0.00380806452286071,0.0284371155295903,0.134397549440293
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,37031,0.0104635168586011,0.00699149638298673,-0.00323981605205289,0.0241668497692551,0.134519716380499
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36991,0.010707845038558,0.00715942475510015,-0.00332462748143831,0.0247403175585543,0.13477432994258
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36991,0.0112525472868334,0.00753157017265807,-0.0035093302515764,0.0260144248252432,0.135186410500665
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,40058,-0.00908216375913567,0.00608704927585773,-0.0210127803398168,0.00284845282154549,0.135706292971738
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,36991,0.00525114885124784,0.00352200086949904,-0.00165197285297028,0.012154270555466,0.135997029044946
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,37056,0.00324433635348201,0.00217772863224559,-0.00102401176571935,0.00751268447268337,0.136306016126281
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39817,-0.00484787659337365,0.00325455179589364,-0.0112267981133252,0.00153104492657788,0.136357593976262
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,36962,0.00622479910119321,0.00418889954912505,-0.00198544401509188,0.0144350422174783,0.137297223014586
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.0061156756563627,0.00413823009143723,-0.00199525532285427,0.0142266066355797,0.139471743855768
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESPL1,Separin,36962,0.00792979366687066,0.00538148318226341,-0.00261791337036562,0.0184775007041069,0.140631365659543
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36962,0.00611596823645609,0.00416818100866284,-0.00205366654052308,0.0142856030134353,0.142318711690933
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,39866,0.00810732911386807,0.00552844635559636,-0.0027284257431008,0.0189430839708369,0.142538536104352
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,0.00706439415798284,0.00483190048159454,-0.00240613078594246,0.0165349191019081,0.143756313475386
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,37368,-0.00580675467696695,0.00397371281322881,-0.0135952317908954,0.00198172243696152,0.143958589461924
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,-0.0169269505807422,0.0115840316208998,-0.0396316525577057,0.00577775139622143,0.143975138852836
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,39657,-0.0154101820559459,0.0105490255017959,-0.0360862720394658,0.00526590792757403,0.144085915035646
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,39866,-0.0124675456611028,0.00855153881711672,-0.0292285617426516,0.00429347042044595,0.14487943670593
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,37445,-0.00400652489006366,0.00275650215996967,-0.00940926912360421,0.0013962193434769,0.146113212339311
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,37039,0.00393354781429459,0.00270729531086658,-0.0013727509950039,0.00923984662359308,0.146263179910501
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,39585,-0.00868868931640782,0.00598013937545958,-0.0204097624923086,0.00303238385949295,0.146264750393558
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRN,Progranulin,39787,-0.0035694865840039,0.00246216556275234,-0.00839533108699849,0.00125635791899069,0.147152235925218
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37043,0.00573661191775165,0.00396569136101968,-0.00203614314984692,0.0135093669853502,0.148043870559926
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37056,-0.00452724927646918,0.00313298560687117,-0.0106679010659367,0.00161340251299831,0.148474003466991
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,37039,0.00486112539105115,0.00336807244160325,-0.00174029659449122,0.0114625473765935,0.148960881816377
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,36991,0.00627510094373105,0.00435726409999815,-0.00226513669226532,0.0148153385797274,0.149849647098326
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,37021,-0.0158797782439168,0.0110574974637534,-0.0375524732728735,0.00579291678503998,0.150994924966027
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39585,-0.0120119882353131,0.00837925199692598,-0.028435322149288,0.00441134567866185,0.151723617661656
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,37437,0.0150442833856653,0.0105562411476206,-0.00564594926367108,0.0357345160350016,0.154135291453346
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37147,0.00748053232151253,0.00525336030944522,-0.0028160538850001,0.0177771185280252,0.154483883123943
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,37021,0.00771600100945253,0.00543306571650679,-0.00293280779490077,0.0183648098138058,0.155575236413923
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,37368,0.00393161397592146,0.00277142332834117,-0.00150037574762723,0.00936360369947014,0.156031070045643
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,39489,-0.00665729680364846,0.0046955337883194,-0.0158605430287545,0.00254594942145758,0.156271028680342
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39587,-0.0085530926108421,0.00604369136599053,-0.0203987276881836,0.00329254246649934,0.157026726258522
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,37382,-0.00991001907436678,0.00702601182639066,-0.0236810022540925,0.00386096410535891,0.158422264522828
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,0.00519018153053603,0.00368377043127228,-0.00203000851475764,0.0124103715758297,0.158878262451383
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37039,-0.0119377506714631,0.00848276422064156,-0.0285639685439206,0.00468846720099433,0.159363549733237
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37445,-0.0102381044223819,0.00730626753157723,-0.0245583887842733,0.00408217993950944,0.161154109236602
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,-0.00339953801151601,0.00242698834908618,-0.00815643517572492,0.0013573591526929,0.161316381404324
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37382,0.00775835812208515,0.00554527364190694,-0.00311037821605245,0.0186270944602227,0.161807785738444
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.0053776669848053,0.0038443456274992,-0.0129125844147037,0.00215725044509313,0.161881181384258
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39788,-0.00427864099599788,0.00307435720026311,-0.0103043811085136,0.00174709911651781,0.164026973182015
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,0.003088047670782,0.00222190532317613,-0.00126688676264322,0.00744298210420721,0.164603006389863
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,39315,0.00351929665281047,0.00253869002613913,-0.00145653579842222,0.00849512910404316,0.165686055530726
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37186,-0.00581800566227928,0.00420320426617968,-0.0140562860239914,0.00242027469943289,0.166325477736511
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,-0.0112499269067292,0.00814394522609155,-0.0272120595498686,0.00471220573641025,0.167184053876612
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.0105906582760134,0.00770377739004005,-0.00450874540846507,0.0256900619604919,0.169236752523102
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36962,-0.0127380596031553,0.00927227099876609,-0.0309117107607368,0.00543559155442624,0.169533523403712
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,0.00806989165501457,0.00588904124525322,-0.00347262918568174,0.0196124124957109,0.170609364192575
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,0.00477245129700633,0.00348422575204802,-0.00205663117700778,0.0116015337710204,0.170790646511145
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,37039,0.00395121907949325,0.00288824105349218,-0.00170973338535143,0.00961217154433793,0.171323986453671
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,-0.00660614061953502,0.00483397148618999,-0.0160807247324674,0.00286844349339737,0.171771107895846
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,36962,-0.0108784134150497,0.00797716212188899,-0.0265136511739522,0.0047568243438527,0.172687112885952
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36991,-0.00810464557428391,0.00594577839182732,-0.0197583712222654,0.00354908007369763,0.172876751419614
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,36991,0.00605745538791344,0.00446023785218573,-0.00268461080237059,0.0147995215781975,0.174454836691672
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,39489,0.0043282841051526,0.00320373878700814,-0.00195104391738336,0.0106076121276886,0.17671169012126
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.0114827979737372,0.00853230333495202,-0.0282061125102432,0.00524051656276877,0.178389256343278
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39788,-0.00349841162551562,0.00260247714419487,-0.00859926682813756,0.00160244357710632,0.178882762328819
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,39489,0.00468309788329831,0.00349150432913775,-0.00216025060181169,0.0115264463684083,0.179847846525907
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,39573,-0.0045427950317159,0.00339026389223226,-0.0111877122604911,0.00210212219705934,0.180279929403098
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,-0.00579711046539196,0.00434183860108468,-0.0143071141235179,0.00271289319273402,0.181842401880655
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,-0.00565487129879488,0.00423762708313196,-0.0139606203817335,0.00265087778414377,0.182081224489394
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.00501482493099199,0.00375854515568976,-0.00235192357415993,0.0123815734361439,0.182146059061489
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.00661727242571931,0.00496275560550452,-0.00310972856106955,0.0163442734125082,0.18242729811208
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGN,Cingulin,37039,-0.00519173826727054,0.00389419589735953,-0.0128243622260952,0.00244088569155414,0.182489535655355
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37388,-0.00372886451159029,0.00279969284254763,-0.00921626248298364,0.00175853345980306,0.182920934815641
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.00356607845067715,0.00267831574159198,-0.00168342040284313,0.00881557730419742,0.183059091729131
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37039,-0.00392594320701377,0.00295098277406906,-0.00970986944418913,0.00185798303016159,0.183414475134013
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,39587,-0.00656787572898981,0.00495479140389047,-0.0162792668806151,0.0031435154226355,0.185004574422488
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,39868,-0.0152472264154591,0.0115033127615329,-0.0377937194280635,0.00729926659714536,0.185036233012861
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,-0.00376779476631979,0.00284315722391324,-0.00934038292518973,0.00180479339255015,0.185122246545658
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,36991,-0.00977742353217852,0.00741297967896723,-0.0243068637029543,0.00475201663859725,0.187205492603273
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,39585,-0.00499485118954161,0.00379791248667548,-0.0124387596634255,0.00244905728434233,0.188476320401161
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,36991,0.00620907349020309,0.00472651177782089,-0.00305488959432586,0.015473036574732,0.188980462592768
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.0041598846973703,0.00317338823900861,-0.00205995625108658,0.0103797256458272,0.189926130144424
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,39585,0.00421877703649289,0.00323117501761139,-0.00211432599802544,0.0105518800710112,0.191691407191028
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39587,-0.00761240457177265,0.00583108336041381,-0.0190413279581837,0.00381651881463843,0.191746106988318
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37039,-0.00652560543037708,0.00500417538837169,-0.0163337891915856,0.00328257833083143,0.192245406980801
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,39489,-0.0078932778868921,0.00606084868059912,-0.0197725413008664,0.00398598552708218,0.192819813391665
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,37021,0.0080867977319033,0.00624258975574678,-0.0041486781893604,0.020322273653167,0.195196882062579
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,-0.0125729768534668,0.00975865660836895,-0.0316999438058699,0.00655399009893637,0.197631547050981
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,40052,0.00936914372596892,0.00729526959918005,-0.00492958468842399,0.0236678721403618,0.199063580876404
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37169,0.00569186311584406,0.00443794111292254,-0.00300650146548412,0.0143902276971722,0.199673556052927
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39585,-0.00427321253440683,0.00333600721153535,-0.0108117866690161,0.00226536160020247,0.200234953139518
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,0.008438922924467,0.00659058916512525,-0.00447863183917849,0.0213564776881125,0.200409424745562
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,37056,0.00523392131106285,0.00409874040914052,-0.00279960989085257,0.0132674525129783,0.201639375905424
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,39788,-0.00534599533476503,0.00418827844011764,-0.0135550210773956,0.00286303040786554,0.201826293315036
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,36991,-0.00741568650196142,0.00582555568605352,-0.0188337756466263,0.00400240264270348,0.203055556522811
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,37056,0.0133692435627471,0.010504523341203,-0.00721962218601077,0.033958109311505,0.203142320802008
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,37368,0.00574013494615952,0.00451313589079769,-0.00310561139980395,0.014585881292123,0.203440200712128
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.00818850572394543,0.00645495188993171,-0.0208402114282116,0.00446319998032072,0.204619814490841
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39477,-0.00588329012726856,0.00464189077202358,-0.0149813960404348,0.00321481578589765,0.205019051763754
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36991,0.00926003261606264,0.00735055592169823,-0.00514705699046589,0.0236671222225912,0.207773616273413
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,37056,0.00328389952743931,0.00260863524297462,-0.00182902554879095,0.00839682460366958,0.208104147124249
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,-0.00392659479629205,0.00313365231693453,-0.0100685533374837,0.00221536374489964,0.210212992674184
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,0.00433206959043598,0.00346296683202047,-0.00245534540032414,0.0111194845811961,0.210967452508657
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,0.00325562544978223,0.00260492930470499,-0.00185003598743955,0.00836128688700401,0.211396934150513
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,39866,0.00420237888507733,0.00336429396561368,-0.00239163728752548,0.0107963950576801,0.211642496486897
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40011,-0.00814505007168678,0.00652121206160366,-0.02092662571243,0.00463652556905639,0.211680023465932
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,37411,-0.00438981631469472,0.00352618644690902,-0.0113011417506364,0.00252150912124696,0.213183074283957
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,-0.00333437338220507,0.00267886201758434,-0.00858494293667037,0.00191619617226024,0.213261442987914
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37056,0.0115846929374853,0.00931190878194481,-0.00666664827512655,0.0298360341500971,0.213494848242133
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,39918,0.00485246233762694,0.00390333987858913,-0.00279808382440775,0.0125030084996616,0.213828319519805
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,-0.00550072700714608,0.00442797022549477,-0.0141795486491158,0.00317809463482367,0.214155879915335
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,37056,-0.00905348275458108,0.00729730718092865,-0.0233562048292012,0.00524923932003908,0.214753148696555
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,-0.00369533297753376,0.0029863033845021,-0.00954848761115788,0.00215782165609037,0.21594993327849
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,39868,-0.00541980871288632,0.00438370772497293,-0.0140118758538333,0.00317225842806062,0.216345643813005
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,0.0105284462310915,0.00851982475901861,-0.00617041029658499,0.027227302758768,0.216570385514139
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39720,-0.00487601612049599,0.00394830220553164,-0.012614688443338,0.00286265620234603,0.216861722782828
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,0.00342804640648529,0.00277829718580797,-0.00201741607769832,0.0088735088906689,0.2172748194691
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,39754,-0.00636490384365963,0.00516223380308242,-0.0164828820977012,0.00375307441038192,0.217603426890283
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37021,-0.00576340308833619,0.00467530303417697,-0.014926997035323,0.00340019085865067,0.217697195167813
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,-0.00809412586711713,0.00657482898741888,-0.0209807906824581,0.00479253894822386,0.218315774537389
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36991,0.00773349887396061,0.0062836879042766,-0.00458252941842153,0.0200495271663428,0.21844735803125
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,36991,-0.00764669365925546,0.00621328108497434,-0.0198247245858052,0.00453133726729425,0.218456613167107
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,-0.00534144271002233,0.00434397784913918,-0.0138556392943351,0.00317275387429046,0.218857903730488
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.00476531897138724,0.00387844430715788,-0.00283643187064219,0.0123670698134167,0.219214600621847
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39990,-0.00762771475925647,0.00620877046387689,-0.0197969048684552,0.00454147534994224,0.219262737259983
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,-0.00858463483329003,0.00699365721998795,-0.0222922029844664,0.00512293331788635,0.219657474331386
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39868,0.0038780703410514,0.00316559182742922,-0.00232648964070986,0.0100826303228127,0.220567019994129
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37021,-0.00568060615222823,0.00465116042687911,-0.0147968805889113,0.00343566828445483,0.221982619371824
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,37039,-0.00603019346775704,0.00495116845722925,-0.0157344836439264,0.00367409670841229,0.223271084298001
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37169,-0.00633135680571296,0.0052021600230697,-0.0165275904509296,0.00386487683950366,0.223601803808986
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,-0.0101528559705275,0.00834638007765916,-0.0265117609227395,0.0062060489816844,0.223835958404724
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,40017,-0.00731258231862436,0.00601406873913321,-0.0191001570473254,0.00447499241007673,0.224035959364898
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,37056,0.00463527064252347,0.00381891709166255,-0.00284980685713514,0.0121203481421821,0.22485892422624
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,-0.00462527001836144,0.0038415204553687,-0.0121546501108841,0.00290411007416121,0.22860318718978
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00719599847856806,0.00601214966007095,-0.00458781485517099,0.0189798118123071,0.231363369430831
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00617742213785648,0.00517245315618094,-0.0163154303239711,0.00396058604825817,0.232385055208358
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,37388,0.0026890733525222,0.00225509304010094,-0.00173090900607565,0.00710905571112005,0.233107905537909
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36962,0.00486375677715548,0.00408385032584567,-0.00314058986150204,0.012868103415813,0.233685634797055
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,37437,0.00590024223561077,0.00495700606905725,-0.00381548965974144,0.015615974130963,0.233955818923066
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,-0.00473168442126712,0.0039776797480108,-0.0125279367273683,0.00306456788483405,0.234241259981574
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39788,-0.00374556706240358,0.00315435542104515,-0.00992810368765206,0.00243696956284491,0.235076909295231
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,37039,-0.00572946627242152,0.00482979442948473,-0.0151958633542116,0.00373693080936856,0.23553494726912
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37043,0.00425995753098517,0.00363349031392645,-0.00286168348431066,0.011381598546281,0.241051777790186
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36991,0.00574675828517254,0.00490319059489049,-0.00386349528081282,0.0153570118511579,0.241200396058667
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,37411,-0.0184332766647194,0.0157372839388282,-0.0492783531848227,0.0124117998553839,0.241493802425832
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,-0.00759283560865369,0.00649374122172276,-0.0203205684032303,0.00513489718592292,0.242321708941861
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,39587,-0.00690292952615104,0.00591754760109333,-0.018501322824294,0.0046954637719919,0.243422508605707
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,36962,-0.00843355580398055,0.00723346598024946,-0.0226111491252695,0.00574403751730839,0.243672870169596
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39587,-0.00461821602741698,0.00396690190533914,-0.0123933437618817,0.00315691170704773,0.244365856809892
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,37021,0.00494436797411637,0.00425006225368277,-0.00338575404310186,0.0132744899913346,0.244703078966929
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,39585,-0.00563043991049272,0.00484461619593801,-0.0151258876545312,0.00386500783354578,0.245169612563116
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,39788,-0.009764229646964,0.00841067893060494,-0.0262491603509497,0.00672070105702168,0.245686791297595
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37021,0.00832734048352322,0.00717656492345794,-0.00573872676645435,0.0223934077335008,0.245926624386141
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,37388,0.0100734036353489,0.00870533515160421,-0.00698905326179537,0.0271358605324931,0.247230336915288
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,37424,0.00167764272811123,0.00145682734733951,-0.00117773887267422,0.00453302432889667,0.249516966933309
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,37411,-0.00900191678120148,0.00783433144236256,-0.0243572064082321,0.00635337284582914,0.250562052881217
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,37424,0.00259467899949197,0.00225902872050343,-0.00183301729269475,0.00702237529167869,0.250748769957851
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39477,0.00564859533817467,0.00492327660265385,-0.00400102680302688,0.0152982174793762,0.251265152424575
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39477,-0.00542723759686342,0.00473091460812723,-0.0146998302287928,0.00384535503506594,0.251322453865282
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37437,0.00315013472818278,0.00276110450282971,-0.00226163009736346,0.00856189955372901,0.25393307970066
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36962,-0.00337812379171273,0.0029650769329265,-0.00918967458024867,0.00243342699682321,0.254597240176927
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,39477,0.0156628164113125,0.0137577372738102,-0.0113023486453554,0.0426279814679805,0.254940370046595
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,37437,0.00330071351872476,0.00290746095996538,-0.00239790996280738,0.00899933700025691,0.256287965788158
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,-0.00730192943857439,0.0064369618595666,-0.0199183746833249,0.00531451580617615,0.256657727274029
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,39489,0.00504104771766359,0.00444504747923606,-0.00367124534163909,0.0137533407769663,0.256777605857561
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,37388,-0.00644285464623124,0.00568127542532117,-0.0175781544798607,0.00469244518739826,0.25679335669234
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,37411,0.0024504351837421,0.00216406332371985,-0.0017911289307488,0.00669199929823301,0.257515493425569
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,37437,0.0101982443331398,0.00901459381416743,-0.00747035954262836,0.027866848208908,0.257947222955104
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,36991,0.00600736125378193,0.00531277057930097,-0.00440566908164798,0.0164203915892118,0.258185267516677
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,37021,0.00455366610345674,0.00403416861968421,-0.00335330439112431,0.0124606365980378,0.259013605836992
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,39749,0.00630140315282643,0.00558507516288348,-0.00464534416642519,0.017248150472078,0.259228206112642
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,39489,-0.0039879455151754,0.00354289021251861,-0.0109320103317119,0.00295611930136107,0.260343990098743
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,39489,-0.00342388840702626,0.00304335681460298,-0.0093888677636481,0.00254109094959559,0.260590718115463
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36962,0.00610409923167846,0.00543715505016784,-0.0045527246666505,0.0167609231300074,0.261600717233168
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,37039,-0.00576411622816391,0.00514332355569199,-0.0158450303973202,0.00431679794099238,0.262436539905263
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,0.00465252503447489,0.00415775589298133,-0.00349667651576851,0.0128017265847183,0.263157620365616
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00519045924964915,0.00464870738345073,-0.0143019257212126,0.00392100722191427,0.264212270030974
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,37056,0.00980437610117576,0.00879730561848416,-0.00743834291105318,0.0270470951134047,0.265095813500515
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,-0.00784871153174315,0.00704346111458259,-0.021653895316325,0.00595647225283872,0.265159498734455
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37368,-0.00584177136901879,0.00526087678844144,-0.016153089874364,0.00446954713632643,0.266838785680592
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,39713,-0.00335117798515271,0.00302002653427763,-0.00927042999233687,0.00256807402203145,0.267165917367282
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,37056,0.00655485777845714,0.00594517182998462,-0.0050976790083127,0.018207394565227,0.270242114278417
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,37411,-0.00463162426840752,0.00420212211123354,-0.0128677836064253,0.00360453506961022,0.27038962397459
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,40030,-0.00225314379125048,0.00204423510863138,-0.00625984460416799,0.00175355702166703,0.270393718959006
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,39783,-0.00795263236991369,0.00724074911958302,-0.0221445006442964,0.00623923590446904,0.272083028735292
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37039,-0.00583378792782933,0.00531848018286165,-0.0162580090862382,0.0045904332305795,0.272709505963426
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,37382,0.02779991555621,0.0254021274526464,-0.021988254250977,0.077588085363397,0.273802058641927
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,39587,-0.00513959398568347,0.00471255705932753,-0.0143762058219654,0.00409701785059849,0.275458234955397
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",37368,0.00478130529105975,0.00438583721686361,-0.00381493565399293,0.0133775462361124,0.275658000239391
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37021,0.00781339866683298,0.00717986182182864,-0.00625913050395115,0.0218859278376171,0.27650996849763
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,39587,0.00577519530967119,0.00532916031686802,-0.00466995891139013,0.0162203495307325,0.278515757757031
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00372229723351167,0.0034355987230521,-0.00301147626367046,0.0104560707306938,0.278628644680621
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,37043,0.00318455935581157,0.00294066288964277,-0.00257913990788825,0.00894825861951139,0.278855181543257
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,0.00676762765410619,0.00627568586052857,-0.0055327166325298,0.0190679719407422,0.280880212332041
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,0.0059015545059274,0.00547401921330292,-0.00482752315214633,0.0166306321640011,0.28100780658222
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,36991,0.00364855110957628,0.0033947385298563,-0.00300513640894205,0.0103022386280946,0.282499048838172
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,-0.00902978830324667,0.00840359002619344,-0.0255008247545858,0.00744124814809247,0.282611151406884
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,39971,0.0122259353300692,0.0113963713883987,-0.0101109525911922,0.0345628232513306,0.283380547899614
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,37368,-0.00468836768414348,0.00437116828351446,-0.0132558575198318,0.00387912215154486,0.283484923996092
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,39868,0.00800582807421367,0.0074776337950985,-0.00665033416417938,0.0226619903126067,0.284349022780523
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,39841,0.00711449496829094,0.00665381789906444,-0.00592698811387537,0.0201559780504572,0.284979941810655
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,39489,0.00683187801029614,0.00640464367036457,-0.00572122358361841,0.0193849796042107,0.286120658255824
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37056,0.0034060599437294,0.00319420484327278,-0.00285458154908524,0.00966670143654404,0.286296336514058
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.00352327426674175,0.00330861446594003,-0.0100081586199842,0.00296161008650072,0.286949675845025
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36962,0.00490735726790901,0.00461974859524196,-0.00414734997876522,0.0139620645145832,0.28813890469599
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,37039,-0.00682677828919706,0.00643481814524842,-0.019439021853884,0.00578546527548985,0.288749160116365
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,36818,0.00415204845748887,0.00391384612619834,-0.00351908994985988,0.0118231868648376,0.288772645230025
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36991,0.00455189262053785,0.00429431108932848,-0.00386495711454598,0.0129687423556217,0.289172267591413
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.00617266514929393,0.00585225351736073,-0.00529775174473311,0.017643082043321,0.291558765634609
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,39587,-0.00649468133825518,0.00616694520493816,-0.018581893939934,0.00559253126342362,0.29229117956692
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37021,-0.00424643060190613,0.00403793550507169,-0.0121607841918467,0.00366792298803438,0.292986772461191
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37021,-0.00593193322919342,0.00564708733292754,-0.0170002244017314,0.00513635794334455,0.293534596404375
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,37039,-0.00698866098181415,0.00665851721387034,-0.020039354721,0.00606203275737171,0.293929501993954
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,37411,0.00307395560805777,0.00292939658133464,-0.00266766169135811,0.00881557290747366,0.294036826888563
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39587,-0.00502264800907915,0.00478681197205616,-0.0144047994743092,0.00435950345615093,0.294070972233628
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,37021,-0.00791037752107635,0.00758154662000011,-0.0227702088962766,0.00694945385412387,0.296794952583186
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0178243204869872,0.0171322803549092,-0.0157549490086348,0.0514035899826093,0.298172861654497
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,37039,-0.00350285836946775,0.0033745699632446,-0.0101170154974272,0.00311129875849166,0.299281546100111
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37411,0.00370397501969454,0.00357321599734276,-0.00329952833509727,0.0107074783744864,0.29994350892456
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,37124,0.00963918957338058,0.00938099815997108,-0.00874756682016274,0.0280259459669239,0.30419308841353
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37169,-0.00447295451149551,0.00436006266524812,-0.0130186773353818,0.00407276831239082,0.304961019695344
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37411,0.00354606839106367,0.00345699150873122,-0.00322963496604951,0.0103217717481769,0.30501965503005
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,37368,-0.00373126810715492,0.00364158504842966,-0.0108687748020771,0.00340623858776722,0.305557341969163
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,40030,0.00316847424899413,0.00309522953005553,-0.00289817562991471,0.00923512412790297,0.30600943950144
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39699,-0.0029006564112611,0.00283606126488838,-0.00845933649044233,0.00265802366792013,0.306429219264087
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,-0.0120908720276091,0.0118316445952929,-0.0352808954343832,0.0110991513791651,0.306839107568951
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,39998,-0.00416668945956281,0.00408749933329235,-0.0121781881528158,0.00384480923369018,0.30804085200911
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,36962,0.00402155166399408,0.00394876289260095,-0.00371802360550378,0.0117611269334919,0.308490883934223
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,39477,0.0089529997648373,0.0088385168128405,-0.00837049318833008,0.0262764927180047,0.31109843155821
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37124,-0.00254317275726802,0.0025379630832899,-0.00751758040051622,0.00243123488598019,0.31633642108244
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37056,-0.00766578063559504,0.00768459600245951,-0.0227275888004157,0.0073960275292256,0.318515157391872
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,37021,0.00642390203273356,0.00645360509490976,-0.00622516395328958,0.0190729680187567,0.319561300276696
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,0.00658530912019618,0.00661802026295028,-0.00638601059518636,0.0195566288355787,0.31972675110504
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39587,-0.00340431482277297,0.0034233158446231,-0.0101140138782342,0.0033053842326883,0.320019366113063
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,-0.0042020485791596,0.00424618880633639,-0.0125245786395789,0.00412048148125972,0.322382250000783
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39913,-0.00356782247852885,0.00360864305459543,-0.0106407628655359,0.00350511790847821,0.322830663866777
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.0039412436015199,0.00399252282289948,-0.0117665883344029,0.00388410113136307,0.323584266102177
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.00974555472407981,0.00987945420915156,-0.00961817552585725,0.0291092849740169,0.323928839389673
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARTN,Artemin,39587,-0.00440600595486314,0.00447242269689076,-0.013171954440769,0.00435994253104275,0.324565690619066
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.00493145115387317,0.00502558024576491,-0.00491868612782607,0.0147815884355724,0.32647764770637
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,37021,0.00488356286463883,0.00497749060900201,-0.00487231872900511,0.0146394444582828,0.32654692033542
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,-0.0056475155197418,0.00576085302895,-0.0169387874564838,0.00564375641700019,0.326943196016796
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,37039,-0.0058787952151772,0.0060008459322151,-0.0176404532423188,0.0058828628119644,0.327271425964998
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,37437,0.00432775773432016,0.00444626904222839,-0.00438692958844749,0.0130424450570878,0.3303987586869
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,0.00495206947728057,0.00510266893336063,-0.00504916163210627,0.0149533005866674,0.331821866618943
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37056,-0.00195385403095455,0.0020147594666613,-0.00590278258561069,0.00199507452370159,0.332178739774591
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,-0.0117235603439922,0.0120940320827675,-0.0354278632262165,0.0119807425382322,0.332376822703838
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,39489,-0.00315859210377302,0.00325987088266835,-0.00954793903380298,0.00323075482625694,0.332594281845131
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,0.00701907627499062,0.0072539956472091,-0.00719875519353923,0.0212369077435205,0.333254177908738
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,37021,-0.00455713464000776,0.00478424742512537,-0.0139342595932535,0.00481999031323796,0.340846234883735
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40058,0.00241148517152851,0.00253217914031062,-0.00255158594348031,0.00737455628653733,0.340940852542946
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,-0.00613620753826459,0.00645123267714803,-0.0187806235854747,0.00650820850894555,0.341533694112066
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,-0.00536469659262332,0.00564035495831415,-0.016419792310919,0.0056903991256724,0.34155721160452
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,37039,-0.00297152112612509,0.00313532174529373,-0.00911675174690079,0.00317370949465061,0.343270878885349
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,0.00511282231603822,0.00540634943668535,-0.00548362257986507,0.0157092672119415,0.344315470617042
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00457139343838419,0.00483784239821458,-0.0140535645388848,0.00491077766211639,0.344714995707905
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,-0.0070372209439414,0.00745480881911865,-0.021648646229414,0.00757420434153115,0.345192380306476
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36991,0.00867176600697329,0.00919277939097928,-0.00934608159934609,0.0266896136132927,0.345532749160967
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,39587,-0.00295360802459657,0.00313379805744057,-0.00909585221718008,0.00318863616798694,0.345950640529681
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,37039,0.0062232976144018,0.00661244434299191,-0.00673709329786235,0.019183688526666,0.346645585079168
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,36991,-0.00847017895451038,0.00906635286270798,-0.026240230565418,0.00929987265639727,0.350195610134522
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36991,0.00710006574412563,0.00761740117663229,-0.00783004056207365,0.0220301720503249,0.35130971136391
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,39868,-0.00252791151617149,0.00271565357179923,-0.00785059251689798,0.00279476948455501,0.351936552317079
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,37056,0.00708978490980155,0.00764303632298004,-0.00789056628323933,0.0220701361028424,0.353624974175512
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.00329198102579892,0.00357777096481822,-0.00372045006524479,0.0103044121168426,0.357523815304305
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37021,-0.00919833690699023,0.0100354605817326,-0.028867839647186,0.0104711658332056,0.359377763913029
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,0.00244870243944749,0.00267729940778953,-0.00279880439981999,0.00769620927871497,0.360409191859309
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,-0.0039753847686603,0.00434936933219383,-0.0125001486597602,0.0045493791224396,0.360723552254949
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,37453,-0.00176600727451091,0.00193487544586198,-0.0055583631484004,0.00202634859937858,0.361403900629968
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,-0.00844855103546787,0.00925679303454107,-0.0265918653831684,0.00969476331223262,0.361421135723069
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,37124,0.00399115142281161,0.00438848986824061,-0.00461028871893999,0.0125925915645632,0.363124437617359
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37169,0.0049053906168604,0.00541599239032276,-0.00570995446817221,0.015520735701893,0.365098711447849
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,-0.00409243308243601,0.00453150421000359,-0.012974181334043,0.00478931516917104,0.366485223857131
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37021,0.00401016666956687,0.00444722151788682,-0.00470638750549131,0.012726720844625,0.367219966772996
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,36962,-0.00536591572641797,0.00597510250338195,-0.0170771166330466,0.00634528518021064,0.369177633222321
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,37056,0.00486941923409325,0.00543681417376927,-0.00578673654649453,0.015525575014681,0.370462287542973
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,36991,0.00839962465242949,0.00944869815968557,-0.0101198237405542,0.0269190730454132,0.374034608794298
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,39564,-0.00363739330241823,0.00409824981636525,-0.0116699629424941,0.00439517633765767,0.374797544727347
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39587,-0.0031639530478283,0.00359257194369095,-0.0102053940574626,0.00387748796180597,0.378497451699704
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,39587,0.00463333033153075,0.0052610446676637,-0.00567831721709011,0.0149449778801516,0.3785010537992
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,39913,0.00331825785163918,0.00378716085474566,-0.00410457742366232,0.0107410931269407,0.380941960402681
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,37169,0.00311045969665508,0.00355037629313624,-0.00384827783789195,0.0100691972312021,0.380995308096056
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36942,0.00413837368959472,0.00474882281945501,-0.00516931903653711,0.0134460664157265,0.383523103145997
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39788,-0.0019499494385359,0.00224552639255595,-0.00635118116794556,0.00245128229087375,0.38520448529407
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37056,-0.0032808622185945,0.00378281336254367,-0.0106951764091801,0.0041334519719911,0.38578934540025
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,37039,-0.00363245234205551,0.00419043745107071,-0.0118457097461541,0.00458080506204308,0.386043692849949
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,37039,-0.00304651630148551,0.00351537728017509,-0.0099366557706287,0.00384362316765767,0.386162903839046
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,-0.00895962246816093,0.0103477338543209,-0.0292411808226299,0.0113219358863081,0.386585820501873
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37021,0.00344658966140885,0.00398130624138784,-0.00435677057171131,0.011249949894529,0.386674220944701
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,-0.00949338824346532,0.0109768602069114,-0.0310080342490117,0.0120212577620811,0.3871347345338
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36962,0.00360565759173239,0.00417492494006006,-0.00457719529078533,0.0117885104742501,0.387798147589928
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,37056,0.00590470701325384,0.0068376775091461,-0.00749714090467252,0.0193065549311802,0.387848376922631
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00539711062149721,0.00625624710393408,-0.00686513370221357,0.017659354945208,0.388331667464583
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,39906,-0.0129362003811749,0.0150341430287339,-0.0424031207174934,0.0165307199551436,0.389551250802618
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,36962,-0.00468012363522244,0.00544247807783097,-0.0153473806677711,0.00598713339732627,0.389846052278151
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,37411,0.00451846698557484,0.00525485024408552,-0.00578103949283278,0.0148179734639825,0.389878131759852
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.00712655815138613,0.00835010906844223,-0.0234927719255329,0.00923965562276064,0.393414946294015
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,37056,0.00262488899200827,0.00307847910325672,-0.0034089300503749,0.00865870803439144,0.393864615432027
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,39489,-0.00482950788514776,0.00568972542086552,-0.0159813697100442,0.00632235393974867,0.395998846432487
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,0.00662036884000265,0.00780805838187108,-0.00868342558846467,0.02192416326847,0.396515044923274
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37169,-0.00447942572437562,0.00528546914737463,-0.0148389452532299,0.00588009380447866,0.396732715683432
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,37039,0.00307675679843602,0.00363547042528029,-0.00404876523511334,0.0102022788319854,0.397391849301776
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,37178,-0.00305318818924815,0.00361593795028069,-0.0101404265717983,0.004034050193302,0.398478054567825
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37056,-0.00316475400116347,0.00374857486947689,-0.0105119607453382,0.00418245274301124,0.398542093288679
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39858,-0.00254448114039258,0.00301401107345927,-0.00845194284437274,0.00336298056358759,0.398560455059222
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,36991,-0.00542066830748386,0.00643161149497712,-0.018026626837639,0.0071852902226713,0.399346428134811
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,39587,0.0054866477692234,0.00651202524692387,-0.00727692171474738,0.0182502172531942,0.39949805523775
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,37437,-0.00655680341733943,0.00783220378936073,-0.0219079228444864,0.0087943160098076,0.402517682326213
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.00582402180760119,0.00696577935969551,-0.00782890573740202,0.0194769493526044,0.403116341454887
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,-0.00574387478170104,0.00688696219073923,-0.0192423206755499,0.00775457111214784,0.404281595074863
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37382,0.00360266457308056,0.0043288808430711,-0.00488194187933878,0.0120872710254999,0.405288607124408
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,-0.00198692030147964,0.00239230315977788,-0.00667583449464429,0.00270199389168502,0.406244197399851
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,-0.00587733536451317,0.00707838900474471,-0.0197509778138128,0.00799630708478646,0.406369566402689
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,39749,-0.00508096239334148,0.00612653669476214,-0.0170889743150753,0.00692704952839232,0.406926306437944
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,39587,0.00257185772270081,0.00311007258422848,-0.00352388454238701,0.00866759998778863,0.408281010046815
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,-0.00239001423857393,0.00289092665797217,-0.00805623048819937,0.00327620201105151,0.408402601193084
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,-0.0029666345750345,0.00359323619415838,-0.0100093775155849,0.00407610836551593,0.409036552293
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.00326251384138557,0.0039520244964929,-0.00448345417174052,0.0110084818545116,0.40908542576144
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,37056,0.00285374887936281,0.00347742831087976,-0.00396201060996151,0.00966950836868713,0.411860919095533
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.00152747119845577,0.00186355829190334,-0.00212510305367478,0.00518004545058633,0.412428305311549
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,37056,0.00241441333355606,0.0029598689985631,-0.00338692990362761,0.00821575657073974,0.414677147759655
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,39564,0.00434459164833432,0.00538811544079749,-0.00621611461562876,0.0149052979122974,0.420065606839357
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,37021,-0.00294990241171807,0.00366528276140961,-0.0101338566240809,0.00423405180064477,0.420936594953633
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,37445,-0.00426092511158226,0.00530815752372177,-0.0146649138580769,0.00614306363491241,0.422154891088655
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,37169,-0.00476926657607375,0.00597039709282314,-0.0164712448780071,0.0069327117258596,0.424409632164476
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,39477,-0.00243170584725671,0.00305054046210533,-0.00841076515298314,0.00354735345846973,0.425382222810599
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,37169,-0.00180869904859871,0.00227560604284211,-0.00626888689256925,0.00265148879537183,0.426731914570228
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,39477,0.0130039397510152,0.0164165138100322,-0.0191724273166478,0.0451803068186783,0.428299515347273
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37056,0.00328015329057972,0.00414413932806897,-0.00484235979243546,0.0114026663735949,0.428657070390357
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,37368,0.00329723172617819,0.00417474326869445,-0.00488526508046294,0.0114797285328193,0.429655715465829
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,39868,0.00605052885337367,0.0076620151060013,-0.00896702075438887,0.0210680784611362,0.429727227398624
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,37169,0.00452888178852967,0.00574161024608579,-0.00672467429379848,0.0157824378708578,0.430253178857317
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37368,-0.00470737083882087,0.00597979832731722,-0.0164277755603626,0.00701303388272088,0.431171405356662
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,0.00330494507772067,0.00420413486071329,-0.00493515924927738,0.0115450494047187,0.431812290290128
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.0113166478945439,0.014401959116872,-0.039544487763613,0.0169111919745253,0.432015621572648
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,37021,-0.00405307011054513,0.0051625158529104,-0.0141716011822495,0.00606546096115925,0.432411466305434
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,40052,0.00249926102011774,0.00319472320049943,-0.00376239645286114,0.00876091849309662,0.434044382219885
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.00456475327447953,0.00585611784752681,-0.00691323770667302,0.0160427442556321,0.43570839458354
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,36962,-0.00557416469606747,0.00716845235155636,-0.0196243313051179,0.00847600191298299,0.436820863438343
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00397487994733359,0.00511579165254557,-0.0140018315863229,0.00605207169165574,0.437183114490276
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,37056,0.00129162284480924,0.0016647432785642,-0.00197127398117658,0.00455451967079507,0.437840192254828
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.0021005314117494,0.00270870017226712,-0.00740958374939296,0.00320852092589416,0.438069987862625
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,39788,-0.0144011925668077,0.0185940767921972,-0.0508455830795143,0.0220431979458989,0.438644118359859
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,39456,-0.00276264272576447,0.00357250416440257,-0.0097647508879935,0.00423946543646457,0.439352393194425
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,0.00374446241117414,0.00485618447118437,-0.00577365915234722,0.0132625839746955,0.440678827346899
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,39788,-0.00225751681143976,0.00292984395177503,-0.00800001095691881,0.0034849773340393,0.44100020233068
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,39477,0.00722655856750004,0.00939281669240881,-0.0111833621496212,0.0256364792846213,0.441684874402882
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,39866,-0.00492405743457265,0.00640433585567957,-0.0174765557117046,0.0076284408425593,0.441985937333787
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36991,-0.00810319145902269,0.0105452490831117,-0.0287718796619216,0.0125654967438762,0.442250892773257
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,37056,0.00374430860949142,0.0049192829798621,-0.00589748603103829,0.0133861032500211,0.446581520706082
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,39489,-0.00523302622544297,0.00691620940566227,-0.018788796660541,0.00832274420965508,0.449281694108982
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,0.00464851269646236,0.00615354315211568,-0.00741243188168436,0.0167094572746091,0.450008274836222
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,37368,-0.00396719373049085,0.00525496652441361,-0.0142669281183415,0.00633254065735982,0.450297083486864
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37039,-0.00589798900819448,0.0078286963658495,-0.0212422338852595,0.00944625586887054,0.451234615362848
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,37169,-0.00315437582938204,0.00419879981144531,-0.0113840234598148,0.00507527180105077,0.452511560705155
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,39858,-0.00326173432318026,0.00439507652020534,-0.0118760843027827,0.00535261565642221,0.458017239323626
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37169,0.0056742733035362,0.00769186409905697,-0.00940178033061547,0.0207503269376879,0.460710950817023
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,-0.00342125205628274,0.00464096064822594,-0.0125175349268056,0.0056750308142401,0.461022277461766
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,37039,0.00312455449007682,0.0042584307239349,-0.00522196972883558,0.0114710787089892,0.463124056051807
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37169,-0.00288560363899456,0.00394385397496605,-0.010615557429928,0.00484435015193889,0.464382274655749
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39817,-0.00288039682123672,0.00395078407384822,-0.0106239336059792,0.0048631399635058,0.465969749782452
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,0.00193383525481053,0.00266278713856289,-0.00328522753677274,0.0071528980463938,0.467699332672235
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,37021,-0.00644498338874967,0.00889067592425888,-0.0238707082002971,0.0109807414227977,0.468517131143073
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,39587,-0.00651368547279971,0.00900990445484659,-0.024173098204299,0.0111457272586996,0.469723055750957
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,0.00407321766410923,0.00567857623581177,-0.00705679175808184,0.0152032270863003,0.473204518130567
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,39246,0.00336726535364484,0.00469778146561718,-0.00584038631896485,0.0125749170262545,0.47352210637998
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39489,-0.00385701941270299,0.00538932035881096,-0.0144200873159725,0.0067060484905665,0.474200729880711
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39477,0.00412216795002776,0.00577545829590727,-0.00719773030995048,0.015442066210006,0.47539945298449
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,37056,-0.00279514163687371,0.00392999699046939,-0.0104979357381937,0.00490765246444629,0.476952735151995
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,-0.00360384313978294,0.00507692965586292,-0.0135546252652743,0.00634693898570838,0.477811670327052
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37169,-0.00489035874006372,0.00689142984585881,-0.018397561237947,0.00861684375781954,0.477946638732733
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,39587,0.00369111598145311,0.00520424940238958,-0.00650921284723048,0.0138914448101367,0.478179614839368
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,37039,-0.00430010861397803,0.00606670298128524,-0.0161908464572971,0.00759062922934104,0.478458113082992
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36962,-0.00302363696302492,0.00426659363990356,-0.0113861604972359,0.00533888657118605,0.478537522883803
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,-0.00225863117218447,0.0031999180963691,-0.00853047064106792,0.00401320829669897,0.480299974580868
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,0.00477553318551728,0.00676858579581866,-0.00849089497428729,0.0180419613453218,0.480484422911542
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,40009,0.00179270061551932,0.00254357248575795,-0.00319270145656626,0.00677810268760491,0.480947141716096
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,0.00445249866629161,0.00637942120934971,-0.00805116690403382,0.0169561642366171,0.485222594675876
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,37039,-0.00553911045202862,0.00798968271481293,-0.021198888573062,0.0101206676690047,0.488144245764828
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40058,-0.00396320787780766,0.00571820289399906,-0.0151708855500458,0.00724446979443051,0.488265354695874
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTTG1,Securin,37169,0.0028944704904061,0.00418416044154381,-0.00530648397501977,0.011095424955832,0.489094773995645
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39064,0.00199864841912484,0.00289541865285612,-0.00367637214047317,0.00767366897872284,0.490028913062009
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37382,0.00370848225160449,0.00537386610281543,-0.00682429530991375,0.0142412598131227,0.49014580841993
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,39885,0.00162110146989397,0.00235512791926247,-0.00299494925186048,0.00623715219164842,0.491255955069745
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.00470722719353898,0.00684061332892356,-0.00870037493115119,0.0181148293182291,0.491383389257162
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,39761,-0.00247750506556448,0.00360461088076962,-0.00954254239187294,0.00458753226074399,0.491893933900865
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,-0.00155613847410851,0.00226553759775907,-0.0059965921657163,0.00288431521749927,0.492172079845456
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,0.00182016452954499,0.0026624651447921,-0.00339826715424753,0.0070385962133375,0.494215280443594
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,36868,0.0029712421235275,0.00436315352972317,-0.00558053879472991,0.0115230230417849,0.495893101069322
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,-0.00203852662502577,0.00299715504972389,-0.00791295052248459,0.00383589727243305,0.496417115970067
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,37169,0.00349386669099131,0.00514507756119691,-0.00659048532895464,0.0135782187109372,0.497105457457034
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,36962,-0.00414133249505901,0.00610148604297292,-0.0161002451392859,0.00781758014916792,0.497313581184901
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39818,-0.00189846312483802,0.00283091668909462,-0.00744705983546348,0.00365013358578745,0.502473744594159
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,-0.00259176191715267,0.00387035934154469,-0.0101776662265803,0.00499414239227493,0.503096355824752
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,37056,0.00214649516586854,0.00320919664735672,-0.00414353026295063,0.00843652059468772,0.50359809963258
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,37382,-0.0020493168857602,0.00306818540229546,-0.00806296027425931,0.00396432650273891,0.504193044583356
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37169,-0.00268812574067088,0.00404386379598395,-0.0106140987807994,0.00523784729945767,0.506227100943204
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,-0.00391544989312632,0.00589889250077462,-0.0154772791946446,0.00764637940839194,0.506855448272036
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,39749,0.00233753424156124,0.00352383059916428,-0.00456917373280074,0.00924424221592322,0.507115823888917
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,0.0042646088735715,0.00647431399861655,-0.00842504656371695,0.0169542643108599,0.51010211446378
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,-0.00454153179604282,0.00691310277380164,-0.018091213232694,0.00900814964060841,0.511225290341599
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,37056,0.00377040556913789,0.00574615092786616,-0.00749205024947978,0.0150328613877556,0.511731371993459
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,37021,-0.00442284385224638,0.00674116367504019,-0.0176355246553251,0.00878983695083239,0.511774464333807
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,0.00568763913098414,0.00867514992334234,-0.0113156547187668,0.0226909329807351,0.512077216554917
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,39477,-0.00576018867561003,0.00878883660540218,-0.0229863084221983,0.0114659310709782,0.512220991993555
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,36962,-0.00391596694354168,0.00598960374047397,-0.0156555902748707,0.0078236563877873,0.513256011452667
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39489,0.00551910088100537,0.00847112843861979,-0.0110843108586894,0.0221225126207002,0.514721114806771
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37169,0.00443515053396917,0.00681588695513521,-0.00892398789809584,0.0177942889660342,0.515246386063862
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,-0.00241136760090283,0.00370661824433936,-0.00967633935980796,0.00485360415800231,0.515343562467242
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37411,-0.00496485031079365,0.00764419514766415,-0.0199474728002154,0.0100177721786281,0.516030856468696
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39868,0.00284462044205969,0.0044062694122591,-0.00579166760596815,0.0114809084900875,0.518557553901411
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37056,0.00617258525106764,0.00956764381324615,-0.0125799966228948,0.0249251671250301,0.518839856643277
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,39587,-0.00420139373729128,0.00656549035202896,-0.017069754827268,0.00866696735268548,0.522233422347603
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36962,0.005529059167684,0.00867656535032878,-0.0114770089189604,0.0225351272543284,0.523979310921202
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,39749,0.00267486385786572,0.00419963609094359,-0.00555642288038372,0.0109061505961152,0.524181223325874
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,37124,-0.00315445303197173,0.00495652419704197,-0.012869240458174,0.00656033439423053,0.524510811163426
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37368,0.00293439997755431,0.00461464587760524,-0.00611030594255197,0.0119791058976606,0.524859909513425
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,-0.00236630058611041,0.00372203761046296,-0.00966149430261782,0.004928893130397,0.524945817591554
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HLA_A,,37411,-0.00205481044309632,0.00323406856043771,-0.00839358482155424,0.00428396393536159,0.525201829257291
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,37453,-0.00133002741588476,0.00209464007186109,-0.00543552195673249,0.00277546712496298,0.525460596213577
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00737050597947868,0.011608429796694,-0.0301230283809989,0.0153820164220415,0.525487037529374
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,-0.00345820139619216,0.00545020690115942,-0.0141406069224646,0.00722420413008031,0.525760179987262
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,37039,-0.00381560486303062,0.00602220574512299,-0.0156191281234717,0.00798791839741044,0.52635990889747
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPGN,Epigen,37368,0.00314543324257539,0.00499051711822465,-0.00663598030914492,0.0129268467942957,0.52852074210149
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37039,0.00225576588355885,0.00358758703524791,-0.00477590470552706,0.00928743647264476,0.529510762337982
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.00307493724891385,0.00489560547492339,-0.0126703239797637,0.00652044948193599,0.529946371991555
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,36962,0.00256148788295052,0.0040804832191222,-0.005436259226529,0.01055923499243,0.530184358928546
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,-0.00139521394259353,0.00222837802895541,-0.00576283487934614,0.00297240699415909,0.53125209024569
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.00153988415521504,0.00246125730930771,-0.00328418017102808,0.00636394848145816,0.531553852801824
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37445,0.00217655801276924,0.00348419079065295,-0.00465245593691055,0.00900557196244903,0.532181474186449
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,37021,0.00289810374900216,0.00464879356088708,-0.00621353163033652,0.0120097391283408,0.533026022651591
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00276531399715347,0.00444020095161263,-0.00593747986800729,0.0114681078623142,0.533432859624361
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,36962,0.00440442191652777,0.0071394582708539,-0.00958891629434586,0.0183977601274014,0.537303081089322
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,39587,0.00477001833003449,0.00773512448008282,-0.0103908256509278,0.0199308623109968,0.537461414440533
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,-0.00619502499043804,0.010052750450473,-0.0258984158733651,0.0135083658924891,0.537739026370145
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,37368,0.00212417293042526,0.00346843926262056,-0.00467396802431103,0.00892231388516156,0.540264241801089
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.00732872746641231,0.0120208816304346,-0.0162322005292394,0.030889655462064,0.542091695233022
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39788,-0.00132010599530992,0.00216960290448013,-0.00557252768809098,0.00293231569747114,0.542894339888886
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,39477,0.00240416827153681,0.00397239935979074,-0.00538173447365304,0.0101900710167267,0.545042838460598
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,37039,0.00358829915024026,0.00592974213971368,-0.00803399544359855,0.0152105937440791,0.545099199709851
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37039,-0.00222723694703962,0.00368963154982951,-0.00945891478470547,0.00500444089062622,0.546088399268953
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,39931,-0.00272942129978408,0.00452904203309132,-0.0116063436846431,0.00614750108507491,0.546750917837341
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,37124,0.00202964543955106,0.00336947436343362,-0.00457452431277883,0.00863381519188095,0.546943076594218
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37169,0.00512168825871723,0.00858613118136844,-0.0117071288567649,0.0219505053741994,0.550846654162594
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C5,Complement C5,37453,-0.000897615802717472,0.00152231325806153,-0.00388134978851808,0.00208611818308314,0.555442263487901
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,38832,0.0028170181967533,0.00480170515197013,-0.00659432390110816,0.0122283602946148,0.55743394832851
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,37056,0.00373391773536519,0.00637616742354017,-0.00876337041477355,0.0162312058855039,0.558150768857121
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,37039,0.00283108010589652,0.00487235075625085,-0.00671872737635515,0.0123808875881482,0.561216595237907
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36962,0.00290833778530597,0.00501396415906939,-0.00691903196647004,0.012735707537082,0.561892505616156
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39866,0.00139668050261606,0.0024380134078023,-0.00338182577667645,0.00617518678190857,0.566736388132334
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,-0.00122196450366933,0.00213993721349,-0.00541624144210973,0.00297231243477107,0.567990014301292
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37039,-0.00442566843587027,0.00777251554013794,-0.0196597988945406,0.0108084620228001,0.569094588135373
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36991,0.00299796265180483,0.00528362153010515,-0.00735793554720127,0.0133538608508109,0.570447548176088
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,-0.00959763311076534,0.0170456553192458,-0.0430071175364871,0.0238118513149564,0.57340710148771
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,37388,-0.00285972418294041,0.00508222624590881,-0.0128208876249217,0.00710143925904086,0.573654475415481
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,-0.00228167524606376,0.00405550362065306,-0.0102304623425437,0.00566711185041623,0.573708660872979
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.00179010946550305,0.00318439197390837,-0.00445129880335736,0.00803151773436346,0.574021035446405
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,39453,-0.00193174101296463,0.00343909167379799,-0.0086723606936087,0.00480887866767943,0.574327869319415
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.00322788955873986,0.00575491388104823,-0.00805174164811468,0.0145075207655944,0.574878532461891
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37021,0.00222344535060947,0.00396512048963521,-0.00554819080907554,0.00999508151029447,0.574976828380036
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,39913,-0.00164449971355975,0.00293499499399103,-0.00739708990178218,0.00410809047466267,0.575277530204284
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,-0.00155405697381561,0.00277376604999962,-0.00699063843181487,0.00388252448418364,0.575303313296769
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37021,0.00284861070907639,0.00509080647153362,-0.0071293699751295,0.0128265913932823,0.575789245941043
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36991,0.00265111953933432,0.00474150961624475,-0.00664223930850539,0.011944478387174,0.576082642812952
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36991,0.00462997511650273,0.00829448873156954,-0.0116272227973736,0.020887173030379,0.576718037088651
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.00333776290068599,0.00599035498904105,-0.00840333287783447,0.0150788586792065,0.577407413229998
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.0025684066175104,0.00463894538327852,-0.00652392633371551,0.0116607395687363,0.579818022843526
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,37169,0.00912323534334453,0.0165285082601819,-0.0232726408466121,0.0415191115333012,0.580978397657267
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,37453,-0.00100557440557904,0.00182662808392947,-0.00458576545008079,0.00257461663892271,0.581979650247964
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,-0.00165733467401569,0.00302523241502417,-0.00758679020746306,0.00427212085943168,0.583811557885301
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,39585,-0.00326329762243956,0.00600229832348713,-0.0150278023364743,0.00850120709159522,0.5866730662567
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,37169,-0.00166984669033302,0.00308535802177348,-0.00771714841300905,0.00437745503234301,0.588367420023317
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.00263777095345547,0.00488008579892632,-0.012202739119351,0.00692719721244011,0.588849499863076
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,-0.00400886389360109,0.00749418519480473,-0.0186974668754184,0.0106797390882162,0.592707375237129
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.00470981941019306,0.00884021135808957,-0.0126169948516625,0.0220366336720486,0.594198649854333
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,37368,-0.00200367376219863,0.00376462840320232,-0.00938234543247517,0.00537499790807791,0.594570754328915
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,37043,0.000951226852510813,0.00178757540784717,-0.00255242094686964,0.00445487465189127,0.594643242659204
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,39585,0.00573016784471869,0.0107741326727374,-0.0153871321938466,0.0268474678832839,0.594840914087117
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,39885,0.00157637319095577,0.00296914126197714,-0.00424314368251943,0.00739589006443097,0.595482342862935
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,37056,0.00254854609956536,0.00483088960706622,-0.00691999753028443,0.0120170897294151,0.597819095413447
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.00357195989334829,0.00682589757180624,-0.00980679934739194,0.0169507191340885,0.600777592180084
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,-0.00157807568239791,0.00302132689574021,-0.00749987639804873,0.0043437250332529,0.601460192963678
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,-0.00255905060888704,0.00492066863908683,-0.0122035611414972,0.00708545992372314,0.603029416625301
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40052,0.00152233884556898,0.0029274315965938,-0.00421542708375487,0.00726010477489283,0.603052967148843
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,37368,0.00177159571446448,0.00341690678845184,-0.00492554159090111,0.00846873301983008,0.604132335556255
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37382,0.00132359779535154,0.00255366140858272,-0.00368157856547059,0.00632877415617367,0.604247868650354
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,37021,0.00245925094844882,0.00476410757183144,-0.0068783998923408,0.0117969017892384,0.605720673239595
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,0.00212481252357033,0.00416099071358975,-0.00603072927506557,0.0102803543222062,0.609604187204741
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,-0.00308444104297502,0.00604696445975062,-0.0149364913840862,0.00876760929813619,0.610003320463707
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,-0.00118247463511797,0.00231824055956059,-0.00572622613185672,0.00336127686162079,0.610006596791207
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.00174926224538511,0.0034336723235501,-0.00498073550877309,0.0084792599995433,0.610448332784331
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,37169,-0.00267974646703583,0.00530081509723775,-0.0130693440576218,0.00770985112355016,0.61319163886385
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39788,-0.0017080420319047,0.00340168964363524,-0.00837535373342976,0.00495926966962036,0.615593025148671
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37039,0.00264763112697044,0.00527879522662636,-0.00769880751721723,0.0129940697711581,0.615985627900077
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37021,-0.00195268643846971,0.00390811170326393,-0.00961258537686701,0.00570721249992758,0.617330181136494
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,0.00215809689703716,0.0043514475916562,-0.00637074038260898,0.0106869341766833,0.619938543140559
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,37039,-0.00348392159367526,0.00703772880786294,-0.0172778700570866,0.0103100268697361,0.620583716448654
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,-0.00226971284299453,0.0045976779281964,-0.0112811615822595,0.00674173589627041,0.621550985527656
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,39931,-0.00164909189686219,0.00335489003772615,-0.00822467637080544,0.00492649257708107,0.62304511693702
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,37169,0.00362844872636614,0.00743930129382499,-0.0109525818095308,0.0182094792622631,0.625741676779354
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,0.00204027482604612,0.00419311334706315,-0.00617822733419766,0.0102587769862899,0.626565826371409
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39477,-0.00167197393961999,0.00343718465267906,-0.00840885585887094,0.00506490797963096,0.626664157856371
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,36991,-0.00204220465681209,0.00426866513699978,-0.0104087883253317,0.00632437901170749,0.632360953350076
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,39438,-0.00207186727934946,0.00434265522909506,-0.0105834715283758,0.00643973696967685,0.633299826034395
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.00133158354538333,0.00279841986629551,-0.00681648648332253,0.00415331939255587,0.634199055419613
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,37056,0.00300152244109931,0.00631987184635469,-0.00938542637775588,0.0153884712599545,0.634841828466765
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,37411,0.00212725414544953,0.00448262264915503,-0.00665868624689432,0.0109131945377934,0.635111332574384
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,0.0023979727273439,0.00506684195958447,-0.00753303751344166,0.0123289829681295,0.636030040249482
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,37021,0.00222408324212561,0.00470898001671545,-0.00700551759063667,0.0114536840748879,0.636715654667137
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,36931,-0.00166456188076614,0.00353287469772786,-0.00858899628831275,0.00525987252678046,0.63753178970703
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,37039,-0.00106565086974774,0.00226601440650761,-0.00550703910650265,0.00337573736700717,0.638166040544154
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,36991,-0.00302584386653803,0.00644101979480995,-0.0156502426643655,0.00959855493128948,0.638522048453685
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,37021,0.00276259703668889,0.00591897150935857,-0.00883858712165391,0.0143637811950317,0.64069650180107
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37437,0.00135909233116033,0.00291982708910852,-0.00436376876349237,0.00708195342581303,0.641602279702638
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,39415,-0.00140292995727276,0.00302085067442645,-0.00732379727914859,0.00451793736460308,0.642356567724436
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,39489,-0.00258355862553773,0.00557321114228482,-0.013507052464416,0.00833993521334051,0.642964218855137
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40052,0.00104430413936772,0.00226008898901328,-0.00338547027909831,0.00547407855783375,0.644042147337953
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00362807721136537,0.00785396052812982,-0.0190218398464998,0.0117656854237691,0.644130192671316
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,37380,-0.00213641198079649,0.00467700971953616,-0.0113033510310874,0.00703052706949438,0.647829223396321
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,36991,0.00216529456626266,0.00475277938926682,-0.00715015303670032,0.0114807421692256,0.648696030222528
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,0.00215740091707744,0.0047407411937211,-0.00713445182261592,0.0114492536567708,0.64906155756392
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37382,0.00661297625537879,0.0145867227632489,-0.021977000360589,0.0352029528713466,0.650299789443579
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37039,-0.00464740391168368,0.0103626940892174,-0.0249582843265498,0.0156634765031824,0.653818168223641
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,37437,0.00192615511074566,0.00429495102053521,-0.00649194888950335,0.0103442591109947,0.653821453657023
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36991,-0.00216823082539132,0.00486755071027604,-0.0117086302175324,0.00737216856674971,0.656004844056174
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,-0.00232286272160039,0.0052209969903148,-0.0125560168226174,0.00791029137941662,0.656393560361133
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,40058,0.00177169304094564,0.00400668258258775,-0.00608140482092634,0.00962479090281763,0.658361585809122
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37445,-0.00111405406313447,0.00253607356921103,-0.00608475825878809,0.00385665013251915,0.660463461149731
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,37380,0.00138951783865971,0.00316783916487473,-0.00481944692449477,0.00759848260181419,0.660934709477857
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,37056,-0.0020445016451772,0.00466479536046617,-0.0111875005516909,0.00709849726133651,0.661188144991898
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,39856,-0.00171507396264778,0.00393128131623771,-0.0094203853424737,0.00599023741717814,0.662651556325672
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,39766,-0.00227635684596038,0.00524761751314123,-0.0125616871717172,0.00800897347979643,0.664447817362153
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39585,-0.00210879093574478,0.00488472801970023,-0.0116828578543572,0.00746527598286767,0.665957372840152
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37043,0.00177487031103545,0.00413850233897296,-0.00633659427335154,0.00988633489542245,0.668026456706342
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,39489,0.00224115892868174,0.00525723846296064,-0.00806302845872111,0.0125453463160846,0.669895382295083
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.000868783814111765,0.00204920537590858,-0.00314765872266905,0.00488522635089258,0.671599748593569
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,-0.00198048040289796,0.00470570987884466,-0.0112036717654335,0.00724271095963758,0.673857622061394
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,0.00236271574593734,0.00562941483576787,-0.00867093733216768,0.0133963688240424,0.674704958341521
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,39858,0.00791281595707515,0.0188780450755663,-0.0290881523910347,0.044913784305185,0.675108911585405
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,0.00197952995626735,0.00472978382445185,-0.00729084633965828,0.011249906252193,0.675570567531918
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37169,-0.00192751368868587,0.0046253944691066,-0.0109932868481348,0.00713825947076307,0.67688689112293
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,0.00209716241323462,0.00503598746754191,-0.00777337302314751,0.0119676978496168,0.677098353412962
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.0012353957650726,0.00298120249185853,-0.00707855264911533,0.00460776111897013,0.678591321318179
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,39585,-0.0011260839101294,0.002722688901997,-0.00646255415804352,0.00421038633778472,0.679178153074079
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,-0.00153119452820591,0.00376516103723226,-0.00891091016118113,0.00584852110476932,0.684252694192408
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37039,0.00147671147789551,0.00364105342500802,-0.0056597532351202,0.00861317619091123,0.68506325387026
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEB,Nebulin,37021,-0.00151216861418715,0.00376214811266855,-0.00888597891501751,0.00586164168664322,0.687732597649696
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,40009,-0.00513768650506836,0.0128752707415599,-0.0303732171585258,0.0200978441483891,0.689872528804187
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,39830,0.00314553022565042,0.0078840988954641,-0.0123073036094592,0.0185983640607601,0.689919588895763
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,37056,0.00103722662035573,0.00260990140768991,-0.00407818013871649,0.00615263337942795,0.691064309605342
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,37056,0.00185797523061657,0.00468670362418469,-0.00732796387278543,0.0110439143340186,0.69179026481151
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,36991,-0.00185302797891996,0.00469355137537347,-0.011052388674652,0.00734633271681204,0.692994722175692
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,40052,0.00160989058696762,0.00408424226462435,-0.0063952242516961,0.00961500542563133,0.693459853825497
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,37437,0.00309829170928861,0.00786501530342531,-0.012317138285425,0.0185137217040022,0.693636444884736
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,0.0011693002021675,0.00297183160352996,-0.00465548974075121,0.00699409014508622,0.693984228066202
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36991,0.00299117621677039,0.0076971605071383,-0.0120952583772207,0.0180776108107615,0.697572634314428
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39908,-0.00102211905747748,0.0026647458982384,-0.00624502101802474,0.00420078290306979,0.701301571925067
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37039,-0.00245587666504441,0.0064580334609043,-0.0151136222484168,0.010201868918328,0.703741904084646
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,39913,-0.000822108913985614,0.00216206096711199,-0.00505974840952512,0.00341553058155389,0.703769947917831
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37368,0.00216668340084165,0.00573154683425589,-0.00906714839429989,0.0134005151959832,0.705415965171803
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36962,0.00139607423355583,0.00371532199102339,-0.00588595686885002,0.00867810533596167,0.707100441945037
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36962,-0.00197546147176641,0.00529148313985469,-0.0123467684258816,0.00839584548234877,0.708910006067144
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,37002,-0.00311025545200384,0.00833358657761575,-0.0194440851441307,0.013223574240123,0.708991243334227
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,36962,0.00341124305542902,0.00922475009584464,-0.0146692671324265,0.0214917532432845,0.711543108458635
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,-0.00336358839417842,0.00909901630591138,-0.0211976603537647,0.0144704835654079,0.711638001636747
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37169,0.00238895399138347,0.00657855133187608,-0.0105050066190937,0.0152829146018606,0.716503931183868
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,-0.00198006900350289,0.00548521053701129,-0.012731081656045,0.00877094364903923,0.718117792556739
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,0.0009460332797129,0.00262504475597175,-0.00419905444199172,0.00609112100141752,0.718563193154294
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,-0.00278482287374877,0.0078007290533459,-0.0180742518183067,0.0125046060708092,0.721101108864023
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,40009,-0.00103710859936307,0.00291291049642267,-0.00674641317235151,0.00467219597362537,0.721816302740464
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,37043,0.00223095877201389,0.00628404758371964,-0.0100857744920766,0.0145476920361044,0.722580740596879
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,37039,-0.00266637399539246,0.007513174435689,-0.0173921958893429,0.012059447898558,0.722675333865407
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,37021,0.00216756566542327,0.00610888257818042,-0.00980584418781035,0.0141409755186569,0.722728664087873
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,39788,-0.00112474482525329,0.00318414664871086,-0.00736567225672659,0.00511618260622,0.723918644258391
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,37021,-0.00172098581951621,0.00488652827672867,-0.0112985812419044,0.00785660960287198,0.724701503203523
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,37021,-0.00179023176751893,0.00516705246762929,-0.0119176546040723,0.00833719106903449,0.72899461439657
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,0.00135538133591582,0.00395192049903066,-0.00639038284218427,0.00910114551401591,0.731628018443936
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39477,0.00106996403604862,0.00313351290722953,-0.00507172126212125,0.0072116493342185,0.732763175288693
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,-0.00175262439158007,0.00518563272445325,-0.0119164645315084,0.00841121574834829,0.735385940007951
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37411,0.00113059359731088,0.00335377601627957,-0.00544280739459709,0.00770399458921884,0.736038713707401
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,39585,-0.00239047675132396,0.00710003920393746,-0.0163065535910414,0.0115256000883935,0.736358859536841
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,39587,0.00162273631896573,0.00486532496287883,-0.00791330060827677,0.0111587732462082,0.738737998758359
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,-0.00182119237133343,0.00549433180842463,-0.0125900827158457,0.00894769797317884,0.740295841550721
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,-0.00134526974052992,0.00409426524623975,-0.00937002962315982,0.00667949014209999,0.742482806689144
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,37021,-0.00110144040477787,0.00336126329345867,-0.00768951645995686,0.00548663565040111,0.743153968855109
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,37351,0.00163502141492203,0.0050379649279881,-0.00823938984393465,0.0115094326737787,0.74553423405348
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37056,-0.00145770633295424,0.00456948875222043,-0.0104139042873063,0.0074984916213978,0.749725020157081
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRL,Prolactin,40009,-0.00240968582472118,0.00756609260248285,-0.0172392273255876,0.0124198556761452,0.750121307721178
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,37100,-0.00180560251627154,0.00568802907399445,-0.0129541395013007,0.00934293446875759,0.750915490158655
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36991,-0.00369708371618305,0.0116830218113512,-0.0265958064664314,0.0192016390340653,0.751666555450945
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37411,0.0024403397354541,0.00774029996729312,-0.0127306482004404,0.0176113276713486,0.752556085282639
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37039,-0.00128044253211417,0.00406200566074404,-0.00924197362717249,0.00668108856294415,0.752596414615727
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37403,0.000710464102982358,0.00225475857100503,-0.0037088626961875,0.00512979090215222,0.752694059086003
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.00154390919549098,0.00492723859709107,-0.00811347845480752,0.0112012968457895,0.754026067800218
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,-0.00196802600125946,0.00633959864982929,-0.0143936393549249,0.0104575873524059,0.756235918997121
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,37161,0.00301327436386094,0.0097989205527334,-0.0161926099194965,0.0222191586472184,0.758459382233145
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37368,-0.00115872327463966,0.00376862466057345,-0.00854522760936362,0.0062277810600843,0.758493574934333
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,-0.00170512221932051,0.00555097521953397,-0.0125850336496071,0.00917478921096606,0.758714833968008
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,39546,-0.00219965263178988,0.00720639059428203,-0.0163241781965827,0.0119248729330029,0.7601901707265
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,37445,-0.00188435034808447,0.00620108976427325,-0.01403848628606,0.0102697855898911,0.761228491800861
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37021,0.00171165934347904,0.00564043400792921,-0.00934359131206221,0.0127669099990203,0.761542334740905
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,36962,-0.00347121734949219,0.0115615749827591,-0.0261319043157,0.0191894696167156,0.764000833458569
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VIT,Vitrin,37437,-0.00110165895549495,0.00368132803646204,-0.00831706190696055,0.00611374399597065,0.764749417964671
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37039,-0.00127762852879359,0.00428699151728444,-0.00968013190267109,0.00712487484508392,0.765689158007301
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,-0.00182147559359631,0.00612183496103806,-0.0138202721172309,0.0101773209300383,0.766060742790532
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,39123,-0.000831762201632969,0.00280422308415128,-0.00632803944656947,0.00466451504330353,0.766767877617844
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.0014313079226204,0.00484239787115706,-0.0109224077500882,0.00805979190484743,0.767556773961926
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,-0.00170888235404958,0.00578566250498747,-0.013048780863825,0.00963101615572585,0.767719717614659
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,39405,0.00198471569759242,0.00672570275817034,-0.0111976617084214,0.0151670931036063,0.767925881344245
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFP,Properdin,37453,-0.000681152204411415,0.00231621323507975,-0.00522093014516773,0.0038586257363449,0.768701192104332
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,-0.00114133577944009,0.00388137680577813,-0.00874883431876523,0.00646616275988504,0.768720268838365
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NENF,Neudesin,37368,-0.00320926874895706,0.010979624431265,-0.0247293326342365,0.0183107951363224,0.770067003052303
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,39587,-0.00112137264730929,0.00390683076638846,-0.00877876094943068,0.00653601565481209,0.774094108440802
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,0.00145551210781405,0.0050777428516126,-0.00849686388134664,0.0114078880969747,0.77438824973659
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36991,-0.00243820844188148,0.00855181837298447,-0.019199772452931,0.0143233555691681,0.775564409834166
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,-0.00204568122527128,0.00723898957287008,-0.0162341007880966,0.0121427383375541,0.777493995258572
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,0.000998434003480093,0.00354634388050087,-0.00595240000230162,0.0079492680092618,0.778300645177264
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37056,0.00307097800767386,0.0109617044162871,-0.0184139626482488,0.0245559186635965,0.779362861462461
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,36991,-0.0010592072874362,0.00380103531559386,-0.00850923650600016,0.00639082193112777,0.780507972431993
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,39477,-0.00279326893674329,0.0101446607105122,-0.0226768039293473,0.0170902660558607,0.783055796954699
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00149428023695328,0.0054592765830182,-0.00920590186576238,0.0121944623396689,0.784308039786889
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37388,-0.00105339611951145,0.00385311829979745,-0.00860550798711445,0.00649871574809155,0.784559186783242
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00179131804687846,0.00656846340296961,-0.0146655063166989,0.011082870222942,0.785076586987058
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,40030,-0.00117687286345921,0.00432050339463245,-0.00964505951693881,0.00729131379002038,0.785323691562958
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,37169,-0.00158698944189509,0.00589804751770331,-0.0131471625765936,0.00997318369280339,0.787879752435753
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,36962,0.00177911399560314,0.00665017379696978,-0.0112552266464576,0.0148134546376639,0.789066140390797
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,39585,0.00141818469494045,0.00535049349834273,-0.0090687825618113,0.0119051519516922,0.790969178775304
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,36962,0.00115635800665898,0.00456845877494206,-0.00779782119222747,0.0101105372055454,0.800181193958564
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,-0.00123118408709263,0.00488500128156783,-0.0108057865989656,0.00834341842478032,0.80101898608563
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37161,-0.00248023529646644,0.00991437091845852,-0.0219124022966452,0.0169519317037123,0.802463092140014
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,36991,0.00121849954000233,0.00487509251746184,-0.00833668179422288,0.0107736808742275,0.802634658396431
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,36962,-0.00197313895481753,0.00796078601518543,-0.017576279544581,0.0136300016349459,0.804248700280182
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.00227030352680761,0.00925823297242222,-0.0204164401527552,0.0158758330991399,0.806289265026866
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,-0.00219692301774602,0.00899008339653588,-0.0198174864749563,0.0154236404394643,0.806946666039268
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,37056,-0.000713243423526868,0.00292549810772253,-0.00644721971466302,0.00502073286760928,0.807387661110203
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,0.0018643194967473,0.00766889143158946,-0.013166707709168,0.0168953467026626,0.807930411374337
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36962,-0.000964253773336832,0.00397203637761823,-0.00874944507346856,0.0068209375267949,0.808194690687587
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,37021,0.00101678545136014,0.00419771777464857,-0.00721074138695106,0.00924431228967135,0.808610842193147
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,0.00220333002109827,0.00914142197089777,-0.0157138570418614,0.0201205170840579,0.809537918774496
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39587,0.0010931618234668,0.00454934529478506,-0.00782355495431192,0.0100098786012455,0.81010863958827
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,-0.00137791387542984,0.00589542135417032,-0.0129329397296037,0.010177111978744,0.81520126300357
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,37382,0.00140149847407452,0.00614625073610583,-0.0106451529686929,0.0134481499168419,0.819630297309355
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,37169,-0.00195569313738201,0.00878885588501651,-0.0191818506720144,0.0152704643972504,0.823912792589418
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,37169,-0.000981973987861423,0.00449065368909918,-0.00978365521849581,0.00781970724277297,0.826909996553129
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,0.000655467952117566,0.00301092950060877,-0.00524595386907563,0.00655688977331076,0.82766919650491
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,37039,0.000994331259028104,0.00462339317108171,-0.00806751935629206,0.0100561818743483,0.829719765654388
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.00191303902721117,0.00894564836103576,-0.0156204317604189,0.0194465098148413,0.830665692155814
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,-0.000749757746683601,0.00352614324411011,-0.00766099850513941,0.00616148301177221,0.831620205902823
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.00267574485104846,0.0126799651760681,-0.0221769868940451,0.027528476596142,0.832873273713695
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37224,-0.000284128742075882,0.00134964789338951,-0.00292943861311932,0.00236118112896755,0.833264551561296
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37169,-0.00153523999729116,0.00732302646546463,-0.0158883718696018,0.0128178918750195,0.833947525469021
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,39489,0.00104443270025583,0.00502760893382128,-0.00880968081003388,0.0108985462105455,0.835435121887404
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,37039,-0.00139038298743047,0.00674118634904922,-0.0146031082315669,0.011822342256706,0.83659727760062
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,37382,-0.00236387958323362,0.0114798493336416,-0.0248643842771713,0.020136625110704,0.836859972141413
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,-0.00100391474993088,0.00489202240983393,-0.0105922786732054,0.00858444917334362,0.837407083208265
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,36962,-0.00164260188080925,0.00804336790864168,-0.0174076029817469,0.0141223992201284,0.838186184290198
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.00158605426844425,0.00780987913655318,-0.0137213088392,0.0168934173760885,0.83907272805733
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,36962,-0.00100991257990424,0.00501110739244534,-0.0108316830690971,0.00881185790928862,0.840283541423101
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,37437,-0.00172949630561569,0.00864326170694009,-0.0186702892512183,0.0152112966399869,0.841407212659121
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,0.000723820715290156,0.00364039621022333,-0.00641135585674757,0.00785899728732788,0.842398561965118
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,0.000642354205598766,0.00328970426664933,-0.00580546615703391,0.00709017456823144,0.845190860124522
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37039,0.000731364922920369,0.00375590723647294,-0.00663021326056659,0.00809294310640733,0.845612098367054
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,-0.00129695004575191,0.00681208961496549,-0.0146486456910843,0.0120547455995804,0.849006862131541
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.00102233788672279,0.00544199468722307,-0.01168864747368,0.00964397170023443,0.850988581662006
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36962,0.00117723034991673,0.00636436125148751,-0.0112969177029988,0.0136513784028322,0.853253648337119
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,-0.000533040492839933,0.00297346517858011,-0.00636103224285696,0.00529495125717709,0.857731783721843
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,39868,0.000797435606635823,0.00453080160795697,-0.00808293554495983,0.00967780675823147,0.860293650403624
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,37039,0.00105591248163427,0.00603574243809227,-0.0107741426970266,0.0128859676602951,0.861126902265639
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,40009,-0.000499930314356815,0.00287642904837968,-0.00613773124918098,0.00513787062046735,0.862022925084681
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,0.000436878336963855,0.00253646176815226,-0.00453458672861457,0.00540834340254228,0.863251998455193
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,39782,-0.000691326193253086,0.00411775020848901,-0.00876211660189154,0.00737946421538537,0.866672501637727
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,-0.00139262542882923,0.00841085072614604,-0.0178778928520755,0.015092641994417,0.868494072924183
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39805,-0.000552184584025088,0.00336069580144346,-0.00713914835485427,0.0060347791868041,0.869491849395299
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37437,0.000631635404428146,0.00392455470524253,-0.00706049181784722,0.00832376262670351,0.87213952591868
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,36991,-0.00152940681640949,0.00963056238970525,-0.0204053091002318,0.0173464954674128,0.873822877214303
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,36903,0.000544856019182912,0.00343143580675146,-0.00618075816204994,0.00727047020041577,0.873841762259418
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,39788,-0.000295426337855534,0.00188431484293786,-0.00398868343001373,0.00339783075430266,0.875418776856161
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37043,0.00398284375515982,0.0258767718738482,-0.0467356291175827,0.0547013166279023,0.877678490736462
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,0.000543783709968437,0.00361089841731977,-0.00653357718797832,0.00762114460791519,0.880297346174588
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,0.000938189946377524,0.00637174883330485,-0.0115504377669,0.013426817659655,0.882943164154147
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.00194413874407333,0.0134406570803648,-0.0282878266215884,0.0243995491334417,0.884992437589317
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37169,0.0012031172825854,0.00839895665181956,-0.015258837754981,0.0176650723201517,0.886098038457185
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,40018,-0.000291215274359508,0.00207728506991164,-0.00436269401138632,0.00378026346266731,0.888511361333587
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36962,-0.000835675264208853,0.00596174515304398,-0.0125206957641751,0.0108493452357573,0.888525517034976
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,40011,0.000425276454256996,0.0030730424808731,-0.00559788680825428,0.00644843971676827,0.889934412342819
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,0.000804368353055705,0.0058497408294252,-0.0106611236726177,0.0122698603787291,0.890633411383577
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,-0.000691330789014011,0.00509090038833887,-0.0106694955501582,0.00928683397213017,0.891983561809026
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,37169,-0.000372061806179547,0.00285777811514605,-0.0059733069118658,0.0052291832995067,0.896415949379294
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,0.000616527221191294,0.00490746559080513,-0.00900210533678676,0.0102351597791693,0.900026359364146
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37382,0.000312820694788849,0.00249745356811518,-0.0045821882987169,0.0052078296882946,0.900322857455098
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37338,0.000561251274771224,0.00448781568707525,-0.00823486747189626,0.00935737002143871,0.900477025208036
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,0.000476272304818833,0.00389652455063675,-0.0071609158144292,0.00811346042406686,0.902718697585569
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,-0.000597716582664476,0.00494106012061962,-0.0102821944190789,0.00908676125374997,0.903716906934646
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,37388,0.000305743408741289,0.00255239046800636,-0.00469694190855117,0.00530842872603375,0.904653593350707
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,36962,0.000621396196708278,0.0053127531175666,-0.00979159991372225,0.0110343923071388,0.906891069120914
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,-0.00066556524509594,0.0056987016997994,-0.0118350205767028,0.0105038900865109,0.907026003410797
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.000723805439269999,0.00646129892973613,-0.0133879513415528,0.0119403404630128,0.910807924740579
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,39788,-0.000311023058234527,0.00283094694016789,-0.00585967906096359,0.00523763294449453,0.912517524014456
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,0.000510897983996089,0.00489747497858607,-0.00908815297403262,0.0101099489420248,0.916918109670983
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,39858,-0.000280226880095343,0.00276435767359166,-0.00569836792033499,0.00513791416014431,0.919256888523567
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,37056,-0.000419773153246784,0.00436499799933233,-0.00897516923193814,0.00813562292544457,0.923388600964345
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,0.000775578125589031,0.00837270783519072,-0.0156349292313848,0.0171860854825628,0.926197536055318
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.000903928413037921,0.00975977129996488,-0.0200330801609691,0.0182252233348933,0.926208622729803
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,39858,-0.000321986387925575,0.00354132190802706,-0.00726297732765861,0.00661900455180746,0.927555187465956
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39585,0.000390585650292192,0.00430185210386462,-0.00804104447328247,0.00882221577386685,0.927656826333869
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,37056,0.000368670713468571,0.00407276276962008,-0.00761394431498679,0.00835128574192393,0.927874550545299
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,37043,-0.000631669717261838,0.00711520443317947,-0.0145774704062936,0.0133141309717699,0.92926012646413
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,0.000357663108349542,0.00408816973475119,-0.00765514957176278,0.00837047578846187,0.930285474365502
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,39964,-0.000286834086016265,0.00332790423454272,-0.00680952638571999,0.00623585821368746,0.931315968978256
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,37445,0.000219238080382194,0.00256704074245403,-0.00481216177482771,0.0052506379355921,0.931940687417554
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,36991,-0.000533177391387859,0.0075185631875508,-0.0152695612389874,0.0142032064562117,0.943466645691947
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,36991,0.000369390585451172,0.00532942837288268,-0.0100762890253989,0.0108150701963012,0.944742740812621
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36962,0.00043697573242062,0.00634885549933857,-0.012006781046283,0.0128807325111242,0.94512799345668
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,37368,0.000403770527473945,0.00595143951373818,-0.0112610509194529,0.0120685919744008,0.945910679163502
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,37411,-0.000255891444159334,0.0038223051505131,-0.007747609539165,0.00723582665084634,0.946624971218327
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,39587,-0.000400192409068946,0.00604300896772026,-0.0122444899858007,0.0114441051676628,0.94720030711378
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,37039,0.000430305959679249,0.00679402038397283,-0.0128859739929075,0.013746585912266,0.949499923494655
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,39868,-0.00023873672714354,0.00396744538268154,-0.00801492967719936,0.00753745622291228,0.952017870842309
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,39524,0.000280417456692471,0.00467719169662267,-0.00888687826868795,0.00944771318207289,0.952192847982891
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,39489,-0.000278004646533966,0.00472406780529533,-0.00953717754491281,0.00898116825184488,0.953073472611459
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,36991,-0.000416139188112466,0.00727810985291569,-0.0146812344998272,0.0138489561236023,0.954405211663511
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37437,0.000142601536455343,0.00255175519932983,-0.00485883865423113,0.00514404172714181,0.955435273855192
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,-0.000391385294257151,0.00703490304623201,-0.0141797952648719,0.0133970246763576,0.955633598825559
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39585,-0.000301675537687795,0.00567405525968074,-0.011422823846662,0.0108194727712864,0.957599096852289
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36430,-0.000267495498829861,0.00517756291762138,-0.0104155188173678,0.00988052781970805,0.958796953086722
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,-0.000260506891499712,0.00546227670206567,-0.0109665692275484,0.010445555444549,0.961962321076077
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,-0.000137271962537382,0.00343000900728885,-0.00686008961682354,0.00658554569174877,0.96807697682228
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36962,0.000206777579146938,0.00558761585816567,-0.0107449495028578,0.0111585046611517,0.97048046204179
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40052,0.000197247580719841,0.00585907612004734,-0.0112865416145729,0.0116810367760126,0.973144461366339
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39489,-0.000161073044367285,0.00523856760223312,-0.0104286655447442,0.0101065194560096,0.975471273668796
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36962,-9.65174905117335e-05,0.00322001758754256,-0.00640775196209516,0.00621471698107169,0.976088076138912
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39489,0.000101427817895464,0.00395394258659389,-0.00764829965182856,0.00785115528761949,0.979534978447838
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,39587,-0.000305675861635123,0.0144010428852635,-0.0285317199167516,0.0279203681934814,0.983065680596683
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,39587,-8.37848029076129e-05,0.00518100052768841,-0.0102385458371769,0.0100709762313617,0.987097738392346
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,37169,-9.26671647854659e-05,0.0059351706167011,-0.0117256015735196,0.0115402672439487,0.987543187561603
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.00025709939945574,0.0186540241342756,-0.0363047879037245,0.036818986702636,0.98900366332647
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39868,3.13852818787392e-05,0.00276453329503974,-0.00538709997639914,0.00544987054015662,0.990942086727371
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37348,-4.62833889833547e-05,0.00410217862391696,-0.00808655349186059,0.00799398671389388,0.990998116638373
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37039,3.53683589572603e-05,0.00392453287901763,-0.00765671608391729,0.00772745280183181,0.992809602799345
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,37056,-2.25829877882775e-05,0.00334069926001541,-0.00657035353741847,0.00652518756184192,0.994606476881334
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,36991,9.07623169069061e-07,0.00776105229243305,-0.0152107548699997,0.0152125701163378,0.99990669245648
